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Overview 
In 1959 Sones developed selective coronary cineangio-
graphy. To date, this technique has remained the only means 
available for the visualization of the coronary arterial 
system with such image contrast and resolution, that the 
presence and severity of coronary stenosis can be determined 
with sufficient accuracy. Consequently, coronary cineangio-
graphy has become the most important tool for clinical 
decision making, used by the physician caring for patients 
with coronary artery disease. However, of prime concern has 
been the relationship between the angiographic severity of the 
stenosis and the resulting reduction or limitation in coronary 
blood flow. 
The concept of coronary flow reserve has been developed 
as a means to describe the functional capacity of a coronary 
artery. Several techniques are currently under development to 
make the assessment of coronary flow reserve possible in awake 
humans. This thesis describes a radiographic technique to 
measure coronary flow reserve, that can be applied during 
routine diagnostic or interventional cardiac catheterization. 
Several methodological aspects on which no previous data 
existed, such as the role of pharmacological coronary 
vasodilation, radiographic data acquisition and digital data 
processing as well as application of this technique in several 
clinical conditions have been studied. 
In chapter 1 the anatomy and function of the coronary 
vasculature are described briefly. The concept of coronary 
flow reserve as a measure of the functional capacity of a 
coronary artery is outlined. The various methods of measuring 
coronary blood flow parameters are discussed with emphasis on 
radiographic techniques. An essential part of all methods that 
measure coronary flow reserve is the induction of a maximal 
coronary hyperemia by pharmacologic means. The value and limi-
tations of the intracoronary administration of papaverine and 
adenosine for the assessment of flow reserve are described in 
chapters 2 and 3, and in chapter 4, respectively. 
In chapter 5 the methodology of the radiographic assess-
ment of coronary flow reserve is described in detail and a 
first attempt is made to relate coronary flow reserve to quan-
titatively determined coronary artery dimensions. Myocardial 
imaging with thallium-201 during exercise has been shown to be 
a useful non-invasive method to investigate the physiologic 
significance of a coronary stenosis. In chapter 6 the results 
of this technique are compared in 38 patients to measured 
coronary flow reserve and coronary artery dimensions. In chap-
ter 7 the relationships between quantitatively determined 
coronary artery dimensions and coronary flow reserve are des-
cribed in 81 patients. An attempt is made to relate these in-
vasive measurements to "bed-side" cardiology that is angina 
pectoris and non-invasive evidence of myocardial ischemia. 
Since the introduction of percutaneous transluminal coro-
nary angioplasty in 1977, this procedure has gained increasing 
importance in the treatment of coronary artery obstructions. 
Successful coronary angioplasty, defined as a residual 
percentage diameter stenosis of less than 50% results in 
marked improvement in the clinical condition of the patient, 
but doubt has remained whether this procedure can restore the 
coronary flow reserve of atherosclerotic coronary arteries to 
normal. In chapter 8, a comparison between the radiographical-
ly assessed coronary flow reserve and intracoronary blood flow 
velocity measurements with a Doppler catheter is made in the 
setting of coronary angioplasty. It is shown that coronary 
flow reserve as measured by these two techniques is not 
restored to normal immediately following angioplasty. 
Nevertheless, 3 to 5 months after angioplasty coronary flow 
reserve can be normalized in selected patients as is described 
in chapter 9. In chapter 10 two issues are addressed. First, 
the intra- and interobserver variability, as well as the 
short-, medium-, and long-term variability of the radiographic 
assessment of coronary flow reserve are characterized. Second, 
the immediate and long-term functional results of coronary 
angioplasty in 25 patients are described in detail. 
This thesis describes the implementation and validation 
of a radiographic technique that uses selective coronary cine-
angiography as a means to measure coronary flow reserve during 
routine cardiac catheterization. With the development of digi-
tal catheterization equipment this technique may become a val-
uable and practical addition to the angiographic delineation 
of coronary artery dimensions. 
CHAPTER 1: INTRODUCTION 
1. Anatomy and function of the coronary vasculature 
A. Epicardial coronary arteries. 
The epicardial coronary arteries originate from ostia in 
the left and right sinuses of Valsalva. In adult humans, the 
main left coronary artery is 3,5 to 5,5 mm in diameter (1). It 
gives rise to two major branches: the left anterior descending 
artery and the circumflex coronary artery. The diameter of the 
right coronary artery is 2.5 to 5.0 mm at its origin (1). Like 
all vessel's, epicardial coronary arteries act as conduits, 
semi-permeable membranes and metabolic units (2). Under normal 
circumstances they contribute little to the total coronary 
resistance. However, when coronary flow is increased due to a 
reduction in the resistance of small vessels, atherosclerotic 
epicardial arteries may become the dominant contribution to 
the coronary resistance (see figure 1A). The coronary resis-
tance can then be decreased by dilation of the epicardial 
artery in response to nitroglycerine or papaverine (3,4). When 
the left ventricle contracts, blood in the intramural coronary 
arteries is forced retrograde into the epicardial vessels. As 
blood flow in the proximal coronary arteries is antegrade 
throughout systole, the retrograde flow must be masked by 
dilation of the epicardial vessels which act as a functional 
capacitance by storing blood and energy during systole (5,6). 
B. Intramural coronary vessels. 
Intramural coronary vessels penetrate perpendicularly 
into the myocardium from the epicardial coronary arteries. 
These arteries and arterioles form a dense vascular network in 
the wall of the ventricles, and play a dominant role in the 
regulation of coronary vascular resistance (2). Compressive 
forces are greater in the subendocardium than in the subepi-
cardium resulting in a lower perfusion pressure in the sub-
endocardial intramural vessels. This is partly compensated for 
by a greater vascular volume and a lower vascular resistance 
in the subendocardial myocardium (7). 
C. Capillaries. 
Capillary density in left and right ventricles is 2 to 5 
x 103 capillaries/mm2 and the average capillary diameter is 5 
micrometer. The ratio of number of capillaries/musclefiber in 
adult humans is normally 1:1 (8,9). The capillaries act prima-
rily as semipermeable membranes. Oxygen, electrolytes and nut-
rients leave and simultaneously co2 and metabolites enter the 
vascular space (2). 
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D. Coronary veins 
The heart has three venous systems (10). The largest one 
drains primarily the left ventricle and consists of epicardial 
veins that converge into the coronary sinus. The second system 
of anterior superficial veins drains mainly the right ventric-
le. The third system, the Thebesian veins, composed of small 
venules which enter directly into all four chambers, is quan-
titatively significant with respect to drainage of the atria, 
but not of the ventricles. During systole, some venous blood 
is forced into the coronary sinus and some is stored in the 
venous system, the~eby contributing to the capacitance of the 
coronary vasculature. Venous tone does not contribute signifi-
cantly to the total coronary vascular resistance (11). 
2. Regulation of coronary blood flow. 
Coronary blood flow and myocardial oxygen consumption are 
closely coupled (12, 13). Schwartz et al (14) have shown that 
if the oxygen requirements of the left ventricle are increas-
ed, that within one cardiac cycle vascular resistance decreas-
es and coronary flow rises. Thus, the close coupling between 
myocardial oxygen consumption and coronary blood flow is ad-
justed on a beat to beat basis. This relationship is the 
dominant feature of the coronary blood flow regulation (15). 
The three major determinants of myocardial oxygen consumption 
are heart rate, myocardial contractility and wall stress; 
shortening, activation and basal metabolic requirements are 
only of minor importance (16). The primary mechanism for 
increasing oxygen delivery to the ~yocardium is coronary 
dilation resulting in increased coronary blood flow (15). In 
normal circumstances coronary blood flow can increase about 
fivefold (17, 18) • During maximal coronary dilation a linear 
relationship exists between coronary driving pressure and 
coronary flow (19). When normal coronary vasomotor tone is 
present, coronary flow remains relatively constant over a wide 
range of perfusion pressures (20). This is called autoregula-
tion. Drugs which cause maximal relaxation of smooth muscle, 
such as adenosine, dipyridamole or papaverine abolish autore-
gulation. 
3. The concept of coronary flow reserve. 
The concept of coronary flow reserve as a functional 
measure of stenosis severity was initially proposed by Gould 
et al (21). Two methodological approaches have been developed 
to assess the coronary flow reserve of individual coronary 
arteries in the clinical setting, and the definition of coro-
nary flow reserve is therefore method-dependant. The first 
approach uses quantitative coronary angiography to determine 
the pressure flow characteristics of coronary stenoses (22) 
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Figure IA 
Schematic of a stenotic coronary artery and distal bed. Pao = aortic pressure, Q = 
coronary flow, Pc = distal coronary perfussion pressure, Pv = effective coronary back 
pressure. When coronary flow is increased by reduction of the resistance of the small 
vessels, the atherosclerotic epicardial artery becomes the dominant contribution to the 
total coronary resistance. 
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(see figure lB). Young et al (23-26) developed fluid dynamic 
equations that describe the relationship between the pressure 
distal to a stenosis and the flow. When coronary flow 
increases the coronary perfusion pressure distal to the 
stenosis decreases in a nonlinear fashion, according to the 
equation: 
Pc = Pao - f Q - s Q2 , 
where Pc = pressure distal to the stenosis, Pao = aortic pres-
sure, f = coefficient of viscous friction, s = coefficient of 
exit separation and Q = flow (23-26). Viscous friction is 
mainly dependent on the absolute cross-sectional area of the 
artery at the site of the stenosis and on the length of the 
stenotic lesion. Exit separation is mainly dependent on the 
cross-sectional area at the site of obstruction and on the 
normal area distal to the stenosis. From the relationship 
between coronary perfusion pressure and coronary flow under 
conditions of maximal coronary vasodilation as described by 
Bache and Schwartz (27), and assuming a resting coronary blood 
velocity of 15 cm/s, Kirkeeide et al (28) calculated a 
coronary flow reserve from the quantitative angiographic data. 
This X-ray predicted flow reserve is schematically shown in 
figure 2A. The relationship between pressure and flow during 
maximal coronary vasodilation is represented by the dashed 
line. The dotted line is the relationship between distal 
coronary pressure and coronary blood flow. The intersection of 
these curves is the coronary flow reserve according to 
Kirkeeide et al. The major advantage of this approach is that 
it integrates multiple angiographically defined anatomical 
characteristics of a coronary stenosis into a single 
parameter. However, the effect of a coronary stenosis on blood 
flow is a response of an anatomic hemodynamic system in which 
the stenosis is but one component (28). Therefore, several 
important factors such as the prevailing perfusion pressure, 
hypertrophy, collaterals or previous myocardial infarction are 
not taken into consideration. 
The second approach uses the ratio of maximal to resting 
coronary blood flow as a measure of coronary flow reserve. 
Temporary occlusion of a coronary artery or potent coronary 
vasodilation can produce maximal coronary vasodilatation. This 
results in a hyperemic response characterized by a marked 
increase in flow which gradually subsides ( 17, 29) • Figure 2B 
is a schematical representation of the approach that is based 
on the measurement of the ratio of maximal to resting coronary 
blood flow as a measure of flow reserve, in a format as 
proposed by Hoffman and Klocke (30,31). Several important 
complexities of both approaches of coronary flow reserve 
should be taken into consideration, and some of these are 
illustrated in figure 2C (30,31). At a constant level of 
myocardial metabolic demand, coronary flow is maintained 
constant over a wide range of coronary pressure. This is 
called autoregulation. When maximal coronary vasodilation is 
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Figure 2 
P = coronary perfusion pressure, CFR = coronary flow reserve. The dotted lines 
represent the calculated distal coronary perfussion pressure as a function of coronary 
blood flow. The dashed lines describe the relationship between coronary blood flow 
and perfussion pressure during maximal coronary vasodilation. 
In fig 2A the theory of the X -ray predicted CFR as developed by Kirkeeide et al ( 27) is 
shown schematically. The open circle represents a CFR of 3. 
Fig 2B is a schema tical representation of the approach that uses the measurement of 
the ratio of maximal to resting coronary blood flow as a measure of CFR, in a format as 
used by Hoffman and Klocke (30,31). At a constant level of metabolic demand, 
coronary flow is maintained constant over a wide range of perfussion pressure. This is 
called autoregulation ( sollid line) The open circle represents a CFR of 3. 
In fig 2C both approaches are combined to show the complexities of the concept of 
CFR. The open circle still represents a CFR of 3, but small changes in perfussion 
pressure (A), an increase in resting blood flow (B), or an altered pressure - flow 
relationship during maximal vasodilation can all result in a substantially lower CFR. 
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induced by a temporary occlusion of the artery or by 
pharmocological means, coronary blood flow rises about three 
fold in this example. However, aside from the presence of the 
coronary stenosis several other variables influence this ratio 
of resting and hyperemic coronary flow. These variables can be 
considered in terms of their effects on coronary pressure, 
resting coronary blood flow level, and the pressure flow 
relationship during maximal coronary vasodilation. Coronary 
perfusion pressure is linearly related to coronary blood flow 
during maximal vasodilation (19). Therefore, small changes in 
pressure result in significant changes in flow (A in figure 
2C), even in a normal coronary artery. Likewise small dynamic 
changes in stenosis geometry resulting in changes in distal 
coronary perfusion pressure can change coronary flow reserve 
substantially (4). The resting coronary blood flow level 
varies with metabolic demand (12). An increase in resting flow 
(B in figure 2C) results in a decrease of the measured flow 
reserve. The pressure flow relationship during maximal 
vasodilation varies substantially due to changes in hemodyna-
mic variables. For instance, left ventricular hypertrophy 
shifts this relationship to the right (C in figure 2C). 
Several other variables are also important in this regard such 
as heart rate, contractility, blood viscosity and left 
ventricular end-diastolic pressure (31). 
4. Methods of measuring coronary blood flow and flow reserve 
Several methods have been developed to measure coronary 
blood flow or flow reserve which are not applicable during 
cardiac catheterization but are useful in the animal labora-
tory and/or during cardiac surgery, and have contributed 
enormously to our understanding of coronary pathophysiology. 
Timed venous collection with a graduated cylinder and a stop-
watch is the oldest method of measuring coronary blood flow 
(32). It is a simple and accurate method of measuring coronary 
blood flow and is widely used in animal laboratories. The 
major limitation of this technique is that it can be employed 
only when the heart is either excised or exposed and this 
technique is therefore rarely used in humans (33). Electromag-
netic flow meters are based on the principle of Faraday's 
induction law. Perivascular or extracorporal electromagnetic 
flow probes can measure rapid changes in flow and are used in 
animal preparations and during cardiac surgery to assess 
bypass graft flow (34, 35) • The major limitation is that the 
coronary artery must be dissected prior to probe placement 
(36). The microsphere technique is based on the principle that 
when particles that do not recirculate because of capillary 
entrapment are injected, their distribution will be proportio-
nal to the blood flow, provided that certain criteria are met 
(37). This technique is the only method that allows accurate 
measurements of the transmural distribution of myocardial 
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perfusion, but is only applicable in the animal laboratory 
(38,39). 
Several applications of the three classical principles to 
measure blood flow in intact animals and man (indicatordilu-
tion, first-pass distribution and inert substance washout) 
have been adapted to the coronary circulation. The indicator-
dilution principle as introduced by Stewart (1897) and 
developed by Hamilton (1931) has been modified for 
measurements of coronary blood flow during cardiac 
catheterization. Ganz et al (40) developed a thermodilution 
method for measuring coronary sinus flow. However, several 
conditions must be met to obtain valid measurements. The 
injectate infusion rate must be adequate and sensitive 
thermistors and an insulated catheter system must be used. If 
multiple comparable measurements of flow are needed a stable 
position of the catheter in the cardiac venous system is 
mandatory. Flow from the anterior left ventricular wall can be 
measured separately if the catheter is placed in the great 
cardiac vein (40-42). The main advantages of the technique 
are that it is simple and relatively inexpensive and allows 
multiple measurements at short intervals with a frequency 
response sufficient to measure changes in flow occurring in 2 
to 3 s (40). The major disadvantage of the technique is that a 
stable catheter position can not always be obtained and that 
small changes in catheter position induce large changes in 
measured flow and thus pose a difficulty in relating measured 
flow to a specific myocardial region ( 43) • An other 
application of this principle was recently developed by Vogel 
et al (44). They measured absolute coronary blood flow with an 
angioplasty catheter and electrical impedance measurements 
induced by a 5% dextrose indicator bolus. 
The principle of first-pass distribution was introduced 
by Sapirstein (45). If a diffusible indicator is infused into 
the arterial circulation, the concentration of the substance 
in an organ will depend upon the arterial concentration of the 
indicator, the organ extraction ratio of the indicator and 
organ blood flow (45). Thallium-201 scintigraphy is a widely 
used clinical application of this principle. Relative coronary 
blood flow can be assessed following the same basic principles 
with tracers labeled with positron emitters (36). This is a 
very promising technique that permits accurate and repeated 
measurements of regional coronary flow in awake humans (46). 
However, the technique is expensive and the resolution is 
limited to about i-2 cm2 (36). 
The method of inert-substance washout was developed by 
Kety and Schmidt (47) for measuring cerebral blood flow. A 
modification of this technique can be used in the coronary 
circulation (48). A major advantage of this technique is that 
it can be used in humans to measure flow per gram of tissue in 
the left ventricle. Grines et al (49) developed an application 
of this method that measures absolute regional coronary blood 
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flow. Hydrogen saturated saline is infused into a coronary 
artery. The hydrogen is detected during washout in the pulmo-
nary artery by means of the voltage response of a platium-
tipped electrode and volume flow is calculated according to 
the Kety-Schmidt principle (47). This technique is potentially 
easily applicable during coronary angioplasty (50). The major 
disadvantages seem that subselective cannulation of the coro-
nary arteries is necessary and that volume flows above normal 
are substantially underestimated (49). 
Recently, Doppler methods have been developed that allow 
the assessment of coronary flow and/or flow reserve of 
individual coronary arteries. Ultrasonic flow meters measure 
phasic and mean coronary blood flow velocity using the Doppler 
effect. A piezoelectric crystal for the emission and detection 
of ultrasonic sound waves can be mounted in a suction cup, and 
placed on epicardial coronary vessels at the time of cardiac 
surgery (17). A piezoelectric crystal can also be mounted on 
the tip of an angiography catheter or on an angioplasty 
balloon catheter (51,52), to assess coronary blood flow 
velocity and vasodilatory reserve during diagnostic or 
interventional catheterization. Currently, ultrasonic probes 
provide the only available means of assessing phasic coronary 
blood flow velocity in the coronary arteries in awake humans. 
The principal disadvantages of the technique are that absolute 
flow cannot be determined without knowledge of the angle 
between blood column and crystal and the cross-sectional area 
of the coronary artery (36), and that the introduction of a 
Doppler catheter into a coronary artery is not without risk 
(51). 
Radiographic techniques 
Selective coronary angiography is the standard means for 
obtaining anatomic information and is the most important tool 
for clinical decision making used by the physician caring for 
patients with coronary artery disease. Several approaches have 
been developed to assess coronary blood flow with radiographic 
techniques during cardiac catheterization and coronary angio-
graphy (53). Rutishauser et al (54) measured the density of 
contrast medium at two sequential locations in a proximal 
coronary artery to measure the transit time. After determi-
nation of .the volume of the arterial segment between the two 
points, volume flow can be calculated. Spiller et al (55) 
reported good correlations between a similar approach using 
contrast wave-front transit time for diastolic and systolic 
coronary blood flow and data obtained by electromagnetic flow 
meters. The major limitation of this approach is that it can-
not be applied to branching and/or circuitous arterial seg-
ments which are often present in the coronary arterial system 
of humans, and that multiple radiographic projections must be 
used if the arterial segment cannot be positioned parallel to 
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Figure 3A 
Sequence of events following injection of radiographic contrast in a coronary artery 
during baseline (--) and already hyperemic ( --) coronary blood flow, as described 
by Hodgson et a1 (59) and Cusma et al (61). Q =volume flow, the arrow marks the 
timing of the contrast injections. 
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In the myocardial region of interest a baseline(-) and hyperemic (--)time-density 
curve can be generated with the use of digital subtraction of selected end-diastolic 
cineframes. Mter application of a fixed density threshold a myocardial contrast 
appearance time can be measured a baseline (Tl) and hyperemia (T2). The maximal 
contrast density is also measured at baseline (Dl) and hyperemia (D2). Coronary 
flow reserve (CFR) can then be calculated according to the equation: 
CFR= Q (--) = D2 Dr 2 
Q(-) 
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the plane of the image intensifier. An indicator dilution 
video densitometric method was developed by Foerster et al 
(56) and was recently validated by Nissen et al (57). However, 
subselective injection of contrast medium is necessary and 
streaming or reflux of the contrast medium must be prevented. 
The fundamental problem with all radiographic techniques 
is that contrast media cannot be used to measure coronary 
blood flow by the traditional methodological approaches (53). 
An essential prerequisite of indicator dilution (Stewart-
Hamilton), inert substance washout (Kety-Schmidt), or first-
pass distribution (Sapirstein) techniques is that the indica-
tor substance does not affect the flow being measured. Unfor-
tunately, radiographic contrast media have substantial vas-
cular effects (49), although nonionic media may disturb blood 
flow less than ionic agents (53). Hodgson et al (59) studied 
the effects of a bolus injection of contrast medium on base-
line and hyperemic coronary blood flow. They found that the 
ratio of baseline to hyperemic flow is approximately constant 
during the first five seconds after contrast injection. This 
is illustrated in figure 3A. Using ECG gated power injection 
of a contrast agent at a rate that is presumed to be sufficien-
tly rapid to achieve complete replacement of blood with con-
trast, a mask mode subtraction technique was developed that 
determines myocardial time-density curves before and during 
coronary vasodilation before the vascular effects of the 
contrast medium disturb the ratio between resting and hyper-
emic coronary blood flow. This approach has been validated in 
the animal laboratory by Hodgson et al (60) and Cusma et al 
(61), and is illustrated in figure 3B. The major advantage of 
this technique is that it can be performed during routine 
cardiac catheterization, without increasing the risk to the 
patient (18,53,62). Although at present coronary flow reserve 
can only be assessed in a two dimensional projection of the 
myocardium, developments towards three dimensional reconstruc-
tion from biplane angiographic views are in progress (63). 
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CHAPTER 2: PAPAVERINE: THE IDEAL CORONARY VASODILATOR FOR 
INVESTIGATING CORONARY FLOW RESERVE? A STUDY OF TIMING, 
MAGNITUDE, REPRODUCIBILITY AND SAFETY OF THE CORONARY 
HYPEREMIC RESPONSE AFTER INTRACORONARY PAPAVERINE. 
Sunnnary 
A potent, short-acting vasodilator that induces a maximal 
hyperemic response of the coronary vascular bed is needed to 
determine coronary flow reserve. In 12 patients, we measured 
coronary sinus blood flow by thermodilution over a period of 2 
min during which a bolus of 10 mg papaverine was given into 
the left main coronary artery. This was repeated after 5 min 
to assess the reproducibility of the changes. The maximal 
hyperemic response lasted from 24 till 37 sec after papaverine 
administration. There was no significant difference between 
the two consecutive hyperemic responses.(Student's t-test for 
paired observations). The mean difference between first and 
second hyperemic responses at 30 sec was 7.0% (SD ± 6.2%). 
In conclusion, 10 mg of intracoronary papaverine is a 
short-lasting and reproducible means of inducing a maximal 
hyperemic response in the coronary vascular bed and therefore 
appears to be the ideal agent for investigating coronary flow 
reserve. 
Introduction 
The concept of coronary flow reserve is essential in 
understanding the physiological significance of obstructive 
coronary artery disease (1,2). The recent development of 
methods such as digital subtraction cine angiography or 
subselective coronary artery blood flow velocity measurements 
using a Doppler catheter have made the assessment of regional 
coronary flow possible during routine cardiac catheterization 
(3,4). Coronary reactive hyperemia defined as the ratio of 
maximal coronary blood flow to resting flow can be used as a 
measurement of coronary flow reserve. In order to detect a 
limitation in coronary flow reserve due to an obstruction in a 
major epicardial coronary artery, measurements should be 
obtained when distal coronary resistance has been minimized by 
dilating this arteriolar bed pharmacologically (1). Since the 
advent of interventional catheterization, multiple assessment 
of coronary flow reserve is mandatory, for instance to evalu-
ate the effect of an intervention or to assess coronary flow 
reserve in different myocardial regions (3). Long-acting 
vasodilators, such as dipyridamol not only make multiple 
assessments of the hyperemic response impossible but may also 
give undesirable side effects such as a long-lasting endo-epi-
cardial redistribution of coronary blood flow with a concomi-
tant increase in oxygen consumption (5), thereby inducing 
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ischemia and angina pectoris. 
Therefore, a potent short-acting vasodilator that will 
induce a maximal hyperemic response is needed to facilitate an 
accurate and reproducible means of determinating coronary flow 
reserve. When digital subtraction cine-angiography is used to 
measure coronary flow reserve, angiograms during maximal 
hyperemia must be compared with baseline angiograms. Timing of 
the peak hyperemic effect is then of crucial importance. We 
studied reproducibility, timing and duration of the coronary 
hyperemic response after intracoronary papaverine by measuring 
coronary sinus blood flow with thermodilution. 
Patients and methods 
Twelve patients who underwent cardiac catheterization and 
coronary angiography for clinical indications, were studied 
after informed consent was obtained. The patients were studied 
without sedation, following overnight fasting. All medication 
was withheld on the day of the catheterization. A thermo-
dilution catheter (Webster laboratories) was introduced after 
percutaneous puncture of the femoral vein or after cutdown of 
a right antecubital vein and positioned in the coronary sinus. 
Catheter position was verified by contrast injection. Coronary 
sinus blood flow was measured according to the thermodilution 
technique by infusing saline 50 ml/min with a Medrad mark IV 
infusion pump. The temperature of the coronary sinus blood was 
measured at 25/sec from which flow was calculated (ml/min) and 
averaged for 5 sec intervals (see fig la and lb). In each 
patient a stable position of the catheter was assured by 
fluoroscopy and a stable baseline measurement was recorded. 
Thereafter the coronary catheter was inserted after percuta-
neous puncture of the femoral artery or after cutdown of the 
brachial artery. The tip was 'positioned into the ostium of the 
left main coronary artery under fluoroscopy. Coronary sinus 
blood flow was measured continuously over 2 min during which a 
bolus of 10 mg papaverine was given into the left main coro-
nary artery, to record the timing and magnitude of the coro-
nary hyperemic response. This was repeated after 5 min to 
assess reproducibility of the changes. Reproducibility was 
assessed by comparing for first and second injections of 
papaverine the ratio of coronary sinus blood flow 30 sec after 
intracoronary papaverine to baseline flow. 
The spontaneous variations of all 5 sec intervals of the 
baseline flows were used to calculate the standard deviation 
of the mean baseline flow expressed in percentage. This 
standard deviation was used to define the duration of the 
plateau phase of the maximal hyperemic response. Systemic 
arterial pressure and heart rate were recorded continuously. 
Thereafter, the diagnostic study was completed. 
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Figure 1 
Coronary sinus blood flow measurement with thermodilution. 
a. Stable baseline recording. 
b. Recording during a 10 mg bolus injection of papaverine into the left main coronary 
artery. 
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Table I: Patient characteristics. 
Pat age sex CAG LVEF 
1 55 m 0 44% 
2 64 m 0 59% 
3 60 m 1 64% 
4 57 f 0 66% 
5 63 m 2 65% 
6 67 m 2 50% 
7 59 m 1 67% 
8 62 f 1 76% 
9 48 m 3 66% 
10 61 m 3 65% 
ll 61 m 1 70% 
12 52 m 0 66% 
Abbreviations: CAG - coronary arteriogram, number of vessels 
with lesions of more than 50%; LVEF = left ventricular 
ejection fraction. 
Results: 
Patient characteristics 
The patient characteristics are shown in table I. The 
mean age of the patients was 57.4 years (range 48-67), 10 were 
male, 2 female. Four patients had no angiographic significant 
coronary artery disease (greater than 50% diameter stenosis), 
4 patients had one-vessel disease, 2 patients had two-vessel 
disease and 2 patients had three vessel disease. The mean left 
ventricular ejection fraction was 67% (range 44- 76%). 
Timing of the coronary hyperemic response 
The average plateau phase of the maximal hyperemic 
response was reached after 24 sec and lasted up to 37 sec 
after the intracoronary injection of papaverine (fig 2). The 
peak effect of individual intracoronary injections was reached 
after a mean time of 31.3 sec, (standard deviation± 3.4 sec). 
Peak hyperemia following each individual papaverine injection 
(n = 24) was within the defined plateau-phase of the maximal 
hyperemic response. 
Magnitude of the coronary hyperemic response 
The mean. baseline coronary sinus blood flow was 105.7 
(range 71 - 175) ml/min before the first papaverine injection 
and rose to a mean peak value of 194.4 (range 130 - 325) 
ml/min. The mean baseline coronary sinus blood flow was 109.6 
(range 69 - 180) ml/min immediately before the second papa-
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Figure 2 
Timing of the average coronary hyperemic response of all 24 papaverine injections. 
The shaded area is 1 SD calculated from the spontaneous variations in the baseline 
recordings. The plateau phase of the hyperemic response lasted from 24 till 37 sec 
after the intracoronary injection of papaverine. The peak effect of the injections was 
reached after a mean time of 31.3 sec, (standard deviation± 3.4 sec). 
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Table 2: Reproducibility of changes in coronary sinus blood 
flow after intracoronary papaverine. 
first ;ea;e injection second ;ea;e injection 
Pat 
Ao1 A B c Ao2 D E F G 
1 90 102 173 1. 70 92 106 174 1.64 3.5 
2 103 71 132 1. 86 105 75 126 1. 68 9.7 
3 91 91 181 1. 99 85 83 153 1.84 7.5 
4 106 78 219 2.81 107 79 223 2.82 0.3 
5 83 94 159 1.69 79 95 177 1.86 10.0 
6 82 117 174 1. 49 83 119 184 1.55 4.0 
7 89 110 335 3.05 90 164 398 2.43 20.3 
8 106 90 144 1. 60 104 115 185 1. 61 0.6 
9 105 175 252 1.44 101 180 251 1.39 3.5 
10 96 99 140 1.41 98 69 97 1. 41 o.o 
11 82 86 130 1.51 82 76 130 1.71 13.2 
12 110 155 294 1. 90 106 154 259 1. 68 11.6 
Abbreviations: Pat = patient; pap papaverine; Ao1 = mean 
aortic pressure during the first papaverine injection; A= 
baseline measurement; B = measurement 30 sec after 
intracoronary pap; C = ratio of B/A; Ao2 = mean aortic 
pressure during the second papaverine injection; D = second 
baseline measurement; E = measurement 30 sec after 
intracoronary pap; F = ratio of E/D; G = difference between c 
and F in percentage, calculated as (C-F)/C. Mean difference: 
7.0% with a standard deviation of 6.2%. 
verine injection and rose to a mean peak value of 196.1 (range 
97 - 398) ml/min. In figure 3a the percentage increase in 
coronary sinus blood flow (mean and standard deviation) is 
shown after all papaverine injections (n=24). Coronary vascu-
lar resistance was calculated as systemic arterial pressure 
divided by coronary sinus blood flow and is shown in figure 
3d. 
Reproducibility of the coronary hyperemic response 
In figure 4 the percentage increase in coronary sinus 
blood flow after the first papaverine injection is plotted 
versus the percentage increase in coronary sinus blood flow 
after the second papaverine injection; linear regression 
showed an r-value of 0.92. There was no significant difference 
(Student's t-test for paired observations) in magnitude or 
timing of the hyperemic response between first and second 
injections or in baseline coronary sinus blood flows. The 
responses of individual patients to first and second inj ec-
tions are shown in figure 5. The difference between the first 
and the second hyperemic response, 30 sec after papaverine 
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Figure 3 
a. Percentage increase in coronary sinus blood flow (mean and standard deviation). 
b. Mean arterial pressure. 
c. Heart rate. 
d. Coronary vascular resistance calculated as systemic pressure divided by coronary 
sinus blood flow. 
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injection was calculated as a percentage of the coronary sinus 
blood flow (see Table 2). The average difference was 7.0% with 
a SD of 6.2%. 
Safety 
There was no significant effect of the intracoronary 
given papaverine on either systemic arterial pressure or heart 
rate (fig 3b and c). No patient reported angina pectoris 
despite striking changes in the repolarization phase of the 
surface electrocardiogram (6) and no complications occurred 
during the procedure. 
Discussion 
Visual interpretation of the coronary angiogram is a poor 
means of predicting the physiological importance of obstruc-
tive coronary artery disease (7). Computer-based quantitative 
analysis of the coronary angiogram has solved, in sofar as 
currently possible, the problems of high interobserver and 
intraobserver variability and makes calculation possible of 
hydrodynamic parameters of the coronary artery lesion that are 
correlated with translesional pressure gradient and thallium 
perfusion scintigraphy (8-11). Even so, the relation between 
the quantitatively analysed coronary artery lesion and its 
hydrodynamic repercussion is not fully understood and methods 
that assess the limitation in coronary flow reserve due to an 
obstructive lesion are therefore needed. Various ways to study 
coronary flow reserve have been described (1-4,12). Induction 
of a hyperemic response is an essential part of all these 
methods. The recent description of a digital angiographic 
technique to measure relative coronary blood flow makes 
assessment of coronary flow reserve during routine cardiac 
catheterization possible (4). A safe, reproducible way of 
inducing a maximal hyperemic response is therefore all the 
more imperative (2). 
Assessment of coronary hyperemic response with thermodilution 
measurements of coronary sinus blood flow. 
A wide range of values for the coronary flow reserve of 
normal coronary arteries is reported, depending on the vaso-
dilator used and the measuring technique (3,12-16). The 
carefully validated studies with a Doppler-catheter suggest 
that the maximal coronary blood flow of a normal coronary 
artery is 4 to 6 times resting flow (3). The thermodilution 
measurements of coronary sinus blood flow have shown the 
highest flow increment reported in the literature as hyperemic 
flow 3 times resting flow, which was indeed observed in some 
of our patients (17). With thermodilution, Fault et al studied 
the coronary hyperemic response following a coronary angiogram 
23 
1°HR 
% 
200 .. ,.; ~ 
/. 
180 /. • 
/. 
/. 
160 /. 
/. 
140 
/. 
/. 
/. 
120 / 
/ 
100 ./. 7 
: / 
80 / 
.. 
/ R=O. 92 
60 / .. SEE=21 
/ .. .. 
40 }I 
/ 
/ 
20 / 
/ 
20 40 60 80 100 120 140 160 180 200 "-·o 
2°HR 
Figure 4 
Reproducibility of the coronary hyperemic response after intracoronary papaverine. 
1 oRR = first hyperemic response, 2°HR = second hyperemic response. 
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with a hyperosmolar ionic contrast medium and measured a ratio 
of maximal flow to resting flow of only 2, for patients with 
normal coronary arteries. However, there was a significant 
relation between the coronary hyperemic response and the 
extent of the coronary artery disease (15). Our results 
(compare table 1 and 2) show a similar trend. Since we were 
not specifically interested in the absolute changes in flow 
but especially in timing and reproducibility of the flow 
changes, we felt that thermodilution, which gives continuous 
recordings and is easy to repeat, was in this particular 
instance an adequate technique of investigation. The frequency 
response of the measurement is sufficient to measure changes 
in flow which occur within 2 to 3 sec(1,18,19). 
Vasodilator agents 
The most widespread used vasodilator agents are dipyri-
damol and hyperosmolar ionic contrast media(1,3-5,7). An 
intravenous infusion of dipyridamol in adequate dosage results 
in a maximal coronary vasodilation, but its use has several 
disadvantages (16). First, its long-lasting effect makes 
repeated assessment of the hyperemic response of a coronary 
vascular bed or assessment of different coronary vascular beds 
during the same procedure impossible (3). Second, the long-
lasting endo-epicardial redistribution of coronary blood flow 
in conjunction with an increase in myocardial oxygen consump-
tion (5) may induce ischemia which can only be terminated by 
the intravenous administration of aminophylline (16). Hyper-
osmolar ionic contrast media do not produce maximal arteriolar 
vasodilation (2,6,13). Bookstein and Higgins have shown in 
dogs that the coronary hyperemic response after a bolus injec-
tion into a coronary artery of adenosine-triphosphate or 
papaverine is of the same magnitude as after a 15 sec occlu-
sion of the coronary artery (6). Hodgson and Williams compared 
in human beings, the coronary hyperemia induced by a hyper-
osmolar ionic contrast medium with papaverine and observed a 
twofold greater hyperemic response after papaverine (13). 
The exact dosis of intracoronary papaverine needed to 
produce maximal coronary vasodilation has recently been 
established (14). Wilson and White compared the coronary 
hyperemic response after 4,8,12 and 16 mg intracoronary 
papaverine and reported a maximal hyperemic response after 8 
mg in most coronary arteries and after 12 mg in all coronary 
arteries. Papaverine at this dosage (8-12 mg) produced a 
response equal to intravenous infusion of dipyridamol in a 
dosage of 0.56 to 0.84 mg/kg. The coronary blood flow velocity 
after papaverine and dipyridamol was 4.8 times resting coro-
nary blood flow velocity (14). 
In conclusion, this study shows that reproducibility of 
the coronary hyperemic response after intracoronary papaverine 
is excellent. Timing of the peak effect is crucial if a 
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Figure 5 
Responses ofindividual patients to first (~)and second ( 8) injections of papaverine. 
Numbers 1-12 correspond to patients 1-12 in table 1 and 2. The ordinates present 
percentage increase of coronary sinus blood flow. On the abscissas: 0 = before 
papaverine injection, 30 = 30 sec after papaverine injection. 
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digital angiographic technique is to be used because angie-
grams during maximal hyperemia have to be compared with 
baseline angiograms. We measured the time interval after 
intracoronary papaverine during which hyperemia is maximal, 
and showed the practical feasibility of making an angiogram 
during maximal arteriolar vasodilation. The effect of the 
intracoronary papaverine disappears completely within 5 min so 
that multiple assessments of coronary flow reserve can be 
undertaken during the same procedure. 
Conclusions 
Ten mg intracoronary papaverine is a safe and reprodu-
cible means of inducing a strong hyperemic response in the 
coronary circulation with a peak effect lasting from 24 till 
37 sec and a duration of action less than 5 min, and therefore 
seems an ideal agent for investigating coronary flow reserve. 
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CHAPTER 3: DOES INTRACORONARY PAPAVERINE DILATE EPICARDIAL 
CORONARY ARTERIES? IMPLICATIONS FOR THE ASSESSMENT OF CORONARY 
FLOW RESERVE. 
Summary 
Intracoronary papaverine is used as a means to induce a 
strong and short-lasting hyperemia in several recently devel-
oped methods to measure coronary flow reserve. Changes in 
stenosis geometry due to papaverine would influence the 
measured coronary flow reserve. Therefore, we investigated the 
influence of intracoronary papaverine on stenosis geometry 
with quantitative analysis of the coronary angiogram and 
assessed the influence of papaverine on pressure-flow charac-
teristics of the stenosis and coronary flow reserve. The 
cross-sectional area (mean ± SD) of the stenoses increased 18 
± 7% after papaverine. The normal proximal and distal parts of 
the coronary artery dilated 5 ± 2% after papaverine. This 
results in a decrease of the calculated pressure drop over the 
stenosis varying from 20 to 30%. Coronary flow reserve of a 
flow-limiting epicardial stenosis is overestimated by 16% when 
papaverine is used to induce hyperemia. These papaverine 
induced changes can nevertheless be circumvented by maximal 
vasodilation of the major epicardial coronary artery with 3 mg 
intracoronary isosorbidedinitrate prior to the investigation 
of the coronary flow reserve with papaverine. 
Introduction 
Recently several methods have been developed to measure 
coronary flow reserve ( 1, 2) and to calculate pressure-flow 
characteristics of a coronary stenosis (3). Induction of a 
maximal coronary hyperemia is an essential part of these 
methods. Intracoronary papaverine induces a short-lasting, 
reproducible and maximal hyperemic response in the coronary 
circulation, so this agent has been proposed as an ideal 
vasodilator for these investigations (4,5). Changes in geo-
metry of epicardial stenoses from intracoronary administration 
of papaverine would influence the viscous (Poiseuille) and 
turbulent resistance and consequently alter the pressure-flow 
characteristics of the coronary stenoses, and the measured 
coronary flow reserve (6). The goal of the present investi-
gation was to assess the influence of intracoronary papaverine 
on coronary arterial dimensions and pressure-flow characteris-
tics and to establish whether prior intracoronary administra-
tion of a vasodilator of the epicardial coronary artery 
(isosorbidedinitrate) could prevent these papaverine induced 
alterations. 
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Patients and Methods 
Coronary angiography was performed in 11 patients as part 
of an ongoing study of restenosis after percutaneous trans-
luminal coronary angioplasty. Selection of these patients was 
based on the occurrence of restenosis to some extent. Informed 
consent was obtained for the additional investigation. All 
patients were studied without premedication, but their stan-
dard postangioplasty medical treatment consisting of aspirin 
500 mg/day, and nifedipine 60 mg/day was continued. No patient 
received oral or intravenous nitrates. No patient had clinical 
evidence for vasospastic angina. 
Angiographic procedure 
Coronary angiography was performed with the Judkins 
technique. The angiographic projection was selected such that 
the stenosis, and the proximal and distal parts of the coro-
nary artery were clearly visible and were parallel to the 
image intensifier. Hand-injections were made at a rate and 
volume sufficient to cause back-flow of the contrast agent 
into the aorta. Therefore, essentially all blood in the 
epicardial coronary arteries was replaced by contrast agent. 
Iopamidol, a nonionic agent was injected at 37"C. At this 
temperature it has a viscosity of 9. 4 cP, the osmolality is 
0. 796 osm/kg and the iodine content is 370 mg/ml. For this 
investigation 30 to 40 ml of this agent was used per patient. 
Consequently, the maximal change in blood viscosity induced by 
this procedure is only 2%. Therefore blood viscosity was 
assumed to be constant. A total of four angiograms were 
obtained in the selected angiographic view. First, a baseline 
angiogram was made. A second angiogram was performed 30 sec 
after a bolus injection of 12.5 mg papaverine into the coro-
nary artery. After a pause of 5 min, 3 mg intracoronary 
isosorbidedinitrate was administered and 30 sec later a third 
angiogram was performed. Finally, immediately following this 
third angiogram, 12.5 mg papaverine was given intracoronary 
and the last angiogram of the study was made 30 sec later. 
Quantitative coronary cineangiography 
The procedures for the quantitative assessment of coro-
nary arterial dimensions from 35 mm cinefilm have been imple-
mented on the computer-based Cardiovascular Angiography 
Analysis System (CAAS) and have been described extensively 
(7,8). For the assessment of the absolute and relative dimen-
sions of selected coronary segments with the CAAS, the boun-
daries of a selected coronary segment are detected automati-
cally from optically magnified and video-digitized regions of 
interest of an end-diastolic cineframe. Calibration of the 
diameter data in absolute values (mm) is achieved by detecting 
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the boundaries of a section of the contrast catheter and 
comparing the computed mean diameter in pixels with·the known 
size in millimeters. Each catheter is measured individually 
with a micrometer to determine its true size (9). To correct 
the contour positions of the arterial and catheter segments 
for the pincushion distortion of the image intensifier, a 
correction vector is computed for each pixel based on a 
computer-processed cineframe of a centimeter grid placed 
against the input screen of the image intensifier (8). 
The procedure for contour detection requires the user to 
indicate a number of center positions with the writing tablet 
from the proximal to the distal end of the selected arterial 
segment such that the straight lines connecting these points 
are within the artery. The contours of the vessel are detected 
on the basis of the weighted sum of first and second deriva-
tive functions applied to the digitized brightness information 
along scanlines perpendicular to the local centerline direc-
tions. From the detected contours the diameter function is 
determined in absolute millimeters. 
Since the functional significance of a stenosis is also 
related to the expected normal cross-sectional area of the 
vessel at the point of the obstruction, we use a computer 
estimation of the original arterial dimensions at the site of 
the obstruction to define the reference region (interpolated 
reference). A representative example with the detected con-
tours and the reconstructed reference contours is shown in 
figure 1. The computed reference diameter function allows for 
tapering of the vessel. The interpolated percentage area 
stenosis (AS) is then computed by comparing the squared 
minimal diameter value at the obstruction with the squared 
value of the reference diameter function at this position, 
thereby assuming circular cross-section: 
AS = ( 1 - (minimal diameter/reference diameter) 2 ) x 100%. 
The estimation of the length of the obstruction is made on the 
basis of a curvature analysis of the diameter function. 
The pressure-drop (PD) over the stenosis for coronary 
flows of 1,2,3,4 and 5 ml/sec is calculated using the follow-
ing hemodynamic equation: 
PD (25.1uL /MLCA2 ) Q + d/0.266 (1/MLCA- 1/NA) 2 Q2 
or PD = fQ + sQ2 
where u = blood viscosity, L = stenosis length, NA = normal 
cross-sectional area, MLCA = minimal luminal cross-
sectional area, Q = volume flow, d = blood density, f = 
coefficient of viscous resistance (Poiseuille), and s 
coefficient of turbulent resistance or exit separation 
(3,10,11). 
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Table 1: Clinical characteristics (n 11). 
Mean age (range) 
Sex 
0 
1 
2 
LVEF more than 50% 
57 (41-71) 
9 male, 2 female 
1 
8 
2 
11 
0, 1 and 2 = the number of vessels per patient with an area 
stenosis in excess of 50%, LVEF = left ventricular ejection 
fraction. 
Statistical methods: 
Comparisons between data were carried out with the 
Student's t-test for paired observations. 
Results 
The clinical characteristics of the patients are shown in 
table 1. The mean age of the 11 patients was 57 years (range 
41-71 year). Nine patients were male. Eight patients had 
single vessel disease, two patients had two-vessel disease and 
one patient had no significant coronary artery disease (area 
stenosis in excess of 50%). All patients had a normal left 
ventricular ejection fraction. Eleven discrete proximal steno-
ses were analyzed quantitatively (table 2). When compared to 
the baseline measurements 12.5 mg papaverine given intracoro-
nary induced a 5 ± 2% increase in cross-sectional area of the 
normal proximal and distal part of the coronary artery and 
this resulted in an 5 ± 2% increase in interpolated reference 
area. The cross-sectional area of the stenoses increased from 
2.0 ± 1.1 mm2 to 2.3 ± 0.9 mm2 after intracoronary papaverine 
(18 ± 7% increase). After the first papaverine injection 
percentage area stenoses decreased from 72 ± 11% to 69 ± 10% 
because of the increase in absolute terms in stenosis area. 
After isosorbidedinitrate the proximal and distal parts of the 
coronary artery dilated respectively by 10 ± 4 and 10 ± 3%. 
The increase of the stenosis area after isosorbidedinitrate 
was of the same magnitude as after papaverine. Since isosorbi-
dedinitrate changed the stenosis area and the interpolated 
reference area to the same extent, the relative percentage 
area stenosis was comparable to baseline (72 ± 11% versus 71 ± 
10%). Given after isosorbidedinitrate intracoronary papaverine 
induced no changes in proximal and distal cross-sectional 
area, cross-sectional stenosis area, or relative percentage 
area stenosis. 
The hemodynamic consequences of these vasodilator induced 
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Figure 1 
Detected contours for a representative stenosis of the left anterior descending coronary 
artery. The normal size of the artery over the obstruction has been estimated by the 
interpolated method. 
The diameter function is shown on the bottom. 
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Relation between the pressure drop over the stenosis at a coronary flow of 5 ml/ sec at 
baseline (--) and after papaverine ( --) as a function of baseline stenosis severity. 
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Table 2: Changes in stenosis geometry after coronary 
vasodilatation (n =11) 
Angio 
cross-sectional area (mm2) 
proximal interp. ref. distal 
10 
baseline 8.3±3.1 
20 
pap 8.7±3.1 
% change 
compared to 5±2* 
1 o angio 
30 
ISDN 9.6±3.5 
% change 
compared to 16±7* 
1° angio 
% change 
compared to 10±4* 
2° angio 
ISDN +papa 9.6±3.2 
% change 
compared to 0±1NS 
3° angio 
7.2±2.8 6.0±2.9 
7.6±3.0 6.3±2.9 
5±2* 5±2* 
8.4±3.3 7.0±3.2 
17±7* 17±6* 
11±4* 10±3* 
8.3±3.1 6.9±3.0 
0±2NS 0±2NS 
stenosis area 
mm2 % 
2. 0±1.1 72±11 
2.3±0.9 69±10 
18±7* 4±3* 
2.4±1.0 71±10 
20±8* 2±2NS 
3±2NS 3±2NS 
2. 3±1. 0 72±11 
-3±2NS 1±2NS 
Results are expressed as mean ± SD, * = p less than 0. 05, 
interp.ref. = interpolated reference, pap = papaverine, ISDN = 
isosorbidedinitrate, ic = intracoronary, NS =not significant, 
angio = angiogram. 
changes in coronary arterial dimensions are characterized by 
the alterations in viscous (Poiseuille) resistance and separa-
tion resistance as well as the consequent change in pressure 
drop over the stenosis. Therefore, we calculated the viscous 
and separation coefficient and the resulting pressure drop 
over the stenosis for a physiological range of coronary blood 
flows (table 3). The magnitude of the resulting change in 
pressure drop over the stenosis was critically dependent on 
the baseline severity of the coronary stenosis. The patient 
with the most severe (86%) percentage area stenosis and the 
patient with the mildest (48%) percentage area stenosis are 
shown in table 4 as examples of this phenomenon. The relation 
between the pressure drop over the stenosis at a coronary flow 
of 5 ml/sec at baseline and after papaverine as a function of 
baseline stenosis severity is shown in figure 2. The reduction 
in pressure drop from papaverine ranged from 20-30%. The rela-
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tive contribution of the viscous and separation resistance to 
the pressure drop over the stenosis is a function of the 
coronary blood flow. With coronary blood flows of 1-2 ml/sec 
the viscous resistance is the dominant factor whereas with 
higher coronary blood flows (4-5 ml/sec) viscous and separa-
tion resistances are quantitatively comparable (see fig. 3). 
Mter both papaverine and isosorbidedinitrate this relation 
remained essentially unchanged. 
The total resistance over a coronary stenosis depends 
mainly on three geometric factors: cross-sectional area of the 
stenosis, normal area of the coronary artery, and length of 
the stenotic lesion. The length of the stenotic lesions (mean 
± SD: 7.1 ± 1.9 mm) did not change significantly after papa-
verine and/or isosorbidedinitrate. The vasodilator induced 
reduction of the viscous resistance is due to the increase in 
cross-sectional area of the stenosis. The vasodilator induced 
changes in separation resistance are related to both the 
increase in normal distal area of the coronary artery and the 
increase in cross-sectional area of the stenosis (table 5). 
The increase in normal distal area of the coronary artery 
results in an augmention of the separation resistance. The 
increase in cross-sectional area of the stenosis results in a 
decrease of the separation resistance. This latter change is 
of greater magnitude, so the alteration in separation resis-
tance stems predominantly from the increase in absolute 
stenosis area. 
Discussion 
The variability in quantitative measurements of various 
parameters of coronary arterial segments is reported in a 
previous paper from our laboratory (7). The mean difference 
between obstruction diameters of the stenoses from repeated 
angiographic studies is 0.0 with a standard deviation of the 
difference of 0.22 (mm). Therefore, this system of quantita-
tive analysis allows for a reliable assessment of even very 
small changes in coronary artery dimensions due to interven-
tions such as administration of vasodilating agents. Papa-
verine is an attractive vasodilator for studies of the coro-
nary circulation in human beings, since it induces a maximal 
fall in coronary vascular resistance, has few side effects and 
has a duration of action less than 2 min (4). The exact dose 
of intracoronary papaverine needed to induce a maximal 
coronary vasodilation has recently been established. Wilson 
and White (5) compared the coronary hyperemic response after 
4, 8, 12 and 16 mg intracoronary papaverine and reported 
a maximal hyperemic response after 8 or 12 mg. 
However, using papaverine Gould and Kelley (6) described 
important changes in stenosis geometry in dogs and consequen-
tly important alterations in pressure-flow characteristics of 
the stenosis. Wilson and White (5) studied in human beings the 
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function of coronary blood flow. 
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Influence of intracoronary papaverine on coronary flow reserve ( CFR) as a result of 
the change in stenosis area. The relation between CFR and stenosis area was 
established in a previous study from our laboratory. 
Papaverine induced an increase (mean value ofll patients) in stenosis area from 2.0 
to 2.3 mm2 which corresponds to an increase in CFR from 1.9 to 2.2. 
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Table 3: Hemodynamic effects of altered stenosis geometry 
after vasodilation. 
baseline pap ISDN ISDN +pap 
f 1.88 1. 38 1.31 1.38 
s 0.42 0.29 0.28 0.30 
PD1 2 2 2 2 
2 5 4 4 4 
3 9 7 7 7 
4 14 10 10 11 
5 20 14 14 15 
pap intracoronary papaverine; ISDN intracoronary 
isosorbidedinitrate; PD = fQ + sQ2 , PD = pressure drop 
(mmHg) over the stenosis for coronary flows of 1,2,3,4, 
and 5 ml/sec; Q = flow in ml/sec; f = viscous coefficient 
(mmHg/ml per sec); s = separation coefficient (mmHg/ml2 per 
sec 2 ). Results are mean values from 11 patients. 
Table 4: Hemodynamic effects of altered stenosis geometry 
after vasodilation. A = patient with a 48% area stenosis; B 
patient with a 86% area stenosis. Abbreviations as in table 3. 
baseline pap ISDN ISDN + pap 
A f 0.58 0.45 0.44 0.45 
s 0.05 0.04 0.04 0.04 
PD5 4 3 3 3 
B f 9.3 7.1 7.0 7.1 
s 3.4 2.7 2.7 2.7 
PD5 130 102 104 103 
Table 5: Hemodynamic effects of altered stenosis geometry 
after vasodilation. Relative contributions to the change in 
separation coefficient of the vasodilator induced increases in 
stenosis cross-sectional area (StA) and normal distal area 
(NDA). 
baseline pap ISDN ISDN +pap 
(mmHg/ml2 per sec 2 ) % % % 
StA 0.42 - 40 - 45 - 40 
NDA 0.42 + 5 + 14 + 12 
StA + NDA 0.42 - 31 - 33 - 29 
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impact of papaverine on coronary arterial dimensions and 
concluded that papaverine induced no significant alterations. 
In a previous study from our laboratory we reported that 
papaverine had a small but significant effect on stenosis 
geometry (1). However the patients of Wilson and White and the 
patients in our previous study were all treated with nitrates 
during the investigational procedure. 
The ideal vasodilator should dilate exclusively the 
resistance vessels without affecting the geometry of the flow 
limiting stenosis in the epicardial coronary artery. Unfortuna-
tely as is indicated by our results, intracoronary papaverine 
influences both resistance vessel and epicardial coronary 
artery. The hyperemia induced by intracoronary papaverine 
cannot be solely attributed to a fall in arteriolar resistance 
but is partially due to changes in epicardial stenoses geo-
metry. In other words, the methodological approaches using 
this drug affect the investigated phenomenon, namely the 
pressure-flow relationship of the flow limiting stenoses. In a 
previous study (1) from our laboratory we established the 
relation between coronary flow reserve and the stenosis area 
in patients with single vessel coronary artery disease. An 
increase in stenosis area from 2.0 to 2.3 mm2 would correspond 
to an increase in coronary flow reserve from 1.9 to 2.2, that 
is, an 16% increase and therefore overestimation of the real 
coronary flow reserve (see fig. 4). 
In accordance with our findings, Gould and Kelley (6) 
found important changes in stenoses geometry from papaverine 
in dogs. However, there are some qualitative differences 
between their results and ours, probably because of the 
different nature of the human coronary atherosclerotic lesion 
and stenoses produced by external constriction of normal 
coronary arteries in dogs. In our material the most signifi-
cant change in stenosis geometry was the increase in cross-
sectional stenosis area; in their material the change in 
cross-sectional area of the "normal" parts of the coronary 
artery was the predominant factor in the papaverine induced 
changes in pressure-flow relationship. The predominance of 
viscous resistance over separation resistance at "resting" 
coronary flows was similar in our patients and their material. 
However, at high coronary flows the separation resistance 
contributed about four times more to the pressure drop over 
the stenosis than the viscous resistance in the study of Gould 
and Kelley, whereas in our material, viscous and separation 
resistances were equally important at higher coronary flows. 
In these dogs, an isolated increase in "normal" areas without 
change in the externally constricted vessel lumen further 
augments the separation loss of pressure whereas the viscous 
resistance remains unchanged. In human atherosclerotic coro-
nary artery lesions both separation and viscous resistance are 
significantly changed, because the human atherosclerotic 
coronary artery lesion still has a capability of dilating. 
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This is in accordance with the findings of Brown et al, who 
documented a significant increase in stenosis area and de-
crease in stenosis resistance after nitroglycerin in human 
atherosclerotic coronary arteries (12). 
There are two potential mechanisms for this papaverine 
induced response. As reported by Holtz et al, drugs that cause 
coronary dilatation can be classified according to their mode 
of action (13). Some drugs have a direct effect on the arte-
rial vasculature, for instance nitroglycerine and isosorbide 
dinitrate. On the other hand, adenosine and dipyridamol induce 
a flow-dependent, endothelium-mediated indirect effect by 
which even small variations in coronary blood flow may induce 
substantial alterations in coronary artery dimensions. The 
relative importance of these two mechanisms in the papaverine 
induced changes in stenosis geometry remain to be established. 
Conclusion 
In human beings with atherosclerotic coronary artery 
lesions, intracoronary papaverine induces significant increas-
es in cross-sectional stenosis area and in normal proximal and 
distal areas of the coronary artery. As a consequence of these 
geometric changes, the viscous and separation resistance as 
well as the resulting pressure drop over the stenosis decrease 
considerably. The papaverine induced alterations in stenosis 
geometry and pressure-flow relationship are a serious methodo-
logical problem, since the magnitude of the changes is suffi-
cient to influence measurements of coronary blood flow velo-
city or regional coronary flow reserve significantly. These 
papaverine induced changes can nevertheless be circumvented by 
maximal vasodilation of the major epicardial coronary arteries 
with 3 mg intracoronary isosorbidedinitrate prior to the 
investigation of the coronary flow reserve with papaverine. 
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CHAPTER 4: VALUE AND LIMITATIONS OF INTRACORONARY ADENOSINE 
FOR THE ASSESSMENT OF CORONARY FLOW RESERVE. 
Summary 
An ideal coronary vasodilator for studying coronary flow 
reserve should rapidly produce a maximal hyperemic response, 
be short acting to permit repeated measurements and not alter 
systemic hemodynamics. We measured with a Doppler tip balloon 
catheter, in 12 patients before and/or after percutaneous 
transluminal coronary angioplasty the hyperemic response 
following 12.5 mg intracoronary papaverine and following 
gradually incremental bolus injections of intracoronary 
adenosine, starting from 0. 05 mg until a maximal hyperemic 
response or side effects. The mean dose (± SD) of adenosine 
needed to produce maximal hyperemia was 0. 23 (± 0. 20 mg). 
Coronary blood flow velocity after adenosine increased to 1.6 
± 0.3 times resting coronary blood flow velocity, comparable 
in magnitude to the hyperemia following intracoronary papa-
verine. 
The time from injection to peak effect after adenosine 
was 7. 4 (SD± 2. 2) s and after papaverine 26 (SD ± 7) s. 
Adenosine resulted in a bradyarrythmia in 3 patients. Intra-
coronary adenosine is a potent and very short acting vaso-
dilator for studying coronary flow reserve but side effects 
and unpredictability of the dosage needed to produce maximal 
hyperemia, may limit its applicability. 
Introduction 
The concept of coronary flow reserve which is defined as 
the ratio of maximal coronary blood flow to resting flow is 
essential in understanding the physiological significance of 
coronary artery obstructions (1,2). The recent development of 
methods such as digital subtraction cineangiography or sub-
selective coronary blood flow velocity measurements using a 
Doppler catheter have made the assessment of regional coronary 
blood flow possible during cardiac catheterization (3-5). In 
order to detect a limitation in coronary flow reserve due to 
an obstruction in a major epicardial coronary artery, measure-
ments should be obtained when distal coronary resistance has 
been minimized by dilating the arteriolar bed pharmacologi-
cally (1). In order to evaluate the effect of an intervention, 
such as dilatation of an epicardial vessel, it is necessary to 
perform repeated measurements of coronary flow reserve 
(3, 6, 7) • This can only be achieved by using a potent short-
acting vasodilator that will induce a transient maximal 
hyperemic response. Intracoronary papaverine has been proposed 
as the ideal coronary vasodilator for studies of the coronary 
circulation (6,7). Intracoronary papaverine in a dosage of 8 
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to 12 mg induces a strong and reproducible hyperemia with a 
peak effect after 30 s and a total duration of action of less 
than 2 to 3 minutes. However, recent reports (8,9) suggest 
that papaverine may precipitate with certain radiographic 
contrast agents, and thus potentially cause serious complica-
tions. Adenosine has historically been described as the 
physiological vasodilator in the coronary circulation. al-
though its definitive role has not yet been established. 
(12-14). Adenosine produces maximal coronary vasodilation when 
given intravenously, but intravenous administration results in 
profound alterations of heart rate and arterial pressure (15). 
Therefore, we compared the coronary hyperemic response 
after gradually incremental doses of intracoronary adenosine 
(until maximal hyperemia or side effects) with the coronary 
hyperemic response after 12.5 mg intracoronary papaverine in 
12 patients. 
Patients and methods 
Twelve patients who underwent elective coronary angio-
plasty for stable angina pectoris were studied after informed 
consent was obtained. An angioplasty guiding catheter (8 Fr, 
Angiomedics) was placed into the ostium of the left or right 
coronary artery. Coronary angiography was performed with 
Iopamidol a non-ionic contrast agent. A long guide wire was 
passed across the stenotic lesion to be dilated. An angio-
plasty balloon catheter with an end-mounted Doppler crystal 
was advanced over the guide wire, into the coronary artery 
(16). The studies with the two vasodilators were only per-
formed when a reliable Doppler signal (3,17) was obtained and 
the clinical condition of the patients permitted the additio-
nal investigation (absence of signs of ischemia such as chest 
pain or ST-T segment abnormalities, in the presence of stable 
systemic hemodynamics). In 3 patients the investigation was 
performed before the dilatation of the coronary stenosis, in 6 
patients after the dilatation and in 3 patients measurements 
were obtained before and after the angioplasty. 
After recording of a stable baseline coronary blood flow 
velocity, a bolus injection of 12.5 mg papaverine was given 
through the guiding catheter and the subsequent hyperemic 
response was recorded. When the coronary blood flow velocity 
had returned to the baseline level, the procedure was repeated 
using increasing doses of adenosine starting with of 0.05 mg, 
until either maximal hyperemia was obtained (no further 
increase in maximal blood flow velocity) or side effects 
produced. 
The Doppler device that was used to measure the intracoro-
nary blood flow velocity consisted of a 20 MHz ultrasonic 
crystal mounted on the tip of the angioplasty catheter. 
Recently, Sibley et al ( 17) validated clinically and experi-
mentally the ability of a similar catheter with an end-mounted 
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piezo electric crystal to provide accurate and continuous 
on-line measurement of coronary blood flow velocity and 
vasodilator reserve. The Doppler crystal has a 1.0 mm diameter 
annulus with a 0.5 mm central hole. Blood flow velocity is 
measured from the catheter tip transducer using a range gated 
20 MHz pulsed Doppler device designed specifically for this 
purpose (Baylor College of Medicine). The master oscillator 
frequency of 20 MHz is pulsed at an oscillating frequency of 
62.5 kHz. Each pulse is approximately 1 micros in width and 
therefore contains 20 cycles of the master oscillator frequen-
cy. This allows the recording of velocities up to 100 cm/s at 
a distance of up to 1 em from the cathetertip. The sampling 
window can be adjusted individually to obtain the best signal. 
The output of the pulsed Doppler is in the form of a frequency 
shift (F) that can be related to flow velocity by the Doppler 
equation: 
F = 2f V/c. cos a 
where f is the ultrasonic frequency (20 MHz), V is the mean 
velocity within the sample volume, c is the speed of sound in 
blood (1500 m/s) and a is the angle between the velocity vec-
tor and the sound beam. Using an end-mounted crystal with the 
catheter parallel (± 20°) to the vessel axis, cos a is 1 ± 6%, 
and the relation between the Doppler shift and velocity is 
approximately 3.75 cm/s/kHz. Previous calibration experiments 
in canine femoral and coronary arteries have shown that the 
measured doppler frequency shift is proportional to volume 
flow measured by timed collection (3,18,19). 
Results 
The patient characteristics are shown in table 1. The 
mean age of the patients was 53 years (range: 41-68). Ten of 
the twelve patients were men. Nine patients had one-vessel 
coronary artery disease and three patients two-vessel disease. 
The mean left ventricular ejection fraction was 56% (range: 
38-71%). 
Intracoronary papaverine 
The effects of intracoronary papaverine are shown in 
table 2 and figure 1. Coronary blood flow velocity (mean ± SD) 
increased to 1. 6 ± 0. 3 times resting coronary blood flow 
velocity. The time (mean ± SD) from the intracoronary bolus 
injection to the peak of the hyperemic response was 26 ± 7 s. 
The time (mean ± SD) from injection to subsidence of the 
hyperemic response, that is return of the coronary blood flow 
velocity to its baseline level, was 108 ± 25 s. There was no 
significant effect of the intracoronary papaverine on systemic 
hemodynamics. Blood pressure: -1 ± 3% of baseline blood 
pressure and heart rate: 0 ± 4% of baseline heart rate, during 
the peak of the hyperemic response. 
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Figure 1 
10 30 
---------1 
50 70 90 110 130 s 
Timing and magnitude of the coronary flow reserve (CPR) after adenosine ( o ), and 
papaverine ( • ). I = SD of the magnitude, --- = SD of timing. 
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Table 1: Clinical data. 
pat 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
sex 
M 
M 
M 
M 
M 
F 
M 
M 
M 
F 
M 
M 
age 
53 
54 
44 
55 
41 
53 
56 
47 
48 
68 
57 
61 
NYHA 
III 
III 
III 
II 
III 
III 
II 
III 
III 
III 
III 
III 
VD 
2 
1 
1 
1 
2 
1 
1 
2 
1 
1 
1 
1 
LVEF 
55 
57 
58 
65 
38 
71 
54 
45 
58 
62 
56 
? 
pharmac. ther. 
B,N 
B,C.N 
C,N 
B,N 
B,C,N 
C,N 
B,C 
B,C,N 
B,C,N 
B,N 
B,C,N 
B,N 
pat - patient; M - male; F = female; NYHA = New York Heart 
Association classification for angina pectoris; VD = number of 
vessels with a more than 50% diameter stenosis; LVEF = left 
ventricular ejection fraction; ? = unknown; pharmac. ther. 
pharmacological therapy; B = beta blocker; C = calcium 
antagonist; N = nitrate. 
Intracoronary adenosine 
The effects of intracoronary adenosine are shown in table 
2 and figure 1. The dose needed to produce a maximal hyperemic 
response varied widely. It was 0.05 mg in 2 patients, 0.1 mg 
in 4 patients, 0. 2 mg in 2 patients, 0. 4 mg in 2 patients and 
0. 8 mg in 1 patient. The mean (±SD) dose needed to produce 
maximal hyperemia was 0. 23 (± 0. 20) mg. Coronary blood flow 
velocity (mean ± SD) following this maximal effective dose of 
intracoronary adenosine increased to 1.6 ± 0.3 times resting 
coronary blood flow velocity. The magnitude of the hyperemic 
responses after papaverine and adenosine were related (linear 
regression analysis: r=O. 83 SEE= 0. 2). The time (mean ± SD) 
from the intracoronary bolus injection to the peak of the 
hyperemic response was 7.4 ± 2.2 s. The time (mean ± SD) from 
injection to subsidence of the hyperemic response was 30 ± 5 
s. 
Complications: 
No complications were noted after intracoronary admini-
stration of papaverine. In 3 patients intracoronary admini-
stration of adenosine resulted in bradyarrhythmias. In 1 
patient asystole occured, lasting 5. 2 s (patient 5, table 1 
and 2). In 2 patients a short lasting atrioventricular block 
was induced (patients 6 and 9, table 1 and 2). Apart from 
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Table 2: Results of intracoronary administration of 
vasodilators. 
papaverine 12.5 mg adenosine 
Pat CFR tpeak thyp dos CFR tpeak thyp 
1 LAD B 1.4 32 101 0.05 1.4 7 36 
A 1.4 28 145 0.2 1.6 10 35 
2 ex A 1.7 27 131 0.4 1.8 12 38 
3 LAD A 1.9 19 100 0.4 2.0 5 22 
4 RCA B 1.1 36 137 0.1 1.0 
5 LAD B 1.4 24 142 0.2 1.5 6 24 
6 LAD A 1.6 22 93 0.8 1.6 5 33 
7 LAD A 1.9 i8 82 0.2 2.0 6 25 
8 ex B 1.4 35 105 0.1 1.3 7 38 
9 LAD A 1.6 37 133 0.05 1.8 5 28 
10 LAD A 1.4 27 107 0.4 1.3 9 31 
11 LAD B 2.4 21 102 0.1 1.9 7 33 
A 1.2 19 111 0.2 1.4 10 32 
12 LAD B 1.3 15 58 0.1 1.5 6 22 
A 1.5 17 63 0.2 1.5 8 28 
Pat = patient, LAD = left anterior descending artery, ex = 
circumflex artery, RCA= right coronary artery, B = before 
angioplasty, A = after angioplasty, CFR = coronary flow 
reserve (ratio of maximal coronary blood flow velocity to 
baseline velocity), tpeak =time from injection to maximal 
hyperemia(s), thyp = time from injection to subsidence of the 
hyperemia(s), dos =dose needed to produce a maximal 
hyperemia (mg) • 
these 3 patients with bradyarrhythmias no complications were 
noted following adenosine administration. 
In the other 9 patients, intracoronary adenosine did not 
alter systemic hemodynamics. Blood pressure: -2 ± 2% of 
baseline blood pressure and heart-rate: -2 ± 3% of baseline 
heart rate during the peak of the maximal hyperemic response. 
Discussion 
Visual interpretation of the coronary angiogram is a poor 
means of assessing the physiological importance of obstructive 
coronary artery disease (20). Computer-based quantitative 
analysis of the coronary angiogram has solved, to a consider-
able extent, the problems of high interobserver and intraob-
server variability and it has made possible the calculation of 
hydrodynamic parameters of the coronary artery lesion that 
correlate well with translesional pressure gradient and 
thallium perfussion scintigraphy (21-24). In patients with 
limited coronary artery disease, such as a single discrete 
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proximal obstructive lesion, the physiological significance of 
their coronary stenosis can be predicted with reasonable accu-
racy from quantitative assesment of the coronary artery dimen-
sions (5,25). However, in the large majority of patients with 
coronary artery disease, the physiological importance cannot 
be inferred from morphological data alone. Therefore, methods 
to measure coronary flow reserve are needed. Various ways to 
study coronary flow reserve have been described (3-5,26), and 
the induction of a maximal hyperemic response is an essential 
part of all these methods. 
Vasodilator agents 
Widely used vasodilator agents are dipyridamol and hyper-
osmolar ionic contrast media (1,3,4,20). An intravenous infu-
sion of dipyridamol in adequate dose results in maximal coro-
nary vasodilation, but it has the disadvantage of a long-
lasting duration of action which makes repeated assessment of 
the hyperemic response of a coronary vascular bed or assess-
ment of different coronary vascular beds during the same 
procedure impossible (3,6). Hyperosmolar ionic contrast media 
do not produce maximal vasodilation (2,27,28). Bookstein and 
Higgins (27) have shown that in dogs, the hyperemic response 
after a intracoronary bolus injection of adenosine-triphos-
phate or papaverine is of the same magnitude as after a 15s -
occlusion of the coronary artery. The exact dose of intracoro-
nary papaverine needed to produce maximal coronary vasodila-
tion has recently been established. Wilson and White (6) 
compared the coronary hyperemic response after 4,-8,12 and 16 
mg intracoronary papaverine and reported a maximal hyperemic 
response after 8 mg in most coronary arteries and after 12 mg 
in all coronary arteries. Papaverine in this dose (8-12 mg) 
produced a response equal to that of an intravenous infusion 
of dipyridamol in a dose of 0.56 to 0.84 mg1kg body weight. 
Coronary blood flow and /or flow velocity of normal coronary 
arteries in the absence of factors known to decrease flow 
reserve, increases four to six times the resting value after 
intracoronary papaverine (5,6). 
Therefore, we compared the vasodilating potential of 
intracoronary adenosine with 12.5 mg intracoronary papaverine. 
Our results show that the coronary vasodilation after adeno-
sine is of a comparable magnitude to that observed after 
papaverine. The time from intracoronary injection of adenosine 
to peak hyperemia as well as the total duration of the hyper-
emic response is about four times shorter than papaverine (see 
fig. 1). However, several characteristics of adenosine limit 
its practical applicability. First, the dose needed to induce 
maximal hyperemia varies widely from patient to patient and 
seems unpredictable. This makes adenosine an unsuitable agent 
for coronary vasodilation if a radiographic technique is 
used to measure coronary flow reserve (5). Second, three of 
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our twelve patients developed bradyarrhythmias immediately 
following adenosine administration in a dose close to that 
needed to produce adequate hyperemia. Although these brady-
arrhythmias were short-lasting, they produced discomfort for 
the patients and precluded a meaningful interpretation of the 
coronary flow velocity data following this adenosine inj ec-
tion. These bradyarrhythmic effects of intracoronary adenosine 
are in accordance with its well-known electrophysologic 
effects when administered intravenously (13,14). 
Magnitude of coronary hyperemic responses after papaverine and 
adenosine 
Wilson and White (6) have shown that intracoronary papaverine 
and intravenous dipyridamol increase coronary blood flow 
velocity ranging from 3. 5 to 6 times baseline velocity (in 
patients with normal coronary arteries). In our patients, who 
were studied in the setting of coronary angioplasty for signi-
ficant coronary artery disease, vascular reserve was much 
lower, as might be expected (29-31). Introduction of a guide 
wire and a catheter with a Doppler device into a coronary 
artery may cause serious complications. Wilson et al (3) 
reported one patient with a total occlusion of a coronary 
artery following blood flow velocity measurements with an 
intracoronary Doppler catheter. Therefore we feel that to 
perform research with such devices is only justified in the 
setting of coronary angioplasty when the intracoronary posi-
tioning of guide wire and catheter is mandatory as a part of 
the procedure. A consequence of this is that our findings and 
conclusions are restricted- to patients with symptomatic coro-
nary artery disease. 
Conclusion 
Intracoronary adenosine is a potent and very short-acting 
vasodilator. However, its clinical applicability is limited by 
side effects and unpredictability of the dose needed to induce 
a maximal hyperemic response in the coronary circulation. 
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CHAPTER 5: DOES THE QUANTITATIVE ASSESSMENT OF CORONARY ARTERY 
DIMENSIONS PREDICT THE PHYSIOLOGIC SIGNIFICANCE OF A CORONARY 
STENOSIS? 
Suiiliilary 
To study the relationship between the quantitatively 
assessed coronary artery dimensions and the regional coronary 
flow reserve as measured by digital subtraction cineangio-
graphy, we investigated 17 coronary arteries with a single 
discrete proximal stenosis and 12 normal coronary arteries, 
before and after intracoronary administration of papaverine. 
Coronary flow reserve was found to be curvilinearly related_ to 
minimal luminal cross-sectional area (r = 0. 92, SEE = 0. 73) 
and to percentage area stenosis (r = 0.92, SEE= 0.74). Normal 
coronary arteries had a coronary flow reserve of 5. 0 (SD ± 
0.8), which differed significantly from the coronary flow 
reserve of the coronary arteries with obstructive disease, in 
which values ranging from 0. 5 to 3. 9 were found. Coronary 
arteries with a percentage area stenosis between 50 and 70% 
and a minimal luminal cross-sectional area between 2 and 4.5 
Illiil2 differed significantly (p = 0.001) with respect to the 
coronary flow reserve, from coronary arteries with a percen-
tage area stenosis in excess of 70% and a minimal luminal 
cross-sectional area less than 2 Illiil2 • With the use of hemo-
dynamic equations that describe the pressure loss over a 
stenosis, a theoretical pressure-flow relation can be inferred 
that characterizes the severity of the stenosis. Based on this 
theoretical pressure-flow relationship, coronary arteries that 
have a limited coronary flow reserve and critical stenosis, 
(distal coronary perfusion pressure below 40 mmHg at coronary 
flow of 3 ml/sec) can be identified with high sensitivity 
(83%) and specifity (82%). Thus, in coronary artery disease 
the consequent reduction in coronary flow reserve can be 
predicted with reasonable accuracy by quantitative assessment 
of coronary artery dimensions. 
Introduction 
Visual interpretation of the coronary angiogram inade-
quately predicts the physiologic importance of obstructive 
coronary artery disease (CAD) (1). Computer-based quantitative 
analysis has helped minimize the problems of high inter-
observer and intraobserver variability in the assessment of 
the coronary angiogram (2-4), and it allows the calculation of 
the pressure-flow characteristics of the coronary artery 
lesion (5), that are correlated with the translesional pres-
sure gradient and with exercise thallium perfusion scinti-
graphy (6, 7). However, the relationship between the quanti-
tative analyzed dimensions of an obstructive coronary artery 
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lesion and the consequent limitation in coronary blood flow is 
not yet fully understood. The recent description of a digital 
angiographic technique for the measurement of relative coro-
nary blood flow has rendered the assessment of regional 
coronary flow reserve possible by use of the ratio of maximal 
coronary blood flow to resting flow as a measurement of this 
variable (8). The goal of this investigation was to study the 
relationship of quantitatively assessed coronary artery 
dimensions and calculated coronary artery pressure-flow 
characteristics to the regional coronary flow reserve as 
measured by digital subtraction cineangiography. 
Patients and methods 
Seventeen coronary arteries of patients with single 
vessel CAD and 12 coronary arteries of patients with normal 
coronary arteries were studied. The 17 coronary artery lesions 
were all single discrete stenoses in the proximal parts of the 
vessels before any significant sidebranch occurred. Coronary 
angiography by the Sones or Judkins technique was performed 
for chest pain syndromes. Informed consent was obtained for 
the additional investigation. All patients were studied 
without premedication, but their medical treatment (nitrates, 
calcium antagonists and beta-blockers) was continued on the 
day of the investigation. None had systemic hypertension, 
cardiac hypertrophy, anemia, polycythemia, documented previous 
myocardial infarction, valvular heart disease or angiographic 
evidence of collateral circulation. 
The procedures for the determination of the CFR and the 
quantitative assessment of coronary arterial dimensions from 
35 mm cinefilm were implemented on the computer-based Cardio-
vascular Angiography Analysis System (CAAS), and have been 
extensively described (4,9). 
Angiographic procedure and induction of a maximal hyperemic 
response. 
The heart was atrially paced at a rate just above the 
spontaneous heart rate. An EGG-triggered injection into the 
coronary artery was made with Iopamidol at 3rc through a 
Medrad Mark IV infusion pump. This nonionic contrast agent has 
a viscosity of 9.4 cP at 37°C, an osmolality of 0.796 osm/kg 
and an iodium content of 370 mg/ml. For the left coronary 
artery 7 ml was injected at a flow rate of 4 ml/sec; the 
coronary angiogram was obtained in a left anterior oblique 
projection. For the right coronary artery 5 ml was injected at 
a flow rate of 3 ml/sec and the angiogram was taken in a left 
or right anterior oblique projection. The rate of injection 
the contrast medium was judged to be adequate when backflow of 
contrast medium into the aorta occurred. The angiogram was 
repeated 30 sec after a bolus injection of 10 mg papaverine 
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into the coronary artery (10). 
Quantitative coronary cineangiography 
For the assessment of the absolute and relative dimen-
sions of selected coronary segments with the CAAS, the boun-
daries of a selected coronary segment are detected automati-
cally from optically magnified and video digitized regions of 
interest (ROI) of a cineframe. Calibration of the diameter 
data in absolute values (mm) is achieved by detecting the 
boundaries of a section of the contrast catheter and compari-
son of the computed mean diameter in pixels with the known 
size in millimeters. Each catheter is measured individually 
( ll) • To correct the contour positions of the arterial and 
catheter segments for the pincushion distortion, a correction 
vector is computed for each pixel based on a computer-proces-
sed cineframe of a centimeter grid placed against the input 
screen of the image intensifier (9). 
The procedure for contour detection requires the user to 
indicate a number of center positions with the writing tablet 
proximal and distal to the lesion such that the straight line 
segments connecting these points are within the artery. The 
contours of the vessel are detected on the basis of the 
weighted sum of first and second derivative functions applied 
to the digitized brightness information along scanlines 
perpendicular to the local centerline directions. From the 
detected contours the diameter function is determined in 
absolute millimeters. In this study, each lesion was analyzed 
in at least two, preferably orthogonal projections. Three 
projections were used if two orthogonal projections could not 
be obtained of a nonsymmetric lesion. 
Since the functional significance of a stenosis is also 
related to the expected normal cross-sectional area of the 
vessel at the point of the obstruction, we use a computer 
estimation of the original arterial dimensions at the site of 
the obstruction to define the reference region (interpolated 
reference) (4,9). Representative examples of two orthogonal 
views with the detected contours of a right coronary artery 
and the reconstructed reference contours are shown in figure 1 
• The computed reference diameter function allows for tapering 
of the vessel. 
The interpolated percentage area stenosis (AS) is then 
computed by comparing the squared minimal diameter value at 
the obstruction with the squared value of the reference 
diameter function at this position assuming circular cross-
section: 
AS = ( 1 - (minimal diameter/reference diameter) 2 ) x 100%. 
The estimation of the length of the obstruction is made on the 
basis of a curvature analysis of the diameter function (9). 
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A 
B 
Figure 1 
Detected contours from a representative stenosis in the right coronary artery 
superimposed on the original video image. The normal size of the artery over the 
obstruction is estimated by the interpolated method, and the resulting reference 
contours are shown. 
A: Right anterior oblique projection. 
B: Left anterior oblique projection. 
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Coronary perfusion pressure distal of the stenosis is estima-
ted by subtracting from the mean aortic pressure the theoreti-
cal pressure drop over the stenosis for coronary flows of 1,2, 
and 3 ml/sec (5,12). The theoretical pressure drop was calcu-
lated according to the following hemodynamic equation: 
PD = (25.1uL /MLCA2 ) Q + d/0.266 (1/MLCA- 1/NA) 2 Q2 
where PD = pressure drop, u = absolute blood viscosity, L = 
stenosis length, NA interpolated normal cross-sectional 
area, MLCA = minimal luminal cross-sectional area, Q = volume 
flow, d = blood density (13, 14). Since each stenosis was 
analyzed in 2 or 3 angiographic projections, 2 or 3 pressure 
drops were calculated the mean value was used. To assess the 
influence of 10 mg intracoronary papaverine on the dimensions 
of the epicardial coronary arteries, coronary angiograms 
obtained before and during the measurement of coronary flow 
reserve were compared. Nine normal coronary arteries and 8 
coronary arteries with a focal obstructive lesion were ana-
lysed quantitatively. These 8 coronary artery segments were 
selected because the obstructive lesions were clearly visible 
and perpendicular to the image intensifier during the measure-
ment coronary flow reserve. 
Coronary flow reserve measurements 
For the quantitation of the relative coronary blood flow 
(8), five to eight end-diastolic cineframes were selected from 
successive cardiac cycles (8). Logarithmic nonmagnified 
mask-mode background subtraction was applied to the image 
subset to eliminate noncontrast medium densities. The last 
end-diastolic frame prior to contrast administration was 
chosen as the mask. Each digitized image was also corrected 
for the dark current of the video camera. From the sequence of 
background subtracted images, a contrast arrival time image 
was determined, with the use of a fixed density threshold. In 
this image, each pixel was labeled with the sequence number of 
the cardiac cycle in which the pixel intensity level for the 
first time exceeded the threshold, starting from the beginning 
of the EGG-triggered contrast injection. This density thres-
hold was empirically derived by analyzing in 12 patients the 
relationship between the threshold and the baseline and 
hyperemic .myocardial contrast medium appearance times as well 
as the resulting coronary flow reserve. The intensity level in 
more than 90% of pixels exceeded thresholds of 4,8 and 12% 
(table 1). In 25% of patients less than 90% of pixels reached 
the intensity level of 16% making calculation of the contrast 
medium accumulation unreliable. With a threshold of 4%, and to 
a lesser extent with a threshold of 8%, background noise was 
not eliminated resulting in very short contrast medium appea-
rance times. Therefore we used a threshold of 12% in all our 
56 
Table 1: Influence of density threshold on myocardial contrast 
medium appearance time and coronary flow reserve (CFR) 
DT 4% 8% 12% 16% 
AT! l. 96 2.48 2.88 3.39 
AT2 1.58 l. 73 l. 97 2.19 
CFR 2.26 * 2.63 NS 2.66 * 2.82 
DT = density threshold in percentage of the brightness scale, 
AT! = baseline myocardial contrast medium appearance time, AT2 
= hyperemic myocardial contrast medium appearance time, * = p 
less than 0,01, ns =not significant, AT!, AT2 and CFR are 
mean values calculated from 12 patients. 
patients. In addition to the contrast arrival time image, a 
density image was computed, with each pixel intensity value 
being representative for the maximal local contrast medium 
accumulation. In the second step, the information from these 
two images was combined into a dual parameter image, the 
contrast medium appearance picture. In this picture the 
appearance time was color coded and the contrast medium 
accumulation was represented by the color intensity. 
The coronary flow reserve was defined as the ratio of the 
regional flow computed from a hyperemic image divided by the 
regional flow of the corresponding baseline image. Regional 
flow values were quantitatively determined using the following 
videodensitometric principle: regional blood flow (Q) 
regional vascular volume (RVV)/transit time. Regional vascular 
volume was assessed from the logarithmic mask-mode subtraction 
images. Since at the flow rates we used essentially all 
epicardial blood is replaced by contrast the brightness 
information is proportional (factor k) to the local thickness 
of the projected vascular system (Beers-Lambert relationship). 
If the same regions of interest are used for baseline and 
hyperemic conditions, the coronary flow reserve can be deter-
mined from the regional blood flow values Q(h) and Q(b) at the 
hyperemic and baseline states respectively: 
CFR = Q(h)/Q(b) = CD(h)/AT(h) : CD(b)/AT(b) 
where CD is the mean contrast density and AT the mean appea-
rance time. 
Mean contrast medium appearance time and density were 
computed within user-defined ROI's. The ROI's were chosen in 
such a way that the epicardial arteries visible on the angio-
gram, including diagonal and septal branches, the aortic root, 
the coronary sinus and the great cardiac vein were excluded 
from the analysis. 
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When coronary angiograms were repeated within 5 min, no 
significant differences were found in AT and CD. The mean 
difference between duplicate measurements of AT was 7% with a 
standard deviation of 8%. The mean difference between dupli-
cate measurements of CD was 6% with a standard deviation of 
5%. 
Statistical methods 
Comparisons between groups were made with Student's 
t-test. Leastsquare regression analyses were used to find the 
"best fit" relationship between coronary flow reserve and the 
quantitatively assessed coronary artery dimensions. 
Results 
The mean age of the 29 patients was 56 years (range 
31-71); four patients were women, 25 men. All 17 patients with 
CAD had single vessel disease and all 29 patients had a normal 
left ventricular ejection fraction (more than 55%). 
The results of the quantitative analysis of the coronary 
arteries and the measurements of coronary flow reserve are 
shown in table 2. The investigated vessel was the left ante-
rior descending coronary artery in 16 of the patients, the 
right coronary artery in 7 patients and the left circumflex 
coronary artery in 6 patients. An average of 2.2 angiographic 
projections was used for the quantitative morphologic analyses 
of the coronary angiogram. The mean cross-sectional area of 
the 12 normal coronary arteries, measured in the proximal 
parts before any branching was 7.6 mm2 (range 5.4 to 10.3 
mm2 ). The interpolated reference cross-sectional area of the 
vessels with CAD was 7.0 mm2 (SD ± 1.7 mm2 ). In vessels with 
CAD the AS ranged from 51% to 93% (mean 76%). The minimal 
luminal cross-sectional area (MLCA) ranged from 0.4 to 4.1 mm2 
(mean 1.7 mm2 ). The length of the obstructive lesions ranged 
from 3.0 to 13.6 mm, (mean 7.0 w~). 
The influence of 10 mg intracoronary papaverine on the 
dimensions of normal coronary arteries and of coronary arte-
ries with a focal obstructive lesion are shown in table 3. No 
change occurred in the cross-sectional areas of normal coro-
nary arteries and of the pre-and post-stenotic coronary artery 
segments after intracoronary papaverine. There was a small but 
significant decrease in AS (p less than 0.05, mean 3% ranging 
from 0 to 9%). The MLCA increased from a mean value of 2.1 mm 2 
to 2.6 mm2 (p less than 0.05, mean 24%, range 8 to 39%). 
The 12 normal coronary arteries had a mean coronary flow 
reserve of 5. 0 (SD ± 0. 8). coronary flow reserve in vessels 
with CAD ranged from 0.5 to 3.9, mean: 1.6 (SD ± 0.9) and 
differed significantly (p = 0. 001) from the coronary flow 
reserve of normal coronary arteries. The relationship between 
coronary flow reserve and MLCA was best described by a quadra-
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Table 2: Results 
QACA* CFR-measurements 
ang pr MLCA AS L NA Al D1 A2 D2 CFR 
A LSO,RIO 
C CA,CR 
A CR,RIO 
R RAO,LAO 
C LAO,RIO 
C RAO,LAO 
A LSO,RIO 
R RAO,LAO 
A CR,CA 
R RAO,LAO 
A RAO,LSO 
A CR, CA 
R RAO,LAO 2.9 54 
R RAO,LAO 2.2 66 
A RAO,CR,CA 4.1 57 
C RAO,LAO 3.5 63 
R RAO,LAO 2.8 63 
C LAO,RIO,CA3.2 51 
A LSO,CR,RI01.6 81 
A CR,CA 0.7 90 
A RAO,LSO,CR0.9 82 
A CR,RIO,LS01.6 82 
A LAO,RIO 1.1 87 
A CR,CA,RAO 0.8 89 
A LSO,RAO 0.4 93 
R RAO,LAO 0.7 91 
A LSO,RAO 1.7 76 
C LAO,CA 0.7 89 
A CR,LSO,RI00.4 86 
Abbreviations: 
7.6 2.7 77 1.1 202 6.5 
10.3 3.7 54 1.8 162 6.2 
7.6 2.9 59 1.2 128 5.3 
7.3 3.3 69 1.5 163 5.2 
8.6 2.1 79 1.2 226 5.0 
5.7 3.7 57 1.5 115 5.0 
7.0 4.2 38 2.1. 94 4.9 
7.8 3.3 42 2.2 133 4.8 
9.4 4.2 45 2.1 111 4.7 
9.8 3.6 70 1.8 161 4.6 
5.4 3.2 70 1.8 178 4.5 
4.7 2.2 80 1.2 148 3.4 
5.1 6.5 4.8 49 2.4 95 3.9 
8.5 6.4 3.3 98 1.9 174 3.1 
5.7 9.5 3.5 57 2.5 102 2.5 
5.7 9.4 3.2 76 2.1 123 2.5 
5.5 7.7 3.0 65 1.6 85 2.4 
3.0 6.5 2.9 45 2.1 54 1.7 
5.2 8.3 2.3 94 1.9 116 1.5 
8.7 6.8 2.0 74 2.1 105 1.4 
13.6 5.1 2.8 60 2.6 73 1.3 
7.9 8.9 2.2 74 2.3 100 1.3 
9.6 8.2 2.8 57 2.6 59 1.1 
5.9 7.4 2.4 74 2.1 62 1.0 
6.1 6.1 3.6 36 3.8 33 0.9 
6.2 7.2 2.8 103 2.5 80 0.9 
9.9 7.1 2.5 111 2.3 78 0.8 
5.1 6.1 1.4 40 2.3 47 0.7 
6.6 2.9 2.8 56 3.8 39 0.5 
DPP 
Ao P1 P2 P3 
78 77 77 75 
92 90 88 85 
96 96 95 95 
94 94 93 92 
89 88 87 86 
84 84 83 82 
74 72 67 61 
101 81 50 6 
86 70 48 20 
84 81 75 68 
94 86 73 55 
84 72 51 21 
82 33-58-190 
89 73 45 4 
88 85 80 73 
79 65 39 2 
94 45-38-157 
QACA = quantitative analysis of the coronary angiogram; ang pr= 
angiographic projection; MLCA= minimal luminal cross-sectional 
area (mm2 ); AS= area stenosis (%); L= length of the obstructive 
lesions (mm); NA= normal area from normal coronary arteries or 
interpolated reference area of coronary arteries with CAD 
(mm2 ); CFR= coronary flow reserve; A1= myocardial contrast 
appearence time of basal angiogram; D1= myocardial contrast 
density of basal angiogram; A2= myocardial contrast appearance 
time of angiogram after papaverine; D2= myocardial contrast 
density of angiogram after papaverine; Ao= mean aortic pres-
sure; P%= actual pressure drop/Ao x 100% and DPP= distal 
coronary perfusion pressure at coronary flows of 1 ml/sec 
(PI), 2 ml/sec (P2) and 3 ml/sec (P3) ; LSO= left superior 
oblique; RIO= right inferior oblique; CR= cranial; RAO= right 
anterior oblique; LAO= left anterior oblique; CA= caudal. A= 
anterior descending, C= circumflex, R= right coronary artery. 
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tic equation: 
CFR = 0.28 + 0.91 MLCA- 0.039 (MLCA) 2 , 
(r = 0.92, SEE= 0.73) 
and is shown in fig 2. The relationship between coroanry flow 
reserve and AS was best described by a quadratic equation: 
CFR = 5.0 - 3.3 (AS x 10-2) - 1.3 (AS x 10-2) 2 , 
(r = 0.92, SEE= 0.74) 
and is shown in fig 3. The 12 normal coronary arteries (group 
A) were compared with the 6 coronary arteries with a MLCA 
between 2 and 4,5 mm 2 and an AS between 50 and 70% (group B) 
and with the 11 coronary arteries with a MLCA less than 2 mm2 
and an AS in excess of 70% (group C). In group C, coronary 
flow reserve was 1.0 (SD ± 0.3) and differed significantly (p 
= 0.001) from that of group B: 2.6 (SD ± 0.7). The difference 
between group A and group B was also significant (p = 0.001), 
see Table 4. 
From the MLCA, the length of the obstructive lesion and 
the normal cross-sectional area distal to the stenosis a 
theoretical pressure-flow relationship was calculated, for 
each angiographic projection from which the mean values were 
used for further analyzes (table 2). The pressure-flow rela-
tionship for group B arteries differed significantly (p = 
0.01) from that for group C. Group C could be subdivided with 
respect to coronary flow reserve on the basis of these theore-
tical pressure-flow relationships. The pressure-flow relation-
ship of coronary arteries with a coronary flow reserve of 1 or 
less differed significantly from those of coronary arteries 
with a coronary flow reserve greater than 1 (p = 0.01). A 
distal coronary perfusion pressure below 40 mmHg at a coronary 
flow of 3 ml/sec, identified 5 out of 6 patients with a 
coronary flow reserve of 1 or less, (sensitivity: 83%). Only 2 
of 12 vessels with CAD and a coronary flow reserve greater 
than 1 had a distal coronary perfusion pressure below 40 mmHg 
(specifity: 82%). 
Discussion 
In the clinical setting assessment of the relationship 
between the angiographic degree of stenosis and the actual 
impairment of perfusion has been hampered by two basic pro-
blems that now seem to have been solved by new technical 
developments. First, the recent description of a technique 
using digital subtraction angiography has rendered the assess-
ment of regionat8Joronary flow reserve possible during cardiac 
catheterization • Second, the large intraobserver and 
interobserver variability associated with the visual assess-
ment of the coronary angiogram has led to development of 
methods of computer- based quantitative analysis, including 
automated contour detection, which improve accuracy and allow 
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Table 3: Influence of 10 mg intracoronary papaverine on 
coronary artery dimensions. 
9 normal 8 coronary arteries with a focal obstructive 
coronary arteries coronary artery segment 
pre-stenotic 
area (mm2 ) area (mm2 ) MLCA (mm2 ) 
A 10.2 9.1 2.1 
ns ns 
* 
B 10.2 9.6 2.6 
A: before intracoronary papaverine, B: 30 
nary papaverine, * = less than 0.05, NS = 
post-stenotic 
AS % area (mm2 ) 
75 6.6 
* 
ns 
72 6.6 
sec after intracoro-
not significant. 
for the precise determination of most dimensions of a given 
stenosis in a coronary artery (4,9). 
Pharmacological vasodilation 
One of the methodological cornerstones in the assessment 
of coronary flow reserve is the induction of a maximal hyper-
emic response (15). A wide range of values for the coronary 
flow reserve of normal coronary arteries has been reported, 
depending on the vasodilator used (16,17). Carefully validated 
studies with a Doppler-catheter suggest that the maximal 
coronary blood flow velocity of a normal coronary artery is 4 
to 6 times the resting value ( 16). The most commonly used 
vasodilator agents are dipyridamole and hyperosmolar ionic 
contrast media. An adequate intravenous infusion of dipyrida-
mole results in maximal coronary vasodilation, but its long-
lasting effect makes repeated assessment of the hyperemic 
response of a coronary vascular bed or assessment of different 
coronary vascular beds during the same procedure impossible. 
Hyperosmolar ionic contrast media do not produce maximal 
vasodilation (10). 
The exact dose of intracoronary papaverine that is needed 
to induce maximal coronary vasodilation has recently been 
established. Wilson an White compared the coronary hyperemic 
response after 4,8, 12 and 16 mg intracoronary papaverine and 
reported a maximal hyperemic response after 8 or 12 mg in all 
coronary arteries (10). Conversely, coronary steal phenomenon 
has been observed following pharmacological vasodilation. We 
recorded a coronary flow reserve of less than 1.0, in some of 
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Table 4: Relation between quantitative assessed coronary 
artery dimensions and CFR. 
normal arteries 
group A 
N = 12 
more than 4.5 
arteries 
group B 
N = 6 
2-4.5 
with CAD 
group C 
N = 11 
less than 2 
AS(%) 0 50-70 more than 70 
CFR(mean ± SD) 5.0 ± 0.8 * 2.6 ± 0.7 
* 
1.0 ± 0.3 
CFR - coronary flow reserve, MLCA - minimal luminal 
cross-sectional area, AS = area stenosis, * = p less than 
0.01. 
Table 5: Calculated distal coronary perfusion pressure (mmHg) 
for theoretical coronary flows of 1 (P1),2 (P2) and 3 (P3) ml/sec, of vessels with CAD subdivided according to CFR. 
CFR 
No of 
patients 
mean range AS MLCA Ao P1 P2 P3 
(%) (mm2) (mmHg) 
A 6 2.6 1.7-3.9 59 3.1 89 88 87 86 
B 5 1.3 1.1-1.5 86 1.1 88 78 63 42 
c 6 0.8 0.5-1.0 87 0.8 86 62 20 -41 
Abbreviations: CAD - coronary artery disease, CFR - coronary 
flow reserve, AS% = percentage area stenosis, MLCA = minimal 
luminal cross-sectional area, Ao = mean aortic pressure, A = 
CFR greater than 1.6, B = CFR greater than 1.0 but less than 
1.6, C = CFR 1.0 or less. 
Table 6: Identification of coronary arteries with a critical 
stenosis on the basis of calculated distal coronary 
perfusion pressure (DPP) 
DPP (mmHg) CFR (mean ± SD) 
less than 40 0.96 ± 0.3 
p 0.01 
greater than 40 2.1 ± 0.9 
CFR 1. 0 or less 
CFR greater than 1.0 
no of patients 
5 2 
1 9 
CFR = coronary flow reserve, sensitivity: 5/6 x 100% - 83%, 
specifity: 9/11 x 100% = 82%. 
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our patients who received papaverine, and Bates et al (17) 
made the same observation in patients receiving hyperosmolar 
ionic contrast medium. 
Relationship between coronary artery dimensions and coronary 
flow reserve 
In the experimental animal the physiological significance 
of artificially produced arterial stenoses has been extensi-
vely studied (14,18-21). Gould et al produced varying degrees 
of coronary narrowing and showed that stenoses in excess of 
30-45% diameter narrowing reduced coronary vasodilator respon-
ses in a predictable fashion (20) • However, in human beings 
with CAD the relationship between the visually estimated 
percentage diameter stenosis and the consequent reduction in 
coronary flow reserve is poor (1). Harrison et al found that 
MLCA predicted the coronary flow reserve better than percen-
tage area stenose in proximal lesions in the left anterior 
descending coronary artery (22). Due to diffuse CAD the 
estimation of the normal coronary arterial dimensions was 
impossible, and precluded the use of relative measures of 
stenosis severity. In our patients the interpolated reference 
cross-sectional area of the vessels with CAD was on average 
7.0 mm2 and the cross-sectional areas of the 12 normal coro-
nary arteries was on average 7. 6 mm2 which indicates the 
isolated and focal character of their coronary artery disease. 
Therefore, stenosis severity could be assessed in absolute 
measurements (MLCA) as well as relative percentage (AS) and 
these two parameters were similarly related to coronary flow 
reserve. AS and MLCA were curvilinearly related to coronary 
flow reserve and these relations were best described by 
quadratic equations. Harrison et al found in vessels with an 
expected normal cross-sectional area between 7 and 10 mm2 , 
that a MLCA below 3. 5 mm2 was predictive of a decreased 
coronary flow reserve. We observed in vessels with an expected 
normal cross-sectional area of 7.0 mm2 (SD ± 1.7 mm2 ) that a 
MLCA below 4.5 mm2 was associated with a decreased coronary 
flow reserve. 
In a previous study from our laboratory the relation 
between the pressure-drop over a stenosis and the MLCA was 
analyzed (7). A curvilinear relation was found with a steep 
increase in pressuredrop once the MLCA is less than 2 nm2 • The 
present study confirms the discriminant value of this crite-
rium (table 4) • 
Other angiographic factors that are important in the predic-
tion of coronary flow reserve. 
A pressure-flow relationship that characterizes the 
severity of the coronary stenosis can be derived, by means of 
hemodynamic equations using MLCA, the length of the obstruc-
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tive lesion and the normal distal cross-sectional area of the 
coronary artery. From the relation between coronary perfusion 
pressure and coronary flow under conditions of maximal coro-
nary vasodilation as described by Bache and Schwartz (23), and 
assuming a resting coronary flow velocity of 15 em/sec, 
Kirkeeide et al calculated a coronary flow reserve from the 
angiographic data. They showed in dogs the good correlation 
between such an angiographic approach and measured coronary 
flow reserve (21). In our patients the calculated pressure 
flow relations were related to the reduction in coronary flow 
reserve (table 5). A pressure drop over a stenosis at a flow 
of 3 ml/sec resulting in a distal perfusion pressure below 40 
mmHg indicated the existence of a critical stenosis, defined 
as a vessel with a coronary flow reserve of 1 or less. With 
the use of this criterion, patients with severe CAD and a 
critical stenosis can be identified with a high sensitivity 
(83%) and specificity (82%) (table 6). The rationale for use 
of this pressure is based on previous observations that 
reactive coronary hyperemia is abolished when coronary artery 
perfusion pressure drops below this value (24). 
Limitations 
The intracoronary administration of contrast medium 
results in profound alterations in coronary blood flow, 
characterized by depression in the first seconds followed by 
hyperemia (25). The magnitude and timing of these changes 
depends primarily on amount, iodine concentration and inj ec-
tion rate of the contrast medium (26). The hyperemic to 
baseline coronary blood flow ratio nevertheless remains 
unchanged within the first 5 sec after contrast medium injec-
tion when care is taken to keep these factors constant 
(25,26). The selection of the fixed density threshold influen-
ces the measured myocardial contrast medium appearance time, 
and thus the resulting coronary flow reserve. When however, 
this threshold is chosen so that background noise is elimina-
ted and more than 90% of pixels in the chosen ROI reach the 
threshold, this influence is insignificant (see table 1). 
Although we found a clear relationship between AS, MLCA 
and coronary flow reserve, individual coronary arteries, with 
moderate CAD may differ considerably in coronary flow reserve. 
Approaches that integrate all angiographic dimensions are 
conceptually attractive (21), but limited by the fact that 
coronary flow is estimated. We used theoretical flows of 1, 2 
and 3 ml/ sec to define the pressure-flow relationship since 
resting coronary blood flow in a LAD is 1.3 (range 1.0 - 2.1) 
ml/s (6). 
Many other factors are potential causes of a decreased 
coronary flow reserve. In addition to cardiac hypertrophy and 
previous myocardial infarction, anemia, polycythemia, valvular 
heart disease and collateral circulation may influence coro-
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nary flow reserve (27-30). We have carefully tried to exclude 
patients with these conditions. 
Changes in vasomotor tone are not only an important 
source of variability in the analysis of the coronary angio-
gram (4) but may also influence the coronary flow reserve 
measurement (30,31). Therefore, we continued the medical 
treatment including nitrates and calcium antagonists in all 
our patients with CAD on the day of the investigation. Most 
important to our study, this could affect the papaverine 
induced change in the geometry of stenosis. The increase in 
MLCA (mean 24%, range: 8-39%) and the decrease in AS (mean 3%, 
range: 0-9%) are methodologically disturbing, since they 
result in an increase in the measured coronary flow reserve 
and contribute to the variability in the relation between AS, 
MLCA and coronary flow reserve. Alterations in the volume of 
the epicardial coronary artery could also influence the 
measurement of coronary flow reserve by changing the coronary 
blood flow velocity and thus myocardial appearance time of the 
contrast medium. However, intracoronary papaverine did not 
change the diameter of normal coronary arteries nor the 
diameter of pre- and post-stenotic coronary artery segments. 
This is contrary to the findings of others (31), and probably 
a consequence of the medical treatment. Finally, these fin-
dings can not be extrapolated to other patient subsets, for 
instance patients with more diffuse CAD, collateral circula-
tion or stenosis in more distal coronary arteries of smaller 
size. 
In conclusion, the development of a digital angiographic 
technique to measure regional coronary flow reserve and 
computer based quantitative analysis of the coronary angio-
gram, including automated contour detection, has made the 
assessment of the relationship between a coronary artery 
stenosis and its physiological consequences possible in human 
beings during cardiac catheterization. The reduction in 
coronary flow reserve as a result of a coronary stenosis can 
be predicted with reasonable accuracy by quantitative assess-
ment of coronary artery dimensions. 
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CHAPTER 6: WHICH CINEANGIOGRAPHICALLY ASSESSED ANATOMIC 
PARAMETER CORRELATES BEST WITH FUNCTIONAL MEASUREMENTS OF 
STENOSIS SEVERITY? A COMPARISON OF QUANTITATIVE ANALYSIS OF 
THE CORONARY CINEANGIOGRAM WITH MEASURED CORONARY FLOW RESERVE 
AND EXERCISE/REDISTRIBUTION THALLIUM-201 SCINTIGRAPHY. 
Abstract 
The goal of this investigation was to establish which 
measured anatomic parameter of stenotic lesions correlates 
best with functional severity. Therefore, 38 patients with 
single vessel -disease underwent coronary cineangiography and 
exercise/redistribution thallium-201 scintigraphy. The compu-
terbased Cardiovascular Angiography Analysis System was used 
to determine the cross-sectional area at the site of obstruc-
tion (OA), percentage diameter stenosis (DS), and calculate 
the pressure drop over the stenosis (PD) using fluid dynamic 
equations. Coronary flow reserve was measured radiographi-
cally. Myocardial perfusion defects on thallium scintigrams 
were analysed quantitatively and by visual interpretation. The 
relations between coronary flow reserve (CFR) and the 3 
anatomic parameters were described by the following equations: 
CFR 4.6- 0.053 DS, r = 0.82, SEE: 0.79. 
CFR = 0.5 + 0.75 OA, r = 0.87, SEE: 0.68. 
CFR = 3.6 - 1.5 log PD, r = 0.90, SEE: 0.62. 
The calculated pressure drop was highly predictive of the 
thallium scintigraphy results with a sensitivity of 94% and a 
specifity of 90%. The calculated pressure drop is a better 
anatomic parameter for assessing the functional importance of 
2 stenosis than percentage diameter stenosis or obstruction 
area. However the 95% confidence limits of the relation 
between pressure drop and coronary flow reserve are wide 
making the measurement of coronary flow reserve an indispen-
sable addition to quantitative angiography, especially when 
determining the functional importance of moderately severe 
coronary artery lesions. 
Introduction 
Visual interpretation of the coronary cineangiogram 
inadequately predicts the physiological importance of obstruc-
tive coronary artery disease (1). Computer-based quantitative 
analysis has helped minimize the problems of high interobser-
ver and intraobserver variability in the assessment of the 
anatomic severity of a coronary obstruction (2), and allows 
the calculation of the pressure-flow characteristics of a 
coronary stenosis (3). Exercise/redistribution thallium-201 
perfusion scintigraphy has been used extensively as a non-
invasive means to study the functional consequences of a 
coronary artery stenosis (4,5,6). Recently, the concept of 
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coronary flow reserve has been introduced as a physiological 
measurement of stenosis severity (7,8) and the development of 
digital angiographic techniques has made this measurement 
possible during cardiac catheterization (9,10). In a previous 
study (10) we investigated the relation between minimal 
cross-sectional obstruction area, percentage area stenosis and 
coronary flow reserve. We found a considerable scatter of the 
data despite excellent overall correlations between these two 
quantitative angiographic parameters and coronary flow reserve. 
Approaches that integrate all angiographically determined 
dimensions of an obstruction, such as the calculated pressure-
drop over the stenosis, are attractive as they may allow a 
better angiographic description of functional stenosis severi-
ty (10,11). The goal of this investigation was to study which 
quantitative cineangiographic parameter correlates best with 
functional measurements of stenosis severity. We compared 
percentage diameter stenosis, minimal cross-sectional pbstruc-
tion area and calculated pressure-drop across the stenosis 
with radiographically measured coronary flow reserve and the 
results from exercise/redistribution thallium-201 perfusion 
scintigraphy. 
Patients and methods 
Thirty eight patients with single vessel coronary artery 
disease were studied. The diseased vessel was the left ante-
rior descending coronary artery in 30 patients, the circumflex 
coronary artery in 5 patients and the right coronary artery in 
3 patients. Their mean age was 53 years (range 31-68 years). 
Thirty four (89%) patients were male. Coronary cineangiography 
was performed as part of an ongoing restenosis study after 
percutaneous transluminal coronary angioplasty (28 patients), 
or for chest pain syndromes (10 patients). Informed consent 
was obtained for the additional investigations. All patients 
were studied without premedication, but their medical treat-
ment was continued on the day of the investigation (the 28 
angioplasty patients: calcium antagonist and antiplatelet 
agent, the remaining 10 patients: nitrates, calcium antago-
nists and beta-blockers). Left ventriculography was performed 
in all patients and showed normal systolic and diastolic wall 
motion with an ejection fraction of more than 55%. Patients 
with systemic hypertension, cardiac hypertrophy, documented 
previous myocardial infarction, valvular heart disease, 
angiographic evidence of collateral circulation, anemia or 
polycythemia were excluded as these conditions may influence 
coronary flow reserve (12-14). 
Exercise thallium scintigraphy 
The patients performed a symptom-limited exercise test on 
a bicycle ergometer with stepwise increments of 20 Watt/min on 
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the day before the cardiac catheterization. All patients 
exercised to more than 80% of their expected normal exercise 
capacity (corrected for age, sex and height). This procedure 
has previously been described (15-17). One minute prior to 
maximal exercise, 1,5 mCi Tl-201 was administered. Planar 
imaging was started 3 min. later in 3 views: anterior, left 
anterior oblique 45° and 65°. These same static planar images 
were repeated at rest 4 hours later (redistribution imaging). 
The exercise and redistribution images were processed on a DEC 
gannna-11 system with a quantification procedure developed at 
our institution (15,16). The exercise and redistribution 
images were spatially registered in the computer on the basis 
of the detected positions of point sources defined with a 
cobalt markerpen at two positions on the patients chest. 
Following automated left ventricular contour detection and 
interpolative background correction, exercise, redistribution 
and washout circumferential profiles were computed at 6° 
intervals (quantitative thallium perfusion analysis). The late 
circumferential profiles were normalized to a delay of 4 hours 
between the early and late images. The profiles of the early 
and late images were normalized to 100% and compared with 
normal values defined by the lOth and 90th percentiles of the 
profiles of a group of individuals without apparent heart 
disease. Semiquantitative thallium uptake in all regions was 
scored both in the immediate post exercise and late images on 
a 3-point scale. The scores of regions related to the diseased 
coronary artery were summed per patient and the difference 
between the post-exercise and late images was taken as a 
measure of the amount of redistribution between the post-
exercise and late images. The analog Polaroid images from the 
gamma camera, the background corrected images and the circum-
ferential profiles were interpreted prospectively on a routine 
basis by 3 experienced observers without knowledge of the 
angiographic data. Transient and persistent defects were 
considered abnormal (15,16). 
Quantitative coronary cineangiography 
The coronary arterial dimensions were determined with the 
computer-based Cardiovascular Angiography Analysis System 
(CAAS) (2, 10, 18). In essence, the boundaries of a selected 
coronary artery segment were detected automatically from 
optically magnified and video digitized regions of interest of 
a cineframe. Calibration of the diameter data in absolute 
values (mm) was achieved by detecting the boundaries of a 
section of the contrast catheter and comparing the mean 
diameter in pixels with the known size in millimeter (19). The 
contour positions of the arterial and catheter segments were 
corrected for the pincushion distortion (18). A computer-
estimation of the original arterial dimensions at the site of 
obstruction was used to define the reference region (18). The 
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interpolated percentage diameter stenosis and the minimal 
obstruction area (mm2 ) were calculated by averaging the values 
from at least two, preferably orthogonal angiographic views. 
The length of the obstructions was assessed from curvature 
analysis of the derived diameter function. A mean of 2. 3 
angiographic views per patient was used in this study. 
The theoretical pressure drop for an hyperemic flow of 
three times resting coronary blood flow was calculated accor-
ding to the following hemodynamic equatipn (10,11,20): 
PD = f Q + s Q2 
where PD = pressure drop, f = coefficient of viscous resis-
tance and s = coefficient of separation resistance. Volume 
flow was calculated from the interpolated reference cross-
sectional area, assuming a coronary blood flow velocity of 15 
cm/s. 
Coronary flow reserve measurements 
The c~onary flow reserve measurement with digital 
subtraction cineangiography from 35 mm cinefilm has been 
implemented on the CAAS (10). The heart was atrially paced at 
a rate just above the spontaneous heart rate. An ECG-triggered 
injection into the coronary artery was made with a fixed 
amount of j opamidol through a Medrad Mark IV infusion pump. 
The injection rate of the contrast medium was judged to be 
adequate when back flow of contrast medium into the aorta 
occurred. The angiogram was repeated 30 sec after pharmaco-
logically induced hyperemia by a bolus injection of 12.5 mg 
papaverine into the coronary artery. Five end-diastolic 
cineframes were selected from successive cardiac cycles. 
Logarithmic nonmagnified mask-mode background subtraction was 
applied to the image subset to eliminate noncontrast medium 
densities. The last end-diastolic frame prior to contrast 
administration was chosen as the mask. From the sequence of 
·background subtracted images, a contrast arrival time image 
was determined, using an empirically derived fixed density 
threshold (10). In addition to the contrast arrival time 
image, a density image was computed, with each pixel intensity 
value being representative for the maximal local contrast 
medium accumulation. Coronary flow reserve (CFR) was then be 
calculated as: 
CFR = Qh/Qb = Dh/Th : Db/Tb 
where Q is regional blood flow, D is the mean contrast density 
and T the mean appearance time at baseline (b) and hyperemia 
(h). Mean contrast medium appearance time and density were 
computed within user-defined regions of interest that were 
chosen in such a way that the epicardial coronary arteries 
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visible on the angiogram, the coronary sinus and the great 
cardiac vein were excluded from the analysis. Normal values 
for coronary flow reserve in our laboratory have been esta-
blished. In 24 patients (12 have been published previously 
(10) with normal coronary arteries and absence of factors 
known to decrease vascular reserve, the coronary flow reserve 
(mean ± SD) was 5.0 ± 0.8. Therefore, a coronary flow reserve 
is defined as normal when greater or equal to 3.4. 
Statistical analysis 
Least squares linear and non-linear regression analyses 
were used to define the best-fit relations between the quanti-
tative cineangiographic parameters and coronary flow reserve. 
The differences between the measured coronary flow reserve and 
the best-fit relations were compared with variance analysis 
and the student-t test for paired observations, to determine 
which quantitative angiographic parameter correlates best with 
coronary flow reserve. 
Results 
The measured coronary flow reserve ranged from 0.4 to 
5.5. The interpolated reference area ranged from 2.9 to 9.4 
mm2 , the length of the stenotic lesions ranged from 3. 2 to 
18.6 mm, the obstruction area ranged from 0.4 to 6.8 mm2 and 
the diameter stenosis ranged from 6 to 75%. The calculated 
pressure-drop ranged from 0.3 to 144 mmHg. The thallium uptake 
score on the post exercise images ranged from 0 to 12, the 
thallium uptake score on the late images ranged from 0 to 8. 
The difference in score between post exercise and late images 
(redistribution) ranged from 0 to 10. The quantitative analy-
sis of the circumferential post exercise and late thallium 
images revealed a mean defect on the post exercise image of 
157 (range 0-1094), on the late image 68 (range 0-399) with a 
mean difference (redistribution) of 89 (range 0-1081). The 
final result of the thallium analysis procedure was that the 3 
observers judged 18 thallium scintigrams to indicate exercise 
induced ischemia. The sensitivity and specifity of thallium 
scintigraphy to detect patients with an abnormal coronary flow 
reserve (less than 3.4) was 17/25 = 68% and 18/18 = 100% 
respectively. 
Relations between percentage diameter stenosis, obstruction 
area, calculated pressure drop and measured coronary flow 
reserve. 
The relation between coronary flow reserve (CFR) and 
percentage diameter stenosis (DS) was best described by the 
equation: 
CFR = 4.6- 0.053 DS, (r=0.82, SEE: 0.79), see fig. 1. 
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Table 1: Prediction of measured coronary flow reserve with 
quantitative cineangiography. 
X-ray predicted CFR 2.5 95% confidence limits measured CFR 
DS: 40% 
OA: 2.7 mm2 
PD: 5.6 mmHg 
0.9 4.1 
1.1 - 3.9 
1.3 3.7 
CFR = coronary flow reserve; DS = percentage diameter 
stenosis; OA = obstruction area; PD = calculated pressure-drop 
over the stenosis. 
The relation between coronary flow reserve and obstruction 
area (OA) was best described by the equation: 
CFR = 0.75 OA + 0.5, (r=0.87, SEE: 0.68), see fig. 2. 
The relation between coronary flow reserve and the calculated 
pressure-drop (PD) was best described by the equation: 
CFR = 3.6- 1.5 log PD, (r=0.90, SEE: 0.62), see fig. 3. 
The calculated pressure drop correlated significantly better 
(p = less than 0.05) with measured coronary flow reserve than 
percentage diameter stenosis and obstruction area. 
The predictive value of the 3 angiographic parameters in 
relation to the measured coronary flow reserve is shown in 
table 1 by giving the 95% confidence intervals for a predicted 
coronary flow reserve of 2.5. The sensitivity and specificity 
of the 3 angiographic parameters in identifying patients with 
an abnormal measured coronary flow reserve is shown in figure 
4 and a positive Thallium scintigram is shown in figure 5. 
Discussion 
In the experimental animal the physiological significance 
of artificially produced arterial stenoses have been extensi-
vely studied (20,22). Gould et al produced varying degrees of 
coronary narrowing and showed that stenoses in excess of 30-
45% diameter narrowing reduced coronary vasodilator responses 
in a predictable fashion (22). However, in human beings with 
coronary artery disease the relation between the visually 
estimated percentage diameter stenosis and the consequent 
reduction in coronary flow reserve is poor (1). The two basic 
problems that have hampered the assessment of the relation 
between the angiographic degree of stenosis and the actual 
impairment of perfusion, now seem to have been solved by new 
technical developments. Firstly, the recent description of a 
technique using digital subtraction has rendered the assess-
ment of regional coronary flow reserve possible during cardiac 
catheterization (9,10). Secondly, the visual assessment of the 
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coronary angiogram with its large intraobserver and interob-
server variability has made way for computer-based quantita-
tive analysis of the coronary angiogram including automated 
contour detection, which improves accuracy and allows for the 
precise determination of most dimensions of a given stenosis 
in a coronary artery (2,I8). 
Description of stenosis severity. 
The measurement of percent diameter narrowing is the most com-
monly employed descriptor of stenosis severity, but its use 
has several disadvantages. Firstly, McPherson et al (23) have 
documented that substantial diffuse intimal atherosclerosis is 
often present, even when angiograms reveal only discrete le-
sions. This may make the estimation of the normal dimensions 
of a coronary artery impossible and precludes the use of 
relative measures of stenosis severity. This may explain why 
I2 of our patients with a percentage diameter stenosis of less 
than 50% had a (moderately) reduced coronary flow reserve. The 
obstruction area (mean ± SD) of these patients was 3.0 ± I.O. 
Six of these patients also had a thallium scintigram indica-
ting exercise induced ischemia. Secondly, many factors besides 
percentage diameter stenosis have a significant influence on 
the pressure-flow characteristics of a stenosis (24). Harrison 
et al (25) compared relative and absolute measurements of 
stenosis severity to coronary flow velocity reserve and 
concluded that obstruction area (mm2 ) was a better descriptor 
of stenosis severity than percentage area stenosis in a 
patient population with probably extensive diffuse coronary 
artery disease. In patients with a discrete stenosis and 
little diffuse disease, relative and absolute measurements of 
stenosis severity convey the same information (I0,26). 
The present study confirms that both percentage diameter 
stenosis and obstruction area correlate well with functional 
measurements of stenosis severity such as measured coronary 
flow reserve and thallium scintigraphy. However, for indivi-
dual patients the prediction of coronary flow reserve using 
percentage diameter stenosis and/or obstruction area is 
limited by the wide 95% confidence intervals (see table I). 
Wilson et al. reported a comparable correlation between these 
two parameters and flow reserve with similar wide 95% confi-
dence intervals (26). Approaches that integrate several 
angiographic dimensions are conceptually attractive, and have 
been validated in dogs (II). The 95% confidence limits of the 
relationship between pressure drop and coronary flow reserve 
are less than those between obstruction area or percentage 
diameter stenosis and coronary flow reserve. This indicates 
that the calculated pressure drop over the stenosis as an 
integrated measurement of multiple angiographic parameters is 
indeed a more accurate anatomic description of the functional 
consequences of a coronary artery lesion. The calculated 
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pressure drop is a better parameter to differentiate patients 
with normal from abnormal coronary flow reserve, and predicts 
the results of thallium scintigraphy more accurately. A reli-
able non-invasive method to predict measured coronary flow 
reserve in individual patients would be a valuable tool for 
clinical decision making. Our results show that planar exer-
cise/redistribution thallium-201 scintigraphy, even with 
semiquantitative or quantitative analysis only partly fulfills 
this task. The results of the thallium perfusion analysis 
procedure showed that thallium perfusion may be normal when 
coronary flow reserve is moderately reduced (between 2. 5 and 
3.4). Nevertheless, almost all patients with severe reduction 
in flow reserve (less than 2.5) had a positive thallium 
scintigram. Therefore thallium scintigraphy can be useful in 
selected patients, for instance to assess the occurrence of 
restenosis after angioplasty for single vessel coronary artery 
disease (17). 
Limitations 
The fact that our study involved predominantly lesions of 
the proximal left anterior descending artery should be taken 
into consideration, and our results can therefore not be 
extrapolated to mid and/or distal lesions in the coronary 
tree. 
Conclusion 
The calculated pressure drop over a stenosis, as an 
integrated measurement of multiple angiographic dimensions, is 
a better anatomic predictor of the functional importance of a 
coronary stenosis than percentage diameter stenosis and 
obstruction area. However, the 95% confidence limits of the 
relation between pressure-drop and coronary flow reserve are 
wide, making practical means to measure coronary flow reserve 
an indispensable addition to quantitative angiography espe-
cially to determine the functional importance of moderately 
severe coronary artery lesions. 
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CHAPTER 7: CORRELATIONS BETWEEN ANGINA PECTORIS, NON-INVASIVE 
EVIDENCE OF MYOCARDIAL ISCHEMIA, CORONARY ARTERY DIMENSIONS 
AND CORONARY FLOW RESERVE. 
Summary 
The correlations between clinical manifestations of 
obstructive coronary artery disease (angina pectoris and 
non-invasive evidence of myocardial ischemia), quantitatively 
determined coronary artery geometry and radiographically 
measured coronary flow reserve were studied in 81 patients. 57 
patients had a single, discrete and proximal lesion, with 
coronary flow reserves ranging from 0. 4 to 5. 5, 24 patients 
had angiographically normal coronary arteries, with coronary 
flow reserves ranging from 3.4 to 6.5 (mean ± SD: 5.0 ± 0.8). 
Therefore, we defined a normal coronary flow reserve as 
greater or equal 3.4. The correlations between measured 
coronary flow reserve (CFR) and cross-sectional obstruction 
area (OA), percentage area stenosis (AS) and X-ray predicted 
coronary flow reserve (X-ray), were best described by the 
following equations respectively: CFR= 0.18 + 1.07 OA -0.058 
OA2 ,r= 0.98, SEE=0.66, CFR= 4.8 -0.024 AS -0.00022 AS 2 , r= 
0.98, SEE= 0.73, and CFR= 1.58 0.36 (X-ray) 2 + 0.097 
(X-ray) 3 , r= 0.98, SEE= 0.68. The sensitivity and specificity 
of the 3 angiographic parameters to identify patients with a 
normal or abnormal measured coronary flow reserve was virtual-
ly the same. 
All 37 patients without angina pectoris at rest or during 
exercise testing, and without non-invasive evidence of myocar-
dial ischemia had a coronary flow reserve greater than 2. 5 
(mean± SD: 4.4 ± 1.0, range: 2.5- 6.5). All 27 patients with 
angina pectoris at rest or during exercise testing, and non-
invasive evidence of myocardial ischemia had a coronary flow 
reserve 2.5 (mean ± SD: 1.1 ± 0.5, range: 0.4 - 2.4). 17 
patients had either angina pectoris or non-invasive evidence 
of myocardial ischemia, with flow reserves ranging from 0.9 -
5.5. 
Introduction 
Atherosclerosis, the most important disease affecting the 
coronary circulati.on, manifests itself primarily by producing 
vascular obstruction. As the atherosclerotic plaque enlarges 
within the vessel wall, the vascular lumen is progressively 
compromised. The clinical manifestations of coronary heart 
disease (angina, non-invasive evidence of myocardial ischemia, 
myocardial dysfunction, acute myocardial infarction, sudden 
death) depend in large part on the severity of the obstructive 
lesions (1). Consequently, a major effort has been put forth 
to define the physiological significance of coronary stenoses 
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in animals (2-6) as well as patients (7-10). Recently, measure-
ment of the coronary flow reserve has been proposed as method 
to evaluate the hemodynamic repe.rcussions of a coronary 
stenosis (11,12). Two techniques have been developed that 
allow the measurement of regional coronary flow reserve in 
conscious humans. The first uses a pulsed Doppler coronary 
artery catheter which can measure intracoronary blood flow 
velocity (13) • The second technique is based on the radio-
graphic assessment of myocardial perfusion using contrast 
medium (9,10,14-17). This technique has the advantage that no 
guide wire or other hardware has to be introduced into the 
coronary artery, and it can therefore be applied during 
routine cardiac catheterization. 
Visual interpretation of the coronary angiogram corre-
lates poorly with the measured coronary flow reserve (7). 
Computer-based quantitative analysis has solved the problems 
of high interobserver and intraobserver variability in the 
assessment of the coronary angiogram (18, 19), and it allows 
the accurate determination of coronary artery dimensions (20). 
Quantitatively determined percent area stenosis and minimal 
cross-sectional area at the site of obstruction show a good 
overall correlation with measured coronary flow reserve in 
patients with limited coronary artery disease (8,9). However, 
the prediction of coronary flow reserve of an individual 
coronary artery is hampered by the wide 95% confidence limits 
of these relations. Kirkeeide et al (21) have proposed to 
calculate an X-ray predicted coronary flow reserve taking 
percent narrowing, absolute stenosis area and the length of 
the stenotic segment into account by use of fluid dynamic 
equations. A good correlation between such an angiographic 
approach and measured coronary flow reserve was found in dogs 
(21). 
The purpose of this study was to investigate the corre-
lations between the clinical manifestions of obstructive 
coronary artery disease (angina pectoris, non-invasive evi-
dence of myocardial ischemia), quantitatively determined 
coronary artery dimensions (minimal cross-sectional area, 
percentage area stenosis, X-ray predicted coronary flow 
reserve) and radiographically measured coronary flow reserve. 
Patients and methods 
57 patients with single vessel coronary artery disease 
and 24 patients with angiographically normal coronary arteries 
were studied. Cardiac catheterization was performed for 
clinical indications without premedication. The pharmacolo-
gical treatment of the patients with angina pectoris and/or 
non-invasive evidence of myocardial ischemia (N=44) was 
continued on the day of the catheterization. It consisted of 
metoprolol (N=37), and/or isosorbidemononitrate (N=33), and/or 
nifedipine (N=43). All coronary artery obstructions were 
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single, discrete lesions in a proximal part of a coronary 
artery that apart from this lesion appeared angiographically 
normal. In 53 patients the left anterior descending coronary 
artery was the investigated vessel, in 18 patients the circum-
flex coronary artery and in 10 patients the right coronary 
artery. None of the patients had systemic hypertension, 
cardiac hypertrophy, anemia, polycythemia, documented previous 
myocardial infarction, valvular heart disease or angiographic 
evidence of collateral circulation. Before the cardiac cathe-
terization the clinical history of the patients was obtained 
by a cardiologist not involved in the quantitative analyses of 
coronary artery dimensions or the coronary flow reserve 
measurements. 10 patients had unstable angina pectoris with 
chest pain at rest and concommitant ischaemic ST-T segment 
changes. The presence or absence of angina pectoris and 
non-invasive evidence of myocardial ischemia during exercise 
testing were recorded in the remaining 71 patients. 25 pa-
tients had angina pectoris during exercise testing. Non-inva-
sive evidence of myocardial ischemia was defined as ST-T 
segments changes during exercise and/or reversible defects on 
thallium perfusion scintigrams. The methodology of exercise 
testing and thallium scintigraphy employed in our institution 
has been described (22). 
Quantitative coronary cineangiography 
The coronary arterial dimensions were determined with the 
computer-based Cardiovascular Angiography Analysis System 
(20). The boundaries of selected coronary artery segments were 
detected automatically from optically magnified and video-digi-
tized regions of interest of a cineframe. Calibration of the 
diameter data in absolute values (mm) was achieved by detec-
ting the boundaries of a section of the contrast catheter and 
comparing the mean diameter in pixels with the known size in 
millimeter (23) • Pincushion distortion was corrected (20) • A 
computer estimation of the original arterial dimensions at the 
site of obstruction was used to define the reference region 
(20). The interpolated percentage area stenosis and the 
minimal cross-sectional area (mm2 ) at the site of obstruction 
were calculated by averaging the values from at least two, 
preferably orthogonal projections. The length of the stenotic 
segments was determined using curvature analysis. X-ray 
predicted coronary flow reserve was calculated as developed by 
Kirkeeide et al (21) and modified by Herrold and Borer (24). 
Coronary flow reserve measurements 
This procedure has been described (9, 17, 25) • The heart 
was atrially paced at a rate just above the spontaneous heart 
rate. An EGG-triggered injection into the coronary artery was 
made with a fixed amount of jopamidol through a Medrad Mark IV 
85 
infusion pump. The injection rate of the contrast medium was 
judged to be adequate when back flow of contrast medium into 
the aorta occurred. The angiogram was repeated 30 sec after a 
bolus injection of 12.5 mg papaverine into the coronary artery 
(9). Five or six end-diastolic cineframes were selected from 
successive cardiac cycles. Logarithmic non-magnified mask-mode 
background subtraction was applied to the image subset, to 
eliminate non-contrast medium densities. The last end-diasto-
lic frame prior to contrast administration was chosen as the 
mask. A contrast appearance time was determined, using an 
empirically derived density threshold (9). A density image was 
computed, with each pixel intensity value being representative 
for the maximal local contrast medium accumulation. The coro-
nary flow reserve was defined as the ratio of the regional 
flow computed from' a hyperemic image (Qh) divided by the 
regional flow of the corresponding baseline image (Qb). 
Coronary flow reserve (CFR) was then calculated as: 
CFR = Qh/Qb = Dh/Th Db/Tb 
where D is the mean contrast density and T the mean appearance 
time at baseline (b) and hyperemia (h). Appearance time and 
density were computed within user-defined regions of interest 
that were chosen in such a way that the epicardial coronary 
arteries visible on the angiogram, the coronary sinus and the 
great cardiac vein were excluded from the analysis (9). 
Statistical methods 
Least square regression analyses were used to find the 
"best fit" relation between coronary flow reserve and the 
quantitatively assessed coronary artery dimensions. 
Results 
The minimal cross-sectional area of the 81 coronary 
arteries ranged from 0. 4 to 10.3 mm2 , the percentage area 
stenosis ranged from 0 to 93%, the calculated X-ray predicted 
coronary flow reserve ranged from 1. 6 to 5. 0. The measured 
coronary flow reserve ranged from 0. 4 to 5. 5 in the 57 pa-
tients with single vessel disease. The 24 patients with 
angiographically normal coronary arteries had a measured 
coronary flow reserve ranging from 3.4 to 6.5 with a mean 
value (± SD) of 5.0 (± 0.8). The relationship between coronary 
flow reserve (CFR) and cross-sectional area at the site of 
obstruction (OA) was best described by the equation: 
CFR = 0.18 + 1.07 OA- 0.058 OA2 , r = 0.98, SEE= 0.66, 
and is shown in figure 1. The relationship between coronary 
flow reserve and percentage area stenosis (AS) was best 
described by the equation: 
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Figure 1 
Correlation between coronary flow reserve and cross-sectional area at the site of 
obstruction. CFR = coronary flow reserve, OA = cross-sectional area at the site of 
obstruction. The best fit curve and the 95 % confidence limits (dashed lines) are 
shown. 
Figure 2 
Correlation between coronary flow reserve and percentage area stenosis. CFR = 
coronary flow reserve, AS= percentage area stenosis. The best fit curve and the 95 % 
confidence limits (dashed lines) are shown. 
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Figure 3 
Correlation between coronary flow reserve and X-ray predicted coronary flow reserve 
calculated according to Kirkeeide et a1 (20). CFR = coronary flow reserve, X-ray 
CFR = X-ray predicted coronary flow reserve. The best fit curve and the 95 % 
confidence limits (dashed lines) are shown. 
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CFR = 4.8- 0.024 AS- 0.00022 AS 2 , r = 0.98, SEE= 0.73, 
and is shown in figure 2. The relationship between measured 
coronary flow reserve and X-ray predicted coronary flow 
reserve (X-ray) was best described by the equation: 
CFR = 1.58 - 0.36 (X-ray) 2 + 0.097 (X-ray) 3 , r = 0.98, SEE 
0.68, 
and is shown in figure 3. 
We defined a normal measured coronary flow reserve as 
greater or equal to 3.4 (2 SD below the mean coronary flow 
reserve of the 24 angiographically normal coronary arteries). 
The sensitivity and specificity of cross-sectional obstruction 
area, percentage area stenosis and X-ray predicted coronary 
flow reserve to identify patients with a normal measured 
coronary flow reserve is shown in figure 4. 
The patients were subdivided into 4 groups according to the 
clinical manifestations of coronary artery disease. 37 pa-
tients had no angina pectoris and no non-invasive evidence of 
myocardial ischemia (group I), 9 patients had non-invasive 
evidence of myocardial ischemia without angina pectoris (group 
II), 8 patients had angina pectoris and no non-invasive 
evidence of myocardial ischemia (group III), 27 patients had 
angina pectoris as well as non-invasive evidence of myocardial 
ischemia (group IV), see table 1. The relationship between 
cross-sectional obstruction area, percentage area stenosis, 
X-ray predicted coronary flow reserve, measured coronary flow 
reserve and the clinical manifestations (angina pectoris, 
non-invasive evidence of myocardial ischaemia) is shown in 
figures 5A,5B,6A and 6B respectively. The measured coronary 
flow reserves of all patients in group I were greater or equal 
to 2.5, whereas all patients in group IV had a coronary flow 
reserve less than 2.5. A cutt-of value of 2.5 for measured 
coronary flow reserve therefore separates patients with 
clear-cut evidence of ischemia from those without clinical 
evidence of ischemia. 
The predictive value of angina pectoris at rest or during 
exercise testing to identify patients with a coronary flow 
reserve less than 2.5 was 91% (32 of 35 patients). The predic-
tive value of no angina pectoris to identify patients with a 
coronary flow reserve greater or equal to 2.5 was 89% (41 of 
46 patients). The predictive value of non-invasive evidence of 
myocardial ischemia to identify patients with a coronary flow 
reserve less than 2. 5 was 86% (31 of 36 patients). The 
predictive value of no non-invasive evidence of myocardial 
ischemia to identify patients with a coronary flow reserve 
greater or equal 2.5 was 89% (40 of 45 patients). 
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Table 1: Relation between angina pectoris, non-invasive evidence of 
myocardial ischemia, coronary artery dimensions and coronary flow 
reserve 
N coronarz arterz dimensions 
OA (mm2 ) AS % X-ray pred CFR 
mean SD range mean SD range mean SD range mean SD range 
I 37 6.2 2.1 2.4-10.3 15 23 0-62 4.9 0.2 4.5-5.0 4.4 1.0 2.5-6.5 
II 9 3.1 1.3 1. 6-4.9 50 20 22-78 4.3 0.5 3.6-4.9 2.4 0.7 1. 4-4.0 
III8 2.7 2.2 0.6-6.8 62 26 16-91 4.0 0.9 2.3-5.0 2.8 1.8 0.9-5.5 
IV 27 1.0 0.6 0.4-3.2 84 10 47-93 2.7 0.8 1. 6-4.4 1.1 0.5 0.4-2.4 
I = no angina pectoris and no non-invasive evidence of myocardial ischemia, 
II = no angina pectoris and non-invasive evidence of myocardial ischemia, 
III = angina pectoris without non-invasive evidence of myocardial ischemia, 
IV = angina pectoris and non-invasive evidence of myocardial ischemia, N = 
number of patients, OA = cross-sectional area at the site of obstruction, 
AS = percentage area stenosis, X-ray pred CFR = X-ray predicted coronary 
flow reserve. 
OA (mm 2 ) A AS (%) B 
10 100 N=27 
9 90 N=8 N=37 
8 80 
70 
N=9 
7 
6 60 
5 N=9 N=8 50 
4 40 N=37 
3 30 
2 N=27 20 
10 
II Ill IV II Ill IV 
Figure 5A 
Correlation between cross-sectional area at the site of obstruction (OA) and clinical 
manifestations of coronary artery disease. N = number of patients, I = no angina 
pectoris and no non-invasive evidence of myocardial ischemia, II = non-invasive 
evidence of myocardial ischemia without angina pectoris, ill= angina pectoris without 
non-invasive evidence of myocardial ischemia, IV = angina pectoris and non-invasive 
evidence of myocardial ischemia. 
Figure 5B 
Correlation between percentage area stenosis (AS) and clinical manifestations of 
coronary artery disease. Abbreviations as figure 5A 
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Correlation between X-ray predicted coronary flow reserve calculated according to 
Kirkeeide et al (20) (X-ray CFR) and clinical manifestations of coronary artery disease. 
Abbrebiations as figure 5A 
Figure 6B 
Correlation between radiographically measured coronary flow reserve (CFR) and 
clinical manifestations of coronary artery disease. Abbreviations as figure 5A 
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Discussion 
The major finding of this study is that the clinical 
manifestations of coronary artery disease correlate closely to 
measured coronary flow reserve, and quantitatively determined 
coronary artery dimensions, in a selected patient population 
with limited coronary artery disease. Many studies have 
investigated the relationship between the degree of coronary 
stenosis and the functional capacity of the coronary artery 
(3,4, 7-9). Two approaches have been proposed to analyze this 
relationship in the clinical setting. Firstly, several methods 
have been developed to measure the regional coronary flow 
reserve (10, 13) , which is defined as the maximal coronary 
blood flow divided by the resting coronary blood flow (11,12). 
This approach has been validated in animals (4). Some recent 
studies in humans, as well as the results of this study, 
suggest that at least in selected patients, the measurement of 
coronary flow reserve reflects the physiological significance 
of a coronary stenosis (8,9). In angiographically normal 
coronary arteries we measured a coronary flow reserve (mean ± 
SD) of 5. 0 ± 0. 8, which is in accordance with other reports 
(9,13,26). Secondly, the development of computer-based quanti-
tative analysis of the coronary angiogram has made the accu-
rate determination of coronary artery dimensions possible 
(20). Not only the commonly used gold standard of stenosis 
severity, percent stenosis, but also other geometrical para-
meters such as absolute cross-sectional area at the site of 
obstruction, the angiographically normal cross-sectional area 
before and after the obstruction, length of the lesion, 
eccentricity and plaque area can be quantified. Based on fluid 
dynamic equations first ·derived by Young et al (27-29), the 
pressure flow characteristics of a coronary stenosis can be 
calculated. This has the advantage that multiple parameters of 
stenosis severity are taken into account (21,30). The calcu-
lated pressure drop across the stenosis has been shown to 
correlate with the measured transluminal pressure gradient' and 
exercise thallium perfusion scintigraphy (31,32) and to 
predict with reasonable accuracy the consequent reduction in 
measured coronary flow reserve (9). 
From the relationship between coronary perfusion pressure 
and coronary flow under conditions of maximal coronary vasodi-
lation as described by Bache and Schwartz (33), and assuming a 
resting coronary flow velocity of 15 cm/s, Kirkeeide et al 
(21) calculated an X-ray predicted coronary flow reserve from 
the angiographic data. They showed in dogs a good correlation 
between such an angiographic approach and measured coronary 
flow reserve. This X-ray predicted coronary flow reserve is a 
function of the cross-sectional area of the stenosis, the 
cross-sectional area of the angiographically normal part of 
the coronary artery and the length of the lesion. Other 
factors, such as the exit angle and the relative asymmetry of 
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the stenosis are not taken into account, although they may be 
of hemodynamic significance (27-29). Nevertheless, we found 
that the 95% confidence limits of the relation between X-ray 
predicted coronary flow reserve and measured coronary flow 
reserve are somewhat less wide than the confidence limits of 
the correlations between flow reserve and percentage area 
stenosis or cross-sectional area. Unfortunately, the sensiti-
vity and specificity of X-ray predicted coronary flow reserve 
to identify patients with a normal or abnormal coronary flow 
reserve is not superior to that of cross-sectional obstruction 
area or percentage area stenosis. The relationship between 
X-ray predicted and measured coronary flow reserve that we 
found, suggests that one or more of the assumptions made in 
these calculations that seem valid in animals, may not hold 
true in humans with coronary artery disease. 
Limitations 
Firstly, the present study is restricted to a highly 
selected patient population, with only one circumscript 
stenosis in an otherwise angiographically normal coronary 
artery. Our results cannot be extrapolated to the large 
majority of patients with coronary artery disease, who have 
multiple lesions in the same coronary artery and/or more than 
one diseased vessel. Furthermore, the relation between coro-
nary flow reserve and coronary artery dimensions can be 
influenced by systemic hypertension (34), cardiac hypertrophy 
(35) ,previous myocardial infarction, valvular heart disease 
(36), anemia or polycythemia (37) or collateral circulation. 
Therefore we excluded patients with these conditions. Second-
ly, the extent of coronary atherosclerosis may be difficult to 
delineate angiographically. Me Pherson et al (38) documented 
that substantial intimal atherosclerosis resulting in diffuse 
obstructive disease that involves the entire length of an 
epicardial artery is often present, even when angiograms 
reveal only discrete lesions. As a consequence, angiographic 
parameters of stenosis severity, especially when the angie-
graphically "normal" part of the coronary artery is taken into 
account as is the case for percent area stenosis and X-ray 
predicted coronary flow reserve, may underestimate the func-
tional severity of a lesion and therefore overestimate the 
functional capacity of the coronary artery. 
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CHAPTER 8: A COMPARISON OF TWO METHODS TO MEASURE CORONARY 
FLOW RESERVE IN THE SETTING OF CORONARY ANGIOPLASTY:INTRACORO-
NARY BLOOD FLOW VELOCITY MEASUREMENTS WITH A DOPPLER CATHETER, 
AND DIGITAL SUBTRACTION CINEANGIOGRAPHY. 
Abstract 
Intracoronary blood flow velocity measurements with a 
Doppler ballooncatheter, and the radiographic assessment of 
myocardial perfusion with contrast media, before and after the 
intracoronary administration of papaverine, have previously 
been used to investigate regional coronary flow reserve. In 
the present study we applied both techniques in 21 patients to 
measure coronary flow reserve in the setting of coronary 
angioplasty. Pre-angioplasty (N=l4) and post-angioplasty 
(N=l9) measurements of coronary flow reserve were obtained by 
digital subtraction cineangiography in the myocardial region 
supplied by the dilated coronary artery, and with the Doppler 
probe in the proximal part of the dilated vessel. The reactive 
hyperemia following the final balloon inflation was recorded 
with the Doppler balloon catheter still positioned across the 
stenotic lesion. Coronary stenosis geometry was quantified 
with the Cardiovascular Angiography Analysis System. 
When the epicardial stenosis was the only factor causing 
a reduction in coronary flow reserve, flow reserve measured 
with both digital subtraction cineangiography and with the 
Doppler probe correlated well with the cross-sectional area at 
the site of obstruction, r=0.88, SEE=0.36 and r=0.77, SEE=0.45 
respectively. In contradistinction, if other factors decrea-
sing coronary flow reserve were present (intimal dissection, 
left ventricular hypertrophy, previous myocardial infarction, 
collaterals) measurements obtained with both techniques 
correlated poorly with the cross-sectional area (r=0.55, 
SEE=0.57, and r=0.59, SEE=0.50). Flow reserve measurements 
obtained with digital subtraction cineangiography correlated 
well with the measurements obtained with the Doppler probe 
(r=0.85, SEE=0.38, and r=0.87, SEE=0.34), although the two 
approaches have methodologically nothing in common and their 
respective regions of interest (myocardium for the radio-
graphic technique and intracoronary lumen for the Doppler 
technique) are basically different. Furthermore, the reactive 
hyperemia following the final balloon inflation was related to 
both the flow reserve measured with the angiographic technique 
(r=O. 85, SEE=O. 34) and the Doppler technique (r=O. 83, SEE= 
0.32) using pharmacologically induced coronary vasodilation 
with intracoronary papaverine. This suggests that the same 
quantity of coronary flow reserve that can be recruited 
pharmacologically can be recruited by ischemia following a 
transluminal occlusion. 
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Introduction 
Since the introduction of percutaneous transluminal 
coronary angioplasty (PTCA) in 1977 (1). the procedure has 
gained increasing importance in the treatment of coronary 
artery obstructions. So far. the immediate results of the 
procedure have been assessed by coronary angiography and the 
residual pressure gradient. However • the change in luminal 
size of an artery following the mechanical disruption of its 
internal wall cannot be assessed accurately from the detected 
angiographic contours (2, 3). The measured residual pressure 
gradient may have short and long-term prognostic value, but it 
reflects only the hemodynamic state at rest (4-6). Recently 
the assessment of coronary flow reserve has been proposed as a 
better method to evaluate the functional results of dilatation 
of a coronary artery obstruction (7-10). Papaverine is current-
ly regarded as the vasodilator of choice for the induction of 
maximal hyperemia, as intracoronary administration results in 
an immediate, potent and short-lasting hyperemia (11,12). 
Intracoronary blood flow velocity measurements with a Doppler 
probe, and the radiographic assessment of myocardial perfusion 
with contrast media have previously been used to investigate 
regional coronary flow reserve (13-17). In the present study 
we compared both techniques in the setting of PTCA, and 
compared the pharmacologically induced vasodilation after 
intracoronary papaverine with reactive hyperemia following 
transluminal occlusion. 
Patients and Methods 
Twenty-one patients undergoing elective PTCA for angina 
pectoris were studied. All patients had evidence of myocardial 
ischemia as indicated either by ECG changes at rest or during 
exercise thallium scintigraphy. Informed consent was obtained 
for the additional investigations. All patients were studied 
without premedication, but their medical treatment (nitrates, 
calcium antagonists and beta-blockers) was continued on the 
day of the procedure. 
Protocol of the investigational procedure 
1. Coronary cineangiography was performed in at least two. 
preferably orthogonal projections for quantitative 
analysis of the coronary artery stenosis. after intra-
coronary administration of 2 or 3 mg intracoronary 
isosorbidedinitrate. The intracoronary administration of 
isosorbidedinitrate was repeated at regular intervals 
(20-30 min) to ensure constant and maximal epicardial 
coronary vasodilation during the entire procedure (18). 
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2. Coronary flow reserve was measured by digital subtraction 
cineangiography. 
3. A long guide wire (length: 315 em, diameter: 0.014 inch) 
was passed through the coronary artery stenosis. 
4. A balloon catheter with a Doppler probe at the tip (9) 
was advanced over the guide wire into the coronary artery 
to measure coronary blood flow velocity. The precise 
location of the tip of the balloon catheter with respect 
to the stenotic lesion - immediately proximal to the 
lesion and beyond any major side branches - was deter-
mined by injection of contrast medium. After recording 
the baseline intracoronary blood flow velocity, hyperemia 
was induced by injecting 12.5 mg papaverine through the 
guiding catheter. The ratio of peak mean intracoronary 
blood flow velocity to baseline was then determined as 
previously described by Wilson et al (13). This measure-
ment was obtained in 14 patients. (see table 1). An 
example is shown in figure 1. 
5. Thereafter the balloon was advanced across the stenosis 
and 3 to 7 inflations, lasting 40 to 80 s, and up to 12 
atmospheres were used to dilate the stenosis until repeat 
cineangiography showed a good result (less than 50% 
diameter stenosis). The mean total inflation time was 162 
s/patient (range: 120-352 s). Immediately following the 
final balloon inflation the reactive hyperemia was 
recorded as previously described (9). An example is shown 
in figure 2. 
6. After subsidence of this reactive hyperemic response, the 
Doppler tip was pulled back into the proximal part of the 
coronary artery and the ratio of peak mean intracoronary 
blood flow velocity after 12.5 mg papaverine i.e. to 
baseline velocity was again determined • This measurement 
was obtained in 19 patients (see table 1). 
8. After removal of the balloon catheter and the guide wire, 
coronary flow reserve was measured with digital subtrac-
tion cineangiography, at the same pacing rate and using 
the same radiographic and injection parameters as before 
PTCA. 
9. Coronary cineangiography was repeated post-PTCA in the 
same projections as used at the start of the procedure, 
for quantitative analysis of the coronary artery steno-
sis. 
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Figure 1 
Measurement of the ratio of peak to baseline mean intracoronary blood flow velocity 
with the Doppler balloon catheter. From top to bottem, 3 ECG leads, phasic 
intracoronary Doppler signal, mean intracoronary Doppler signal and aortic pressure. 
Hyperemia was induced by a bolus injection of 12.5 mg papaverine through the 
guiding catheter. 
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Figure 2 
Measurement of reactive hyperemia following the fmal balloon inflation. In this 
patient 3 inflations up to 10 athmosphere were performed. From top to bottem 2 ECG 
leads, phasic intracoronary Doppler signal, mean intracoronary Doppler signal and 
aortic pressure. 
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Quantitative analysis of the coronary artery 
The determination of coronary arterial dimensions from 35 
mm cinefilm was performed with a computer-based Cardiovascular 
Angiography Analysis System (CAAS), previously described in 
detail (15,19,20). In essence, boundaries of a selected 
coronary artery segment are detected automatically from 
optically magnified and video digitized regions of interest of 
a cineframe. The absolute diameter of the stenosis in mm is 
determined using the guiding catheter as a scaling device. 
This involves the automatic edge-detection of the boundaries 
of the catheter in situ and the comparison of this value with 
the actual diameter measurement of the catheter using a 
micrometer. Calibration of the diameter in absolute values 
(mm) is achieved by,comparing the mean diameter of the guiding 
catheter in pixels with the measured size in millimeters. Each 
catheter is measured individually (21). To correct the detec-
ted contour of the arterial and catheter segments for pin-
cushion distortion, a correction vector is computed for each 
pixel based on a computer-processed cineframe with a centi-
meter grid placed against the input screen of the image 
intensifier (20). Since the functional significance of a 
stenosis is related to the expected normal cross-sectional 
area of the vessel at the point of obstruction, we use a 
computer-estimation of the original arterial dimension at the 
site of the obstruction to define the interpolated reference 
area (19, 20). The percentage diameter and area stenosis and 
the minimal luminal diameter (mm) and cross-sectional area 
(mm2 ) are then calculated. 
Coronary flow reserve measurements with digital subtraction 
cineangiography 
The coronary flow reserve measurement from 35 mm cinefilm 
has been implemented on the CAAS (15). The heart was atrially 
paced at a rate just above the spontaneous heart rate. An 
EGG-triggered injection into the coronary artery was made with 
Iopamidol at 37°C through a Medrad Mark IV infusion pump. This 
nonionic contrast agent has a viscosity of 9.4 cP at 37°, an 
osmolarity of 0.796 osm/kg and an iodine content of 370 
mg/ml. The angiogram was repeated 30 s after a bolus injection 
of 12.5 mg papaverine into the coronary artery by way of the 
guiding catheter (11, 12). The injection rate of the contrast 
medium was judged to be adequate if back flow of contrast 
medium into the aorta occurred. When this was not observed on 
the hyperemic image, baseline and hyperemic image acquisition 
were repeated at a higher flow rate, necessitating flow rates 
of up to 6 ml/s in some patients • Fi.ve or six consecutive 
end-diastolic cineframes were selected for analysis. Logarith-
mic nonmagnified mask-mode background subtraction was applied 
to the image subset to eliminate noncontrast medium densities 
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(22). The last end-diastolic frame prior to the administration 
of contrast was chosen as the mask. From the sequence of 
background subtracted images, a contrast arrival time image 
was determined using an empirically derived fixed density 
threshold (15). Each pixel was labeled with the sequence 
number of the cardiac cycle numbered from the cycle in which 
the pixel intensity level first exceeded the threshold. In 
addition to the contrast arrival time image, a density image 
was computed, with the intensity of each pixel being represen-
tative of the maximal local contrast medium accumulation. The 
coronary flow reserve was defined as the ratio of the regional 
flow computed from a hyperemic image divided by the regional 
flow of the corresponding baseline image. 
Regional flow values were quantitatively determined using 
the following videodensitometric principle: regional blood 
flow (Q) =regional vascular volume/transit time (15). Regio-
nal vascular volume was assessed from logarithmic mask-mode 
subtraction images, using the Lambert Beer relationship. 
Coronary flow reserve was then calculated as: 
CFR = Qh/Qb = Dh/Th Db/Tb 
where D is the mean contrast density and T the mean appearance 
time at baseline (b) and hyperemia (h). Mean contrast medium 
appearance time and density were computed within a user-
defined region of interest, which was chosen so that the 
epicardial coronary arteries visible on the angiogram, the 
coronary sinus, and the great cardiac vein were all excluded 
from the analysis (15). Reproducibility data are shown in 
table 2. Normal values for coronary flow reserve measured with 
this technique have previously been established (10, 15). The 
coronary flow reserve of 24 angiographically normal coronary 
arteries was 5.0 ± 0.6. Therefore a flow reserve below 3.4 (2 
SD below the mean) is taken to be abnormal. 
Intracoronary blood flow velocity measurements 
Instantaneous mean cross-sectional flow velocity was 
measured with a Doppler unit operating at 20 mega Hz using an 
ultrasonic crystal mounted on the tip of the angioplasty 
catheter. A balloon diameter size of 3. 0 mm or, 3. 4 mm was 
used. The cross-sectional area at the tip, the site of the 
balloon and the shaft of the catheter was measured by means of 
a microcaliper. The cross-sectional areas at the three diffe-
rent sites were respectively: 1.2 mm2 , 0.65 mm2 and 1.5 mm2 • 
The Doppler cristal has a 1.0 mm diameter annulus with a 0.5 
mm central hole. Two leads are soldered to the crystal and 
pass through the catheter between the original 0. 5 mm lumen 
and a thin-walled tube which serves as a new 0.4 mm lumen. The 
leads exit near the proximal luer hub and are wired to a two 
pin plug for connection to the pulsed Doppler instrument. The 
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connector cable contains an integral torroidal isolation 
transformer which insulates the patient from the instrument 
and which also provides impedance matching for more efficient 
energy transfer. The new inner lumen extends from the luer hub 
through the cristal providing a smooth unobstructed path for a 
guide wire. Blood flow velocity is detected by the zero cross 
method from the catheter tip transducer using a bidirectional 
range-gated 20 MHz pulsed Doppler velocimeter designed 
specially for this purpose (Baylor College of Medicine) • The 
master oscillator frequency of 20 MHz is pulsed at a frequency 
of 62.5 KHz. Each pulse is approximately one milli second in 
width and therefore contains 20 cycles of the master 
oscillator frequency. The parameters chosen (master oscillator 
frequency = 20 MHz and pulse repetition frequency = 62.5 KHz) 
allow velocities up to 100 cm/s to be recorded at a distance 
of up to 1 em from the catheter tip. The sampling window was 
individually adjusted to obtain the optimal signal which 
(usually) resulted in a sampling window of 1. 8 mm (range 
1.5-2.0). 
The output of the pulsed Doppler is a frequency shift 
(F,kHz) which can be related to blood velocity by the Doppler 
equation: F = 2 f (VI c) cos a, where f is the ultrasonic 
frequency (20 MHz), V is the velocity within the sample 
volume, cis the speed of sound in blood (1.500 m/s), and a is 
the angle between the velocity vector and the sound beam. 
Using an end-mounted crystal with the catheter parallel (± 
20°) to the vessel axis> cos a = 1 ± 6%, and the relation 
between the Doppler shift and velocity is approximately 3.75 
cm/s per KHz (17). Previous calibration experiments in canine 
femoral and coronary arteries have shown that the measured 
doppler shift frequency is proportional to volume flow measur-
ed by timed collection (13, 24). Recently, Sibley et al (17) 
validated clinically and experimentally the ability of a 
similar catheter with an end-mounted piezo-electric crystal to 
provide accurate continuous on line measurement of coronary 
blood flow velocity and vasodilator reserve. In our labora-
tory, we verified the accuracy of these velocity probes by 
correlating velocity recorded with the Doppler probe in an 9 F 
femoral sheath with the volume flow measured by a timed 
collection of blood from the side branch of the same sheath. 
Graduated flow rates (range: 12-165 ml/min) and the correspon-
ding velocities (range: 1.2-8.2 Khz) were obtained by incremen-
tal balloon inflation with the balloon positioned in the 
sheath. This simple model allows the assessment of the flow 
velocity relation at different levels. As previously demon-
strated, this relation is linear with correlation coefficients 
generally equal or greater than 0.95 (13,17). Reproducibility 
data are shown in table 2. 
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Statistical methods 
Results are expressed as mean ± SD unless stated other-
wise. Least squares linear regression analyses were used to 
define the relationships between the various measurements. 
RESULTS 
The clinical characteristics, results of the quantitative 
analysis of the coronary angiogram and the coronary flow 
reserve measurements are shown in table 1. The mean age of the 
21 patients was 57 years (range: 37-76), 17 were male. Eight-
teen patients had single vessel coronary artery disease and 3 
patients two vessel disease. The investigated and dilated 
coronary artery was the left anterior descending artery in 14, 
the circumflex artery in 3 and the right coronary artery in 4 
patients. In none of the patients a sidebranch was involved at 
the site of the lesion. The mean left ventricular ejection 
fraction was 67% and ranged from 38 to 81%. Patient 9 had 
sustained a myocardial infarction in the anterior wall resul-
ting in a large akinetic segment and an ejection fraction of 
38%. None of the other patients had clinical evidence for a 
myocardial infarction and all had normal wall motion and an 
ejection fraction of more than 55%. In two patients (patients 
4 and 11) the coronary arteriogram showed grade III/IV collate-
ral filling of the PTCA vessel (23). Patient 12 (see table 1) 
had long standing arterial hypertension with left ventricular 
hypertrophy. None of the other patients had electrocardio-
graphic, echocardiographic or angiographic evidence of left 
ventricular hypertrophy. The mean number of balloon inflations 
was 4. 3/patient and ranged from 3 to 7. The dilation was 
successful in all patients, and none of the patients had a 
CPK-rise after the procedure. Seven patients had a dissection 
of the dilated coronary artery segment after the procedure. 
Five dissections were small (patients 1,7,10,11 and 20), two 
dissections were of moderate severity (patients 17,18). None 
of the dissections had clinical repercussions. The hemodynamic 
data of the individual patients are shown in table 1 and mean 
values (±SD) of the heart rate and aortic pressure are given 
in table 3. 
The cross-sectional area at the site of obstruction was 
1.1 ± 0.6 mm2 before, and 3.2 ± 1.1 mm2 after PTCA. Percentage 
diameter stenosis was 58 ± 9% before, and 32 ± 10% after PTCA. 
Percentage area stenosis was 82 ± 8% before, and 52 ± 14% 
after PTCA. The interpolated reference area was 6.6 ± 1.6 mm2 
and ranged from 3.9 to 9.8 mm2 • During the measurements with 
the Doppler catheter just proximal to the stenosis, the tip of 
the catheter (1.2 mm2 ) occupied 18 ± 5% (range 12 to 31%) of 
the cross-sectional area of the coronary artery. The reactive 
hyperemia was measured with the balloon part of the Doppler 
catheter (0.65 mm2 ) across the stenosis. In this situation the 
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Table 1: Results 
age DV B/A OA AS DS HR1 Ao1 CFR HR2 Ao2 CFR RH 
DSC DOP 
1 F 48 1 LAD A 5.4 35 19 70 91 2.0 67 104 2.1 2.2 
2 M 43 1 LAD A 4.8 51 30 70 95 3.3 51 92 2.9 2.9 
3 M 58 1 RCA A 2.9 64 40 70 93 2.8 68 98 3.0 2.8 
4 M 69 1 RCA A 2.2 66 42 80 91 1.2 72 87 1.1 1.0 
5 M 58 2 LAD B 1.2 86 62 70 99 0.6 57 95 0.9 
A 3.3 63 39 70 83 2.4 70 89 2.9 2.3 
6 M 62 1 LAD B 0.9 86 62 90 97 1.0 69 101 0.9 
A 3.5 40 23 90 97 2.0 83 103 1. 8 2.0 
7 F 53 1 LAD B 1.6 72 47 90 82 2.0 71 80 1.8 
A 3.5 51 30 90 78 2.4 81 76 2.7 2.3 
8 M 56 1 LAD B 0.( 88 64 100 83 0.8 91 85 1.1 
A 3.7 24 17 100 88 2.2 85 98 2.3 2.2 
9 M 53 1 LAD B 1.2 83 59 80 90 1.1 70 90 1.3 
A 4.5 37 21 80 88 3.0 82 89 2.3 2.6 
10 M 55 1 ex A 2.5 49 28 80 96 1.7 70 97 1.9 1.7 
11 M 53 1 ex A 2.7 69 45 70 85 2.2 60 79 2.0 2.1 
12 F 57 1 LAD B 2.9 59 35 70 115 1.1 66 112 1.0 
A 5. 3 41 23 70 111 1.7 62 108 2.2 2.1 
13 M 66 2 LAD B 0.7 82 58 70 81 1.4 59 83 1.2 
A 2.9 44 25 70 84 2.7 61 83 2.4 1.9 
14 M 56 1 RCA B 0.7 87 63 70 81 1.2 61 83 1.1 
15 M 67 2 ex B 0.9 86 68 70 88 1.3 58 88 1.0 
A 1.7 69 37 70 76 1.8 60 79 1. 7 1.5 
16 M 60 1 LAD B 1.3 78 53 80 93 1.4 73 89 1.6 
17 M 56 1 LAD B 0.8 86 62 70 91 1.1 61 96 2.5 
A 2.7 61 37 70 92 1.0 57 99 1.4 1.3 
18 M 37 1 LAD A 1. 8 70 45 70 87 1.1 63 89 1.1 1.0 
19 M 49 1 RCA B 1.4 84 60 80 95 1.3 73 99 1.4 
A 2.5 73 48 80 86 1.6 76 83 1. 7 1.3 
20 F 76 1 LAD B 1.1 75 50 80 91 1.3 63 90 1.4 
A 2.8 36 20 80 82 2.3 81 80 2.5 1.5 
21 M 58 1 LAD B 0.6 90 69 70 80 1.0 65 82 1.2 
A 2.2 64 40 70 75 2.2 63 76 2.3 1.6 
Pat= patient, F= female, M= male, No of DV= number of diseased 
coronary arteries (diameter stenosis greater than 50%), LAD= 
left anterior descending coronary artery, RCA= right coronary 
artery, CX= circumflex artery, B= before PTCA, A= after PTCA, 
OA= cross-sectional area at the site of obstruction (mm2 ), AS= 
percentage area stenosis, DS= percentage diameter stenosis, 
HR= Heart rate in beats/min and Ao= mean aortic pressure 
(mmHg) 1 = immediately preceding CFR-DSC measurements.2 = 
immediately preceding the CFR-DOP and RH measurements. 
CFR-DSC= coronary flow reserve measured with distal 
subtraction cineangiography, CFR-DOP= coronary flow reserve 
measured with Doppler. 
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catheter occupied 20 :!:: 5%, (range: 12-37%) of the luminal 
cross-sectional area at the site of the stenosis. This implies 
that coronary flow reserve assessed with both techniques after 
PTCA was measured in the presence of an area stenosis of 52 ± 
14%, whereas reactive hyperemia was assessed in the presence 
of a residual area stenosis of 62 ± 16%. In 14 patients a 
coronary flow reserve measurement with the angiographic 
technique was also obtained in a myocardial region supplied by 
a coronary artery which was not dilated and which had no 
significant stenosis (less than 50% diameter stenosis). The 
mean coronary flow reserve of these vessels was 3. 4 ± 0. 8 
before PTCA and 3.3 ± 0.9 after PTCA. 
The relationship between coronary flow reserve measured 
with digital substraction cineangiography (CFR-DSC) and the 
cross-sectional area at the site of obstruction (OA) is shown 
in figure 3. Patients 1,4,7,9,10,11,12,17,18 and 20 had condi-
tions associated with a reduced coronary flow reserve, in 
addition to the presence of a coronary stenosis. In these 
patients only a weak relationship was found between these two 
parameters: CFR-DSC = 0.27 OA + 0.9, (r = 0.55, SEE= 0.57). 
In the other patients in whom the epicardial narrowing was the 
sole factor determining the coronary flow reserve, a good 
relationship was found between these two parameters: CFR-DSC = 
0.51 OA + 0.7, (r = 0.88, SEE= 0.36). 
The relationship between coronary flow reserve measured 
with Doppler (CFR-DOP) and the cross-sectional area at the 
site of obstruction (OA) is shown in figure 4. The resting 
Doppler-shift before PTCA was 1.4 ± 0.7 kHz and after PTCA 1.5 
± 0.7 kHz. In the patients with conditions associated with a 
reduced coronary flow reserve aside from the presence of a 
coronary stenosis the relationship between these two para-
meters was weak: CFR-DOP = 0.27 OA + 1.0 (r= 0.59, SEE = 
0. 50). In the other patients a reasonably good relationship 
was found between these two parameters: CFR-DOP= 0.43 OA + 1.0 
(r= 0.77, SEE= 0.45). 
The relationship between the coronary flow reserve 
measured with the angiographic technique and the coronary flow 
reserve measured with Doppler probe is shown in figure 5. 
There is a good relationship between the measurements made 
with these two techniques, irrespective of whether the flow 
reserve is limited solely by the severity of the coronary 
stenosis (CFR-DSC = 0.88 CFR-DOP + 0.12, r = 0.85, SEE= 0.38) 
or whether there are additional patient characteristics 
present such as previous infarction, hypertrophy, collaterals 
or dissection after PTCA (CFR-DSC = 0.96 CFR-DOP + 0.01, r = 
0.87, SEE= 0.34). 
The relationships between the reactive hyperemia (RH) 
recorded after the final balloon inflation with the angio-
plasty catheter still across the lesion, and coronary flow 
reserve measured with the angiographic technique (CFR-DSC=0.27 
+ 0.95RH, r=0.85, SEE=0.34) and with the Doppler catheter 
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(CFR-DOP=0.51 + 0.84RH, r=0.83, SEE=0.32) are shown in figures 
6 and 7 respectively. As expected the mean reactive hyperemia 
was somewhat lower than the coronary flow reserves measured 
with the angiographic technique or with the Doppler probe 
located proximal to the dilated stenosis. Reactive hyperemia 
was 1.9 ± 0.6, coronary flow reserve measured with the angie-
graphic technique 2.1 ± 0.6 and coronary flow reserve measured 
with the Doppler catheter 2.1 ± 0.6. 
Table 2: Reproducibility of the coronary flow reserve 
measurements. 
1" 2" difference ± SD r SEE 
DSC N=13 2.1 ± 1.2 2.1 ± 1.2 -0.02 ± 0.26 0.98 0.26 
DOP N=15 1.6 ± Q.3 1.6 ± 0.3 +0.03 ± 0.18 0.88 0.19 
1"= first determination (mean ± SD), 2°= second determination 
(mean± SD), DSC= digital subtraction cineangiography, 
analysis of repeated image acquisition taken 5 min apart, 
without change in patient position, pacing rate, contrast 
injection parameters or X-ray gantry settings, DOP= repeated 
intracoronary Doppler blood flow velocity measurements 5 min 
apart without change in patient - or Doppler catheter posi-
tion. 
Table 3 Hemodynamic data. 
Before PTCA After PTCA 
DSC-CFR DOP-CFR DSC-CFR DOP-CFR DOP-HR 
HR 78 ± 10 67 ± 9 76 ± 9 69 ± 10 69 ± 10 
Ao 90 ± 9 91 ± 9 88 ± 8 90 ± 10 90 ± 10 
Heart rate (HR, beats/min) and mean aortic pressure (Ao, mmHg) 
immediately preceding the coronary flow reserve measurements 
with digital subtraction cineangiography (DSC-CFR) and coro-
nary flow reserve and reactive hyperemia measurements with the 
Doppler catheter (DOP-CFR and DOP-RH). 
Discussion 
The purpose of the present study was twofold: firstly, to 
compare in the setting of an angioplasty procedure two diffe-
rent techniques of assessing regional coronary blood flow; 
secondly, to compare the pharmacologically induced vasodi-
lation after intracoronary papaverine with reactive hyperemia 
following transluminal occlusion. 
Rationale for comparison of the two techniques to measure 
coronary flow reserve 
Extensive validation studies with the Doppler technique 
have been performed in which the measured changes in velocity 
have been compared with changes in perfusion measured with 
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timed-venous coronary sinus collection (13,24), labeled mi-
crospheres (25), and electromagnetic flow probes (24). These 
studies indicate that under a great variety of conditions, 
changes in coronary blood flow velocity measured by the 
Doppler technique accurately reflect changes in flow (26). 
Recently, small sized Doppler catheters have been developed 
and validated. They are able to make selective measurements of 
flow velocity in the major proximal coronary arteries 
(9,13,17), without causing coronary obstruction (26). For 
instance, in this report the cross-sectional area of the 
Doppler balloon catheter was only 18 ± 5% of the cross-
sectional area of the coronary artery in the segment proximal 
to the stenosis. However, two important limitations of the 
Doppler technique are, firstly: it measures flow velocity 
rather than volume flow - which may lead to inaccurate values 
for flow reserve if significant change occurs in cross-
sectional areas between baseline and hyperemia (18) - and 
secondly: subselective coronary cannulation increases the risk 
during cardiac catheterization (13, 26). Therefore less inva-
sive approches to determine the regional coronary flow reserve 
are urgently needed. 
Selective coronary angiography is the standard means for 
obtaining anatomical information and is the most important 
tool for clinical decision making used by the clinician caring 
for patients with coronary artery disease. Recently, several 
attempts have been made to measure coronary blood flow para-
meters during cardiac catheterization using recent develop-
ments in radiographic technology (16). However, radiographic 
contrast media cannot be used to measure coronary blood flow 
by the traditional methodological approaches (16); an essen-
tial prerequisite of indicator-dilution (Stewart-Hamilton), 
inert substance washout (Kety-Schmidt), or firstpass distri-
bution (Sapirstein) techniques is that the indicator substance 
does not affect the regional flow being measured (8). Unfortu-
nately, all radiographic media have substantial vascular 
effects (27), although nonionic media may disturb blood flow 
less than ionic agents (16). Using ECG-gated power injection 
of a contrast agent at a rate that is presumed to be suffi-
ciently rapid to achieve complete replacement of blood with 
contrast, Hodgson et al (28) developed a mask mode subtraction 
technique that determines myocardial time-density curves 
before and during maximal hyperemia before the vascular 
effects of the contrast medium disturb the ratio between 
resting and hyperemic coronary blood flow. Since some of this 
techniques fundamental assumptions may not be met under cli-
nical conditions, validation studies are of special interest 
(29). In this study we found a reasonable good correlation 
between radiographically determined coronary flow reserve and 
the coronary flow velocity reserve measured with a Doppler 
probe, despite the fact that the two approaches have methodo-
logically nothing in common and that their respective regions 
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of interest (myocardium for the radiographic technique and 
intracoronary lumen for the Doppler technique) are basically 
different. 
Maximal coronary blood flow after pharmacological vasodilation 
versus reactive hypermia induced by coronary occlusion 
In the animal laboratory it has been shown that pharmaco-
logically induced vasodilation after intracoronary administra-
tion of papaverine is of the same magnitude as the reactive 
hyperemia after a 15 s occlusion of the coronary artery (30). 
There is some question as to whether the same quantity of flow 
reserve that can be recruited pharmacologically, can be 
recruited during ischemia (29). In this study, we found that 
reactive hyperemia in patients without hypertrophy, infarc-
tion, hypertension, collaterals or dissection was 2.1 ± 0. 6 
(range 1. 3 to 2. 9), whereas coronary flow reserves in these 
patients both with the Doppler probe and the radiographic 
technique were 2.3 ± 0.6 (range 1.6 to 3.3) after PTCA. The 
cross-sectional area at the site of obstruction averaged 3.05 
mm2 in these patients. Since the balloon catheter was still 
across the lesion the functional lumen averaged 2.4 mm2 (see 
table 1). In a previous study from this laboratory we esta-
blished the relationship between cross-sectional area at the 
site of obstruction and the measured coronary flow reserve in 
a patient population with single vessel coronary disease and 
the absence of other factors that might reduce flow reserve 
such as hypertrophy, infarction, hypertension, collaterals or 
dissection (15). This relationship is shown in figure 6. A 
coronary artery with an obstruction area of 2.4 mm2 would be 
expected to have a vascular reserve of 2. 2 with confidence 
limits extending from 1.3 to 3.0, which corresponds almost 
exactly to the range found in this study. Therefore, we feel 
that our data support the conclusion that the coronary vaso-
dilation after an optimal dose of intracoronary papaverine 
(11) is equipotent to the reactive hyperemia following a 
transluminal occlusion of more than 40 s in patients with 
significant coronary artery disease. 
Limitations 
When comparing these three measures of the functional 
capacity of a coronary artery one has to bear in mind the 
potential sources of data scatter. Fortunately. the radio-
graphic technique as well as the Doppler technique have a good 
reproducibility. Coronary flow reserve and reactive hyperemia 
are both ratios between maximal coronary blood flow and 
resting flow. Resting coronary blood flow is mainly determined 
by aortic pressure and heart rate and coronary blood flow 
during maximal vasodilation is linearly related to the pre-
vailing perfussion pressure (7,8). These two hemodynamic 
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parameters change little between the measurements of flow 
reserve and reactive hyperemia (see table 1 and 3), although 
they certainly contribute to the scatter of the data (see 
figures 5,6 and 7). 
Several studies have shown that in selected patients a 
close relationship exists between quantitatively determined 
stenosis geometry and measured coronary flow reserve (15,31). 
However, coronary flow reserve can be influenced by many 
factors other than epicardial coronary stenosis, such as 
myocardial hypertrophy, tachycardia, hypertension prior 
myocardial infarction, collaterals, dissection after PTCA 
(33), changes in coronary vasomotor tone and changes in 
ventricular end-diastolic and intrathoracic pressures (7, 8). 
Therefore, in order to relate the measured coronary flow 
reserve to quantitatively determined stenosis geometry, we 
have carefully divided our study population into a group of 
patients (A) with one or more of the above mentioned charac-
teristics and a group of patients (B) without any of these 
characteristics (see figures 3 and 4). We tried to prevent 
changes in vasomotor tone which is relevant to both techniques 
(18) by inducing a constant maximal epicardial coronary 
vasodilation with repeated intracoronary administration of 
isosorbide dinitrate (18). In accordance with previous reports 
(15,31) we found a good correlation between cross-sectional 
area at the site of obstruction and measured coronary flow 
reserve in group B, in contrast to a poor correlation between 
these two parameters in group A. 
Coronary flow reserve immediately after PTCA 
Several authors (10,32) have shown that the coronary flow 
reserve of the myocardial region supplied by the dilated 
vessel increases substantially after PTCA, but is not restored 
to normal values. The measurements obtained in the present 
study with two independant techniques confirm this fact. We 
also measured the coronary flow reserve of an adjacent myocar-
dial region supplied by a not significantly diseased coronary 
artery, by the radiographic technique and found a marked 
difference in vasodilator response. For ethical reasons we did 
not obtain this measurement with the Doppler catheter as we 
felt that introduction of the Doppler probe into a second 
coronary artery might introduce additional risks to the 
investigational part of the procedure. Nevertheless, the 
results of the radiographic technique indicate that the 
abnormal vasodilatory response is restricted to the myocardium 
supplied by the dilated coronary artery. There are several 
potential explanations for this phenomenon. 
First, since coronary flow reserve is a ratio between 
resting flow and maximal coronary blood flow, any increase in 
resting flow results in a decrease of this ratio. Neither of 
the techniques we used, provided us with absolute measurements 
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of volume flow. Therefore, we cannot make a definite conclu-
sion regarding resting coronary volume flow after the PTCA. 
However, the resting Doppler shift was virtually the same 
before and after the PTCA procedure, 1.4 ± 0.7 kHz and 1.5 ± 
0.7 kHz respectively. Furthermore, several authors using the 
thermodilution technique in the coronary sinus or the great 
cardiac vein have reported comparable resting volume flows 
before and after PTCA (34-36). 
Secondly, metabolic, humoral or myogenic factors could 
potentially play a role in the limited restoration of coronary 
flow reserve after PTCA. However, the metabolic derangements 
due to the PTCA seem quickly reversible (34,37,38). Although 
humoral factors may play a role in a specific subgroup of 
patients with complicated PTCA, sofar no evidence has been 
presented that implicates that humoral factors are important 
in this regard in the majority of patients (39). The long 
standing reduction in perfusion pressure distal to the steno-
tic lesion may induce alterations in the complex mechanism of 
autoregulation and a prolonged period of time may be needed 
before these abnormalities subside (40). 
Thirdly, the impaired coronary flow reserve could 
be directly related to the residual stenosis (10). Cross-
sectional area measured immediately after PTCA generally 
increases about threefold due to the procedure but remains 
grossly abnormal (10,41). The relationship between cross-
sectional area at the site of obstruction and coronary flow 
reserve as found in a previous study from our laboratory (15), 
is shown in figure 8 with the 95% confidence intervals. The 
data of the present study for patients fullfilling the same 
exclusion criteria (group B) are superimposed: coronary flow 
reserve measured with both techniques and the reactive hyper-
emia following the final balloon inflation with residual 
obstruction area corrected for the presence of the Doppler 
balloon catheter. The large majority of measurements fall 
within the 95% confidence limits of this relation, suggesting 
that the persisting reduction in cross-sectional area perse 
constitutes a sufficient explanation for the limited resto-
ration of coronary flow reserve, although it does not exclude 
other contributing pathophysiological mechanisms. 
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CHAPTER 9: NORMALIZATION OF CORONARY FLOW RESERVE BY 
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY. 
Summary 
15 patients undergoing routine follow-up angiography 5 
months after successful percutaneous transluminal coronary 
angioplasty (PTCA) without angina and with normal exercise 
thallium scintigraphy were selected for analysis. The coronary 
flow reserves of these patients were compared to those of 24 
patients with angiographically normal coronary arteries, to 
establish whether PTCA can restore to normal the coronary flow 
reserve of patients with chronic coronary artery disease. The 
quantitative cineangiographic changes and the concomitant 
alterations in coronary flow reserve as an immediate result of 
the PTCA and the subsequent changes 5 months later are des-
cribed. Coronary flow reserve was measured with digital 
subtraction cineangiography. PTCA resulted in an increase in 
minimal obstruction area from 0.8±0.3 to 3.4±0.7 mm 2 and in 
coronary flow reserve (mean ± SD) from 1.0±0.3 to 2.5±0.6. 
Five months later a further substantial and significant (p 
less than 0. 05) late increase in obstruction area (3. 8±0. 9 
mm2 ) and flow reserve (3.6±0.5) had occurred. In 11 of 15 
patients coronary flow reserve was restored to normal. Changes 
in stenosis geometry are likely to be one of the major deter-
minants of this late normalization of coronary flow reserve. 
Introduction 
Since the introduction of percutaneous transluminal 
coronary angioplasty (PTCA) in 1977 (1), this procedure has 
gained increasing importance in the treatment of coronary 
artery obstructions. The immediate and long-term results of 
PTCA are usually assessed by coronary angiography. Recently. 
the measurement of coronary flow reserve has been proposed as 
a better method to evaluate the hemodynamic repercussions of 
coronary artery obstructions (2,3). Three techniques have been 
developed that allow the measurement of regional coronary 
flow reserve during cardiac catheterization. The first uses a 
pulsed Doppler coronary artery catheter which can measure 
intracoronary blood flow velocity (4). The second technique is 
based on the radiographic assessment of myocardial perfusion 
using contrast medium (5,6). The third technique is an indi-
cator dilution technique with a platinum-tipped PTCA guide 
wire, using hydrogen as the indicator (7). Although PTCA has 
been shown to result in symptomatic, hemodynamic and func-
tional improvement (8-10), doubt has remained whether this 
procedure can restore coronary flow reserve of atherosclerotic 
coronary arteries to a normal level (11-14). Therefore we 
selected 15 patients that were free of angina and had a normal 
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exercise thallium scintigram 5 months after PTCA, and compared 
their radiographically measured coronary flow reserve with the 
flow reserve of 24 patients with angiographically normal 
coronary arteries. We describe the quantitative cineangio-
graphic changes and the concomitant alterations in coronary 
flow reserve, resulting from the acute intervention as well as 
the subsequent changes as observed 5 months after PTCA. 
METHODS 
Patients 
The study population consisted of 24 patients with 
angiographically normal coronary arteries (data on 12 have 
been previously published) (5) and 15 patients with single 
vessel coronary artery disease. These 15 patients had under-
gone successful PTCA for disabling angina refractory to 
intensive pharmacological treatment. They were selected on the 
basis of a normal exercise thallium scintigram and complete 
relief of chest pain 5 months after PTCA, when coronary 
angiography and left ventriculography were performed as part 
of an ongoing study on restenosis after PTCA. Informed consent 
was obtained for all investigations. Before PTCA pharmacologic 
treatment consisted of nitrates, calcium antagonists and 
beta-blockers, and during the 5 months after PTCA the patients 
were treated with aspirin 500 mg/day and nifedipine 60 mg/day 
which medication was continued on the day of the cardiac 
catheterization. All 39 patients had normal systolic and 
diastolic wall motion and an ejection fraction greater than 
55%. Patients with left ventricular hypertrophy, valvular 
heart disease, angiographic evidence of collateral circula-
tion, anemia, polycythemia or hypertension were excluded 
because these conditions may influence coronary flow reserve 
(15-17). 
Exercise thallium scintigraphy 
The patients performed a symptom-limited exercise test on 
the bicycle ergometer with stepwise increments of 20 watt/min. 
All patients exercised to more than 80% of their expected 
normal exercise capacity (for age, sex and length). Images 
were obtained immediately after exercise and 4 hours later, 
and analyzed prospectively by 3 experienced observers without 
knowledge of the angiographic data. Redistribution and persis-
tent defects were considered abnormal (18,19). 
Quantitative coronary cineangiography 
Before PTCA, immediately after PTCA and during repeat 
catheterization 2 or 3 identical angiographic projections were 
filmed. The coronary arterial dimensions were determined with 
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the computer-based Cardiovascular Angiography Analysis System 
(5,20,21). In essence, the boundaries of a selected coronary 
artery segment are detected automatically from optically 
magnified and video digitized regions of interest of a cine-
frame. Calibration of the diameter data in absolute values 
(mm) is achieved by detecting the boundaries of a section of 
the contrast catheter and comparing the mean diameter in 
pixels with the known size in millimeter (22). Pincushion 
distortion is corrected (21). A computer estimation of the 
original arterial dimensions at the site of obstruction was 
used to define the reference region (21). The interpolated 
percentage diameter stenosis and the minimal obstruction area 
(mm2 ) were then calculated by averaging the values from at 
least two, preferably orthogonal projections. A mean of 2. 2 
angiographic projections per patient was used in this study. 
Coronary flow reserve measurements 
The heart was atrially paced at a rate just above the 
spontaneous heart rate. An EGG-triggered injection into the 
coronary artery 300 ms after the R-wave was made with a fixed 
amount of jopamidol at 37°C through a Medrad Mark IV infusion 
pump. This nonionic contrast agent has a viscosity of 9.4 cP 
at 37°, an osmolality of 0.8 osm/kg and an iodine content of 
370 mg/ml. The injection rate of the contrast medium was 
judged to be adequate when back flow of contrast medium into 
the aorta occurred. In every patient the injection rate was 
identical for each coronary injection. The field size of the 
X-ray equipment was 7 inch. The angiogram was repeated 30 sec 
after pharmacologically induced hyperemia by a bolus injection 
of 12.5 mg papaverine into the coronary artery (5,23). Five 
end-diastolic cineframes were selected from successive cardiac 
cycles. 
Logarithmic nonmagnified mask-mode background subtraction 
was applied to the image subset, to eliminate noncontrast 
medium densities. The last end-diastolic frame prior to 
contrast administration was chosen as the mask. A contrast 
appearance time was determined, using an empirically derived 
density threshold that was constant for each study and all 
patients (5). A density image was computed, with each pixel 
intensity value being representative for the maximal local 
contrast medium accumulation. The coronary flow reserve was 
defined as the ratio of the regional flow computed from a 
hyperemic image (Qh) divided by the regional flow of the 
corresponding baseline image (Qb). Coronary flow reserve (CFR) 
was then be calculated as: 
CFR Qh/Qb = Dh/Th : Db/Tb 
where D is the mean contrast density and T the mean appearance 
time at baseline (b) and hyperemia (h). Appearance time and 
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density were computed within user-defined regions of interest 
that were chosen in such a way that the epicardial coronary 
arteries visible on the angiogram, the coronary sinus and the 
great cardiac vein were excluded from the analysis (5). 
Statistical analysis 
Comparisons between groups were made after variance 
analysis with the Student's t-test for paired or unpaired 
observations. 
RESULTS 
Quantitative cineangiography 
The changes in minimal cross-sectional obstruction area 
are shown in table 1 and fig. 1, the changes in percentage 
diameter stenosis are shown in table 1 and fig. 2. Percentage 
area stenosis (mean ± SD) decreased from 89 ± 7% to 51 ± 11% 
immediately following PTCA. Five months later percentage area 
stenosis was further decreased to 42 ± 14% (p less than 
0. 05). 
Coronary flow reserve 
In the 24 patients with angiographically normal coronary 
arteries, coronary flow reserve ranged from 3.4 to 6.5 (table 
2). The mean value was 5.0 (SD ± 0.8). The lower limit for a 
normal coronary flow reserve is therefore 3.4 (2 x SD below 
the mean coronary flow reserve) • This is comparable to the 
normal values for coronary flow reserve reported by other 
groups (4,14). Coronary flow reserve was measured in the 
myocardial region supplied by the dilated coronary artery 
before PTCA, immediately following PTCA as well as 5 months 
later. Consecutive measurements were also obtained in 12 
adjacent myocardial regions supplied by a non-dilated coronary 
artery, (table 1 and fig. 3). The coronary flow reserve of 
these adjacent myocardial regions remained unchanged immedia-
tely following PTCA as well as after 5 months follow-up. 
Coronary flow reserve (mean ± SD) in the myocardial region 
supplied by the dilated coronary artery increased from 1.0 ± 
0.3 to 2.5 ± 0.6 immediately following PTCA (p less than 
0. 00 1) • In none of these patients coronary flow reserve was 
restored to a normal level immediately following PTCA. A 
substantial late improvement (p less than 0.01) in coronary 
flow reserve had occurred 5 ~onths later. Coronary flow 
reserve in the myocardial region supplied by the dilated 
coronary artery 5 months after PTCA was of the same magnitude 
as the coronary flow reserve in the myocardial region supplied 
by a non-dilated and angiographically not diseased coronary 
artery. In 11 of the 15 patients (73%) coronary flow reserve 
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5 p<0.001 
4 
3 
2 
before after 5 months 
angioplasty follow up 
Figure 1 
Results of quantitative analyses of coronary angiograms, before, immediately after and 5 
months after percutaneous transluminal coronary angioplasty. OA = minimal cross 
sectional obstruction area (mm2). 
Figure 2 
(%) 
DS 
100 
80 
60 
40 
p<O. 001 
p<0.05 
before after 5 months 
follow up angioplasty 
Results of quantitative analyses of coronary angiograms, before, immediately after and 5 
months after percutaneous transluminal coronary angioplasty. DS = percentage 
diameter stenosis. 
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Table 1: Results: Coronary flow reserve and quantitative 
angiographic data of PTCA patients. 
before after 5 months follow-up 
Pat age sex vessel OA DS CFR OA DS CFR OA DS CFR 
1 54 
2 31 
3 53 
4 36 
5 62 
6 42 
7 53 
8 66 
9 59 
10 52 
11 64 
12 53 
13 47 
14 58 
15 66 
M 
M 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
LAD 
LC 
LAD 
LC 
LAD 
LC 
LAD 
LC 
LAD 
LC 
LC 
LAD 
R 
LAD 
LC 
LAD 
LC 
LC 
LAD 
LAD 
LC 
R 
LAD 
LC 
R 
LAD 
LC 
1.2 53 1.0 
3.9 
0.5 70 1.0 
3.3 
0.5 72 0.6 
2.6 
0.4 70 1.2 
3.2 
0.8 66 1.0 
2.6 
0.7 66 0.7 
3.8 
1.3 65 0.9 
o. 7 58 1. 4 
3.5 
1.1 64 1. 0 
3.2 
1.4 61 0.9 
3.9 
0.6 68 1.0 
3.8 
0.7 72 0.9 
0.8 76 0.6 
4.1 
0.6 71 1.4 
o. 7 58 1. 4 
3.3 
5.4 14 3.0 
3.7 
3.7 15 2.3 
2.5 
3.3 27 2.8 
2.5 
3.7 14 3.3 
3.4 
2.5 44 2.1 
2.8 
3.8 24 1.5 
3.6 
3.6 31 2.2 
2.9 26 2.7 
3.8 
3.5 36 1.4 
3.5 
3.0 32 2.9 
4.0 
2.4 38 3.1 
3.3 
3.2 49 2.1 
3. 7 47 1.8 
3.6 
2.9 40 2.8 
2.9 23 2.7 
3.5 
5.2 6 
3.1 19 
5.9 7 
2.8 20 
3.8 32 
2.6 38 
2.9 35 
3.1 12 
4.7 21 
3.9 28 
4.1 14 
3.5 39 
4.2 38 
3.6 31 
3.9 13 
2.9 
4.3 
2.5 
3.1 
3.7 
2.2 
2.9 
3.3 
3.8 
2.9 
3.4 
4.1 
3.9 
2.9 
3.4 
3.7 
3.5 
4.3 
3.7 
4.1 
4.6 
3.5 
3.9 
4.4 
3.8 
4.2 
3.6 
CFR = coronary flow reserve; DS = percentage diameter 
stenosis; F = female; LAD = left anterior descending artery; 
LC = circumflex artery; M = male; OA = minimal cross-sectional 
obstruction area (mm2 ); pat= patient; PTCA =percutaneous 
transluminal angioplasty; R = right coronary artery. 
of the dilated coronary artery was restored to a normal level 
of greater or equal to 3.4, whereas in 4 of 15 patients (27%) 
coronary flow reserve was still abnormal (fig. 4 and 5). 
Coronary flow reserve 5 months after PTCA was related to the 
change in minimal cross-sectional obstruction area occurring 
between immediately after PTCA and at follow-up (linear 
regression analysis: r=0.61, SEE=0.46, fig 6). In 10 patients 
the minimal cross-sectional obstruction area 5 months after 
PTCA was larger than immediately following the procedure (late 
improvement) • Only one had a coronary flow reserve of less 
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CFR 
5 p<O. 001 ,.---------, p<O.Ol .--------. 
before after 
angioplasty 
Figure 3 
p=NS 
,.------, 
5 months 
follow up 
Coronary flow reserve (CPR) measured with digital subtraction cineangiography, 
before, immediately after and 5 months after percutaneous transluminal coronary 
angioplasty. The shaded bars represent the CPR of the myocardial region supplied by 
the dilated coronary artery. The open bars represent the CPR of an adjacent 
myocardial region supplied by a nondilated and angiographically normal coronary 
artery. 
CFR 
5 
4 
2 
0 0 
0 
0 
0~------------.------.------r-----.------.---
2 3 4 5 6 
Figure 4 
Coronary flow reserve (CPR) plotted against minimal cross-sectional obstruction 
area (OA) 5 months after percutaneous transluminal coronary angioplasty. The lower 
limit of the normal value for CPR as measured with the digital subtraction 
cineangiographic technique is 3.4. 
126 
CFR 
10 20 
Figure 5 
30 
DS (%) 
40 50 
Coronary flow reserve (CFR) plotted against percentage diameter stenosis (DS) 5 
months after percutaneous transluminal coronary angioplasty. The lower limit of the 
normal value for CFR as measured with the digital subtraction cineangiographic 
technique is 3.4. 
CFR 
5 
4 
3.4~~~~~~~~~~~~~~~~~~~~ 
3 0 0 0 
0 
2 
CFR=O. 29AOA+3. 4 
r=0.61 SEE=0.54 
0 
-1 0 3 
Figure 6 
Relation between coronary flow reserve ( CFR) 5 months after percutaneous 
transluminal angioplasty and the change that occurred in minimal cross-sectional 
obstruction area (D. OA) between immediately after percutaneous transluminal 
coronary angioplasty and 5 months later. The lower limit of the normal value for CFR 
as measured with the digital subtraction cineangiographic technique is 3.4. 
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than 3.4. In 5 patients the minimal cross-sectional obstruc-
tion area 5 months after PTCA was smaller than the area 
immediately following the procedure (late deterioration). The 
percentage of patients showing normalization of coronary flow 
reserve 5 months after PTCA is substantially higher (p less 
than 0. 05, Chi Square test) in the group with late angie-
graphic improvement (90%) compared to the group with late 
deterioration (40%). 
Table 2: Results: Coronary flow reserve of patients with 
anBioBraEhicallz normal coronarz arteries. 
Pat age sex vessel CFR 
1 38 M LAD 6.5 
2 41 M LC 6.2 
3 62 F LAD 5.3 
4 31 M R 5.2 
5 60 M LC 5.0 
6 63 M LC 5.0 
7 54 M LC 5.0 
8 48 M LC 4.0 
9 66 F LC 4.5 
10 52 M LAD 4.0 
11 59 M LAD 5.0 
12 59 M LC 4.8 
13 47 M LC 4.9 
14 58 M LAD 3.7 
15 59 M LAD 4.3 
16 54 F LC 6.4 
17 61 M LAD 4.9 
18 62 M R 4.8 
19 58 M LAD 4.7 
20 57 M R 4.6 
21 64 M LAD 4.5 
22 61 M LAD 3.4 
23 50 M LAD 6.3 
24 58 M LAD 4.0 
CFR coronary flow reserve; F female; LAD = left anterior 
descending coronary artery; LC = circumflex artery; M = male; 
R = right coronary artery. 
Discussion 
The purpose of the present study was to establish whether 
coronary flow reserve in a myocardial region supplied by a 
stenotic coronary artery could be restored to normal by PTCA. 
Immediately after PTCA coronary flow reserve is not normalized 
(11-14). In 11 of our 15 patients without angina and with 
normal exercise thallium scintigraphy 5 months after PTCA, 
coronary flow reserve was normalized. There are several 
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possible explanations for this phenomenon. 
First, since coronary flow reserve is a ratio between 
maximal coronary blood flow and resting flow, an increase in 
resting flow results in a decrease of this ratio. The radio-
graphic technique we used does not provide us with absolute 
measurements of volume flow and we therefore cannot draw any 
conclusion regarding the resting coronary volume flow after 
the PTCA procedure. However, several authors using the thermo-
dilution technique in the coronary sinus or the great cardiac 
vein have reported comparable resting volume flows before and 
after PTCA (24-26). 
Second, metabolic, humoral or myogenic factors may limit 
coronary flow reserve after PTCA. The metabolic derangements 
due to the PTCA seem quickly reversible, as shown by the fast 
decline of temporarily increased lactate, hypoxanthine and K+ 
concentrations (24,27), and are therefore not likely to be of 
major significance. Although humoral factors such as thrombo-
xane release (28) may influence vasoactive regulation in a 
specific subgroup of patients with complicated PTCA, so far no 
evidence has been presented for the persistence of humoral 
derangements after PTCA. The long-standing reduction in 
perfusion pressure distal to the stenotic lesion may induce 
alterations in the complex mechanism of coronary blood flow 
autoregulation (11), and a prolonged period of time might be 
needed before these abnormalities subside (29). 
Third, the impaired coronary flow reserve could be 
directly related to the severity of the residual stenosis. 
Cross sectional area as measured immediately after PTCA, 
generally is about threefold increased as a result of the 
procedure, but it remains grossly abnormal (30,31). In the 6 
months after PTCA important morphological changes may take 
place. Johnson et al (30) reported a late increase in cross-
sectional obstruction area in about one-third of their pa-
tients. In our selected group of patients with no angina an a 
normal exercise thallium scintigram, the percentage of pa-
tients with late angiographic improvement was even higher 
(66%). In a previous study in our laboratory the relationship 
between cross-sectional obstruction area and coronary flow 
reserve in patients with stable angina and single vessel 
coronary artery disease has been established (5). In figure 7 
this relation is shown with the results of the sequential 
coronary flow reserve and obstruction area measurements of the 
present study superimposed. The data of the present study are 
within the 95% confidence limits of the relation between flow 
reserve and obstruction area. Therefore, the persisting 
reduced obstruction area is by itself a sufficient explanation 
for the limited restoration of coronary flow reserve although 
it does not rule out other contributing pathophysiological 
mechanisms. 
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CFR 
6 
4 
2' 
0 
0 3 4 
Figure 7 
Relation between coronary flow reserve (CFR) and cross-sectional obstruction area 
(OA) as previously reported.5 The solid line is the best fit curve and the shaded area 
corresponds to the 95 % confidence limits. The mean values and standard deviations 
of coronary flow reserve and obstruction area as obtained in the present study, before 
percutaneous transluminal coronary angioplasty (circle), immediately after (square) 
and 5 months later (triangle), are plotted on this diagram. 
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Limitations 
There are two important limitations of coronary angio-
graphy in the setting of PTCA. Firstly, the changes in luminal 
size of an artery following the mechanical disruption of its 
internal wall may be difficult to assess by angiographic means 
(31,32). The irregular shape with intimal tears that fill with 
contrast medium to a variable extent will result in some 
overestimation of the true functional luminal size immediately 
following PTCA. Secondly, the extent of coronary atherosclero-
sis may be difficult to delineate angiographically. Me Pherson 
et al (33) documented that substantial intimal atherosclerosis 
resulting in diffuse obstructive disease that involves the 
entire length of an epicardial artery, is often present, even 
when angiograms reveal only discrete lesions. As a consequence 
relative measurements of stenosis severity are an inadequate 
approach to assessing the severity of coronary obstructions. 
This may explain why 4 of our PTCA patients with only very 
mild residual stenoses 5 months after PTCA still had an 
abnormal vasodilatory reserve. 
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CHAPTER 10: ASSESSMENT Of THE IMMEDIATE AND 
FUNCTIONAL RESULT OF PERCUTANEOUS TRANSLUMINAL 
ANGIOPLASTY. 
Abstract 
LONG-TERM 
CORONARY 
The assessment of the functional significance of coronary 
artery lesions during cardiac catheterization has recently 
become possible by calculating coronary flow reserve from the 
myocardial contrast appearance time and density in the resting 
and hyperemic states determined from digitized coronary cine-
angiograms. However, the inter- and intra-observer variabili-
ties, as well as the short-, medium-, and long-term variabili-
ties of the coronary flow reserve measurements have to be 
established prior to the use of this technique as a means of 
assessing the immediate and long-term functional results of 
revascularization procedures such as percutaneous transluminal 
coronary angioplasty (PTCA). Variability was d~fined as the 
mean difference and standard deviation of the difference 
between duplicate determinations of coronary flow reserve. The 
intraobserver variability (mean difference ± SD) in the 
measurement of coronary flow reserve was 0.01 ± 0.07. 
Interobserver variability by two observers was + 0.08 ± 0.52. 
Short-term variability based on the analysis of two coronary 
cineangiograms taken 5 min. apart was - 0.02 ± 0.26. Medium-
term variability (repeated coronary cineangiographies 1-3 
hours apart) was found to be - 0.06 ± 0.52. Long-term variabi-
lity (repeated coronary cineangiographies 3 to 5 months apart) 
was 0.11 ± 0. 63. Having established the reproducibility of 
this radiographic method, we studied the prospective changes 
in coronary flow reserve in 25 patients undergoing PTCA for 
single vessel coronary artery disease. Coronary flow reserve 
measurements and quantitative coronary cineangiography were 
performed before PTCA, immediately after PTCA and 3 to 5 
months later. PTCA resulted in an immediate increase in 
coronary flow reserve from 1,0 ± 0,3 to 2,3 ± 0,6 with a 
concommitant increase in obstruction area from 0, 9 ± 0, 3 to 
3,3 ± 0, 7 mm2 • Nine of our 25 patients developed restenosis 
defined as a diameter stenosis greater than 50% at follow-up. 
The other 16 patients had 3 to 5 months after PTCA a coronary 
flow reserve of 3 ,. 3 ± 0, 6. Coronary flow reserve measurement 
from digitized coronary cineangiograms is a reproducible 
method for the assessment of the physiological importance of 
coronary artery obstructions. Short-, medium-, and long-term 
investigations of the functional results of interventions such 
as pharmacological therapy or revascularization procedures can 
be performed reliably with this technique. 
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Introduction 
Since the introduction of percutaneous transluminal 
coronary angioplasty (PTCA) in 1977 (1), this procedure has 
gained increasing importance in the treatment of coronary 
artery obstructions. The immediate and long-term results of 
PTCA are usually assessed by visual interpretation of coronary 
angiograms. However, the visual interpretation of the coronary 
angiogram provides inadequate information about the physiolo-
gical importance of obstructive coronary artery disease (2), 
and is prone to inter- and intra-observer variations. Although 
computer-based quantitative analysis procedures have reduced 
the high interobserver and intraobserver variabilities (3,4) 
in the assessment of percent diameter stenosis and provides 
absolute data on the stenosis geometry (5), the physiological 
importance of a coronary stenosis can not be inferred from 
geometrical data alone (6, 7). Recently, measurement of the 
coronary flow reserve has been proposed as a better method to 
evaluate the hemodynamic repercussions of a coronary stenosis 
(7, 8). Three techniques have been developed that allow the 
measurement of regional coronary flow reserve during cardiac 
catheterization. The first uses a pulsed Doppler coronary 
artery catheter which can measure intracoronary blood flow 
velocity (9,10). The second technique is an indicator dilution 
technique with a platinum-tipped angioplasty guidewire, using 
hydrogen as the indicator (11). The third technique is based 
on the radiographic assessment of myocardial perfusion using 
contrast medium (6,12-16)". The major advantage of this tech-
nique is that no guide wires or other hardware need to be 
introduced into the coronary artery, so that it can be employ-
ed during routine cardiac catheterization. Although the 
technique is computer-based, a crucial component of the 
analysis procedure is the user-dependent selection of the 
boundaries of the regions of interest, making intra- and 
interobserver variability potential pitfalls. Knowledge about 
the short-, medium-, and long-term variabilities in the 
measurements of coronary flow reserve is an essential prere-
quisite, if this radiographic technique is to be used for the 
determination of the immediate and/or long-term functional 
results of pharmacological therapy or revascularization 
procedures such as PTCA. The aims of this investigation were: 
firstly, to determine the inter- and intraobserver variabili-
ties, as well as the short-, medium-, and long-term variabili-
ties in coronary flow reserve measurements from digitized 
coronary cineangiograms; secondly, to assess the immediate and 
long-term functional result of PTCA and its relation to 
quantitatively determined coronary stenosis geometry. 
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PATIENTS AND METHODS 
Patient selection 
Twenty-five patients underwent PTCA for disabling angina 
pectoris despite optimal pharmacological therapy. The right 
coronary artery was dilated in 5 patients, the circumflex 
artery in 5 patients and the left anterior descending artery 
in 15 patients. Their mean age (±SD) was 54 (±9) years. 
Twenty-four patients were male. Recatheterization was perfor-
med 3 to 5 months later, as part of an ongoing study on 
restenosis after PTCA. Informed consent was obtained for the 
additional investigations. Patients were selected on the basis 
of the following criteria: primary successful PTCA for single 
vessel coronary artery disease (residual diameter stenosis 
less than 50%) , normal blood pressure (mean aortic pressure 
ranged from 85 to 105 mmHg) , normal left ventricular wall 
motion with an ejection fraction of more then 55%, normal left 
ventricular end-diastolic pressure, no angiographic evidence 
of collateral circulation, cardiac hypertrophy, anemia, 
polycythemia, documented previous myocardial infarction, or 
valvular heart disease. 
Coronary flow reserve measurements 
The procedure for the coronary flow reserve measurement 
from digitized coronary cineangiograms recorded on 35 mm 
cinefilm has been implemented on the Cardiovascular Angio-
graphy Analysis System (13). The film speed was 25 frames/s 
with a pulse time of 4 ms. For the right coronary artery a 
left or right anterior oblique projection was used, for the 
left coronary artery a left anterior oblique projection. The 
X-ray gantry settings were standardized in the short- and 
medium-term variability studies. This resulted in a good 
reproducibility of isocenter-image intensifier distance, 
focus-isocenter distance and obj ect-isocenter distance (see 
table 1). Voltage (kV) and current (rnA) of the X-ray generator 
are adjusted automatically in our catheterization laboratory 
by a microprocessor system, during the first 3 or 4 cineframes 
of each cinerun (17). The on-line recorded voltage and current 
are than held constant during the cinerun. This microprocessor 
based technique used results in good reproducibility of both 
voltage and current of the X-ray generator (see table 1). The 
heart was atrially paced at a rate just above the spontaneous 
heart rate, ranging from 70 to 90 beats/min. An EGG-triggered 
injection into the coronary artery was performed with iopami-
dol at 37cC through a Medrad Mark IV infusion pump. This 
non-ionic contrast agent has a viscosity of 9.4 cP at 37°, an 
osmolality of 0.796 osm/kg and an iodine content of 370 
mg/ml. The injection rate and volume of the contrast medium 
were judged to be adequate when back flow of contrast medium 
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Table 1: Variability in X-ray gantry settings and voltage and 
current of the X-ray generator, with repeated 
cineangiographic studies (n = 20). 
overall mean SD 
mean value difference p-va1ue diff. 
LAO (degrees) 53 0.1 NS 0.2 
IID (em) 23.6 - 0.1 NS 2.0 
FID (em) 72.3 0.0 NS 0.1 
OlD (em) 5.4 0.0 NS 0.1 
'Voltage (kV) 71.2 0.1 NS 2. 9 
Current (mA) 717 - 5.5 NS 16.1 
LAO - left anterior oblique projection, liD Isocenter-Image 
intensifier distance; FID = Focus-Isocenter distance, OlD = 
Object-Isocenter distance, SD diff = standard deviation of the 
difference. 
into the aorta occurred. The injection rate ranged from 3 to 6 
ml/s and the injection volume ranged from 5 to 9 ml, depending 
on the size of the coronary artery. The angiogram was repeated 
with identical patient position and X-ray gantry settings, 30 
s after pharmacologically induced hyperemia by a bolus injec-
tion of 12.5 mg papaverine into the coronary artery (12). Five 
or six end-diastolic cineframes were selected from successive 
cardiac cycles. Logarithmic non-magnified mask-mode background 
subtraction was applied to the image subset, to eliminate 
non-contrast medium densities. The last end-diastolic frame 
prior to contrast administration was chosen as the mask. From 
the sequence of background-subtracted images, a contrast 
arrival time image was determined, using an empirically 
derived fixed density threshold (13). Each pixel was labeled 
with the sequence number of the cardiac cycle in which the 
pixel intensity level for the first time exceeded the thres-
hold, starting from the- beginning of the ECG-triggered con-
trast injection. In addition to the contrast arrival time 
image, a density image was computed, with each pixel intensity 
value being representative for the maximal local contrast 
medium accumulation. The coronary flow reserve was defined as 
the ratio of the regional flow computed from a hyperemic image 
(Q(h)) divided by the regional flow of the corresponding 
baseline image (Q(b)). Regional flow values were quantitati-
vely determined from the relationship that regional blood flow 
equals regional vascular volume divided by the transit time 
(13). Regional vascular volume was assessed from the logarith-
mic mask-mode subtraction images, using the Lambert-Beer 
relationship. Coronary flow reserve (CFR) can then be calcu-
lated as: 
CFR Q(h) /Q(b) D (h) /D (b) T(h)/T(b) 
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where D is the mean contrast density and T the mean appearance 
time at baseline (b) and hyperemia (h). Mean contrast medium 
appearance time and density were computed within user-defined 
regions of interest that were chosen in such a way that the 
epicardial coronary arteries visible on the angiogram, the 
coronary sinus and the great cardiac vein were excluded from 
the analysis (13). For each of the 3 major coronary arteries 
(right coronary artery, left anterior descending coronary 
artery, and circumflex artery) only one region of interest was 
chosen and analyzed. Normal values for coronary flow reserve 
as measured with this technique in our laboratory have pre-
viously been established (18). The mean coronary flow reserve 
of 24 angiographically normal coronary arteries was 5.0 (SD: ± 
0.6). A normal coronary flow reserve is therefore 3.4 (2 SD 
below 5.0). This is comparable to the values for normal coro-
nary flow reserve measured with intracoronary Doppler cathe-
ters as reported by Wilson et al (9,10). 
Intraobserver variability 
Intraobserver variability was assessed by measuring the 
coronary flow reserve in 11 regions of interest in 6 patients 
twice from the same cineangiograms by the same observer. In 5 
patients two regions of interest in the myocardium supplied by 
the left coronary artery were analyzed, and in one patient a 
region of interest was analyzed in the myocardium supplied by 
the right coronary artery. Care was taken to ensure that the 
regions of interest in the duplicate determinations were 
identical. 
Interobserver variability 
Interobserver variability was assessed by measuring the 
coronary flow reserve in 12 regions of interest in 7 patients 
from the same coronary cineangiograms by two observers. In 5 
patients two regions of interest in the myocardium supplied by 
the left coronary artery were analyzed, and in 2 patients a 
region of interest was analyzed in the myocardium supplied by 
the right coronary artery. The selected boundaries of the 
regions of interest were unknown to the other observer. 
Short-term variability (5 min.) 
The short-term variability was defined as the variation 
in measured coronary flow reserve from two coronary cineangio-
grams taken 5 min apart with identical position of patient, 
X-ray source and image intensifier. Coronary flow reserve was 
measured in 13 regions of interest in 7 patients. In 6 pa-
tients two regions of interest in the myocardium supplied by 
the left coronary artery were analyzed, and in one patient a 
region of interest was analyzed in the myocardium supplied by 
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the right coronary artery. Care was taken to ensure that the 
selected regions of interest in the duplicate determinations 
were identical. 
Medium-term variability (1-3 hours) and immediate functional 
result of PTCA 
Coronary flow reserve was measured before and immediately 
after PTCA in 25 patients. In 5 patients the right coronary 
artery was dilated. In 20 patients undergoing PTCA of the left 
anterior descending coronary artery or the circumflex artery, 
coronary flow reserve was measured in both myocardial regions. 
To calculate the medium-term variability, regions of interest 
(n = 20) were chosen in the myocardium supplied by the non-
dilated coronary arteries. To assess the immediate alterations 
in coronary flow reserve due to PTCA, regions of interest (n = 
25) were chosen in the myocardium supplied by the dilated 
coronary arteries. During the PTCA procedure various vaso-
active drugs were administered (nitrates, Ca-antagonists) as 
clinically indicated, probably resulting in changes in vaso-
motor tone. Care was taken to ensure that cineangiographic 
projection and X-ray gantry settings as well as the analyzed 
regions of interest were identical before and after the PTCA. 
Long-term variability (3-5 months)and long-term functional 
result of PTCA 
During follow-up coronary cineangiography 3 to 5 months 
(mean 4, 2 months) later coronary flow reserve was measured 
again in these 25 patients. To calculate the long-term varia-
bility regions of interest (n = 20) were chosen in the myocar-
dium supplied by the non-dilated coronary arteries. To assess 
the long-term alterations in coronary flow reserve after PTCA 
regions of interest (n = 25) were chosen in the myocardium 
supplied by the dilated coronary arteries. The follow-up 
investigation was always performed in a second cineangio-
graphic room with different X-ray equipment. There was no 
standardized protocol for the administration of vasoactive 
medication before data acquisition; therefore, vasomotor tone 
in both conditions was unknown and ignored. Care was taken to 
ensure that identical regions of interest were analyzed. 
Quantitative coronary cineangiography 
The coronary arterial dimensions were determined before 
PTCA, immediately after PTCA and at follow-up, with the 
computer-based Cardiovascular Angiography Analysis System 
(5, 19). The boundaries of selected coronary artery segments 
were detected automatically from optically magnified and 
video-digitized regions of interest of a cineframe. Calibra-
tion of the diameter data in absolute values (mm) was achieved 
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by detecting the boundaries of a section of the contrast 
catheter and comparing the mean diameter in pixels with the 
known size in millimeter. Pincushion distortion was corrected. 
A computer estimation of the original arterial dimensions at 
the site of obstruction was used to define the reference re-
gion. The interpolated percentage diameter stenosis and the 
minimal cross-sectional area (mm2 ) at the site of obstruction 
were calculated by averaging the values from at least two, 
preferably orthogonal projections. 
Statistical analysis 
The results from the various studies were analyzed for 
significant differences with Student's t-test for paired 
observations (border of significance p = 0.05). Least squares 
linear repression on analysis were used to describe the 
relationships between coronary flow reserve measurements and 
the quantitatively determined coronary artery dimensions. 
RESULTS 
Intraobserver variability 
Figure 1 shows the results of measuring twice the coro-
nary flow reserve in 11 regions of interest in 6 patients by 
the same observer, from the same coronary cineangiograms. 
There is no significant difference between the first and 
second measurements. 
Interobserver variability 
Coronary flow reserve measurements by two observers 
without the knowledge of each others selected regions of 
interest using the same coronary cineangiograms in 12 regions 
in 7 patients is shown figure 2. There is no significant 
difference in the measurements between the two observers. 
Short-term variability (5 min.) 
Figure 3 gives the coronary flow reserve as measured in 
13 regions of interest in 7 patients from repeated acquisition 
and analysis of coronary cineangiograms taken 5 min apart. No 
significant differences between the two measurements were 
found. The hemodynamic data are shown in table 2. 
Medium-term variability (1-3 hours, n 20) 
Figure 4 provides the data on the coronary flow reserve 
measurements for a myocardial region supplied by a coronary 
artery not involved in the dilatation process in 20 patients 
immediately before and after angioplasty. No significant 
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coronary flow reserve, CFR 2° = second 2 
determination of coronary flow reserve, r 
= linear regression correlation coefficient, 
SEE = standard error of the estimate 
Fig. 2, 3,4 and5: abbreviations asinfig.l. 
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Table 2 
Hemodynamic data of short-term variability study (N=7). 
Pao 
HR 
Pao 
10 
97 ± 10 98 ± 9 
77 ± 12 77 ± 12 
mean aortic pressure (mmHg), HR 
Table 3 
difference 
1 ± 3 NS 
0 ± 0 NS 
heart rate (beats/min) 
Hemodynamic data of medium-term variability study (N=20) 
Pao 95 ± 12 
HR 79 ± 11 
91 ± 11 
79 ± 11 
Pao- mean aortic pressure (mmHg), HR 
Table 4 
difference 
4 ± 8 NS 
0 ± 0 NS 
heartrate (beats/min). 
Hemodynamic data of long-term variability study (N=20). 
Pao 91 ± 11 
HR 79 ± 11 
20 
97 ± 15 
81 ± 13 
difference 
6 ± 13 NS 
2 ± 8 NS 
Pao =mean aortic pressure (mmHg), HR heart rate (beats/min). 
differences were found between the measurements obtained 
before and after the angioplasty. The hemodynamic data are 
shown in table 3. 
Long-term variability (3-5 months, n = 20) 
Figure 5 gives the coronary flow reserve as measured in a 
myocardial region supplied by a non-dilated coronary artery, 
immediately following angioplasty as well as 3 to 5 months 
later. There is no significant difference between the two 
measurements. The hemodynamic data are shown in table 4. 
Immediate functional and anatomical result of PTCA (n = 25). 
Diameter stenosis (mean ± SD) decreased from 65 ± 6 to 32 
± 10%. The coronary flow reserves (mean ± SD) of the dilated 
coronary arteries increased from 1,0 ± 0,3 to 2,3 ± 0,6, and 
the cross-sectional area at the site of obstruction (mean ± 
SD) increased from 0,9 ± 0,3 to 3,3 ± 0,7 mm2 • The data of the 
individual patients are shown in figures 6 and 7. Eighteen of 
the 25 patients (72%) had an increase of coronary flow reserve 
greater than 2 SD of the medium-term variability. 
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CFR 
Figure 6. 
Cross-sectional area at the site of obstruction ( OA) and coronary flow reserve ( CFR) 
before and immediately after PTCA. 
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Relation between change in obstruction area (!::,. OA) and change in coronary flow 
reserve (!::,. CFR) as immediate result of PTCA. The vertical lines mark 1 SD of the 
medium-term variability. 
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Long-term functional and anatomical result of PTCA (n = 25). 
Three to five months after PTCA the mean percentage 
diameter stenosis (mean ± SD) was 38 ± 18%. The coronary flow 
reserve (mean ± SD) of the dilated coronary arteries was 2,6 ± 
1,0, and the cross-sectional area at the site of obstruction 
was 2,8 ± 1,4 mm2 • The alterations in these two parameters of 
the individual patients during the 3 to 5 months after PTCA 
are shown in figures 8 and 9. Nine of the 25 patients (36%) 
had restenosis defined as diameter stenosis greater than 50% 
during follow-up angiography. These 9 patients had an obstruc-
tion area (mean ± SD) of 1,3 ± 0,4 mm2 , and a coronary flow 
reserve of 1,5 ± 0,4. The patients without restenosis had an 
obstruction area of 3,6 ± 1,0 mm 2 and a coronary flow reserve 
of 3,3 ± 0,6. Seven of the 25 patients (28%) had an increase 
of coronary flow reserve greater than 2 SD of the long-term 
variability, and 4 of the 25 patients (16%), all with reste-
nosis, had a decrease of coronary flow reserve greater than 2 
SD of the long-term variability. 
DISCUSSION 
To understand the implications of coronary artery disease 
in an individual patient, the clinician must have information 
on anatomy as well as functional capacity of coronary arteries 
and left ventricle. Coronary flow reserve defined as the ratio 
of maximal to resting coronary blood flow has been introduced 
as measure of the functional capacity of coronary arteries 
(7,8). The relation between coronary artery anatomy and 
functional capacity/coronary flow reserve, has been extensi-
vely studied in animal models (20-22). Gould et al produced 
varying degrees of coronary narrowing and showed that stenoses 
in excess of 30-45% diameter narrowing reduced coronary 
vasodilator responses in a predictable fashion (22). Although 
the reduction in coronary flow reserve can be predicted by 
quantitative determination of stenosis geometry in selected 
patients with limited coronary artery disease (10,13), in many 
patients the functional capacity of their coronary arteries 
cannot be inferred from anatomical data alone. For instance, 
the functional capacity of a coronary artery with two or three 
obstructive lesions cannot be predicted by quantitative 
analysis of the coronary angiogram. This implies that accurate 
and reproducible means to measure regional coronary flow 
reserve are a necessary addition to quantitative coronary 
cineangiography. 
The first aim of the present study was to determine inter-, 
intra-, as well as short-, medium-, and long-term variability 
in radiographic coronary flow reserve measurements 
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CFR 
Figure 8. 
Cross-sectional area at the site of obstruction ( OA) and coronary flow reserve ( CFR) 
immediately after PTCA and 3 to 5 months later. 
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Multiple factors potentially contribute to these variabi-
lities. 
First, X-ray gantry settings and voltage and current of 
the X-ray generator must be identical to permit a valid 
comparison of the myocardial contrast density measurements on 
both the baseline and hyperemic cineangiograms. This is also a 
prerequisite if a comparison of two or more coronary flow 
reserve measurements at different times is to be made. The 
X-ray equipment used in this study seems adequate in this 
regard (table 1). 
Second, cine film development must be very stable. In our 
laboratories a 21 step (log 1.5 increment) sensitometric full 
frame strip is generated on each cinefilm with a dummy camera 
prior to the angiographic investigation. This strip is deve-
loped together with the angiographic data and is used to 
control the chemical process. The replenishment of developer 
is done per meter cinefilm instead of per unit of time and 
therefore independant of the speed of the machine. Together 
with accurate temperature control and the use of a medium 
grain developer, this results in a reliable chemical process 
characterized by a mean density of 0. 82 and a gradient of 
1.25. 
Third, many patient related factors are important determi-
nators of the measured coronary flow reserve and contribute to 
the variability of this radiographic method. Changes in heart 
rate may influence the coronary flow reserve (23,24). Further-
more, subtraction of the digitized selected end-diastolic 
cineframes is only possible when a strictly regular rhythm is 
present. Therefore, atrial pacing is mandatory. Changes in 
blood pressure can influence coronary flow reserve in two ways 
(8). Firstly, myocardial oxygen consumption and therefore 
baseline coronary blood flow is to a large degree determined 
by the systemic arterial pressure. Since coronary flow reserve 
is defined as the ratio of maximal to resting coronary blood 
flow, an increase in resting coronary blood flow as result of 
an increase in myocardial oxygen consumption results in a 
decrease of this ratio. Secondly, the coronary blood flow 
during maximal coronary vasodilation is linearly related to 
the coronary driving pressure (25). Cineangiograms that are 
used for the calculation of flow reserve during baseline and 
hyperemic conditions, or repeated radiographic coronary flow 
reserve measurements should thus be obtained with the same 
blood pressure. As shown in tables 2, 3 and 4 alterations in 
blood pressure or heart rate were negligible in this study. 
Coronary flow reserve measured in the animal laboratory can be 
reduced by a large increase in left ventricular diastolic 
pressure (8) or a marked change in contractility and systolic 
function (26). At present there are no data regarding the 
influence of abnormal systolic left ventricular function on 
coronary flow reserve in humans as measured with this radio-
graphic technique, but a study on coronary flow reserve after 
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reperfusion in the acute and chronic phase of myocardial 
infarction is currently underway at our institution. Prelimi-
nary results suggest a marked decrease in coronary flow 
reserve in both the acute and chronic phase of myocardial 
infarction. As all patients in the present study had a normal 
left ventricular function, it seems unlikely that these 
factors play a role in the variabilities described in this 
report. Medium-, and long-term variabilities are certainly 
affected by changes in vasomotor tone (27,28). Alterations in 
collateral channel filling patterns during and after angio-
plasty may also play a role. Although we excluded patients 
with angiographically visible collaterals, collateral vessels 
not visible by standard angiographic techniques are often 
present (29). Especially the long-term study might be influen-
ced by changes in neurohumoral factors. Endothelium derived 
relaxing factor has a physiological dilator role by acting as 
a local autocoid on subjacent smooth muscle and may be an 
important controlling variable in coronary flow and flow 
reserve (30,31). 
Fourth, an prerequisite of this radiographic technique is 
the use of an ECG triggered pump to inject a fixed volume at a 
fixed contrast injection rate (6,15). Although injection of a 
radiographic contrast agent induces profound alterations in 
coronary blood flow (32) , the ratio of hyperemic coronary 
blood flow to baseline flow is unaffected by the contrast 
agent during the first 5 s after injection when injection rate 
and volume are identical in hyperemic and baseline conditions 
(15,16). The injection rate and volume should be sufficient to 
ensure complete filling of the epicardial coronary arteries 
with contrast during pharmacologically induced hyperemia 
(6,15,16). The disturbance in coronary blood flow due to the 
radiographic contrast agent lasts for less then 20 s, and 
sequential injections of contrast agent in doses as used in 
this investigation do not result in persisting changes in 
coronary blood flow (32,33,34). 
Fifth, the method of induction of an hyperemic response 
in the coronary circulation should be reproducible. Intracoro-
nary papaverine induces a strong and short-lasting hyperemia 
that is reasonably reproducible in magnitude as well as in 
timing (35). Wilson and White (36) recently investigated the 
dose of intracoronary papaverine needed to produce maximal 
coronary vasodilation and reported a maximal hyperemic respon-
se after 8 mg in most coronary arteries and after 12 mg in all 
coronary arteries. 
Sixth, the analysis of the cineang:ipgram to permit calcu-
lation of coronary flow reserve from measured myocardial con-
trast appearance time and density involves the selection of 
end-diastolic cineframes, digitization and selection of a 
region of interest. The boundaries of the regions of interest 
are drawn by the observer with a writing tablet which is 
interfaced with the computer. Although the entire analysis 
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procedure can be performed with high reproducibility (see 
figure 1), the observer-dependent selection of the boundaries 
of the regions of interest introduces interobserver variabi-
lity (figure 2). Consequently, rigid criteria should be 
applied to the selection of the boundaries of the regions of 
interest, preferably in an automated manner, not dependant on 
the user. 
The second aim of the present study was to assess the 
immediate and long-term functional result of PTCA. 
Although PTCA resulted in an immediate increase of 
coronary flow reserve from 1, 0 ± 0, 3 to 2, 3 ± 0, 6, coronary 
flow reserve in the myocardium supplied by the dilated coro-
nary artery immediately after PTCA was still substantially 
lower than the coronary flow reserves of the myocardium 
supplied by non-dilated and angiographically not significantly 
diseased coronary arteries (diameter stenosis less than 50%) 
that was 3,2 ± 0,9 (see figure 4). During the 3 to 5 months 
follow-up 9 patients developed restenosis defined as a dia-
meter stenosis greater than 50%. The other 16 patients had 5 
months after PTCA a coronary flow reserve of the dilated 
coronary arteries of 3,3 ± 0,6, which is comparable to the 
coronary flow reserve of adjacent myocardial regions, supplied 
by non-dilated coronary arteries of these patients. There are 
several possible explanations for the limited restoration of 
coronary flow reserve immediately after PTCA. Since coronary 
flow reserve is a ratio between maximal and resting flow, an 
increase in resting flow results in a decrease of this ratio. 
Although several authors- using the thermodilution technique 
have reported comparable volume flows before and after PTCA 
(33, 34), recent work performed in our laboratory (37) with 
intracoronary Doppler catheters, suggests that resting coro-
nary blood flow velocity increases during the PTCA procedure. 
Further studies are necessary to resolve this controversy. 
Metabolic, humoral or myogenic factors may limit coronary flow 
reserve after PTCA. The metabolic derangements due to the PTCA 
seem quickly reversible, as shown by the fast decline of 
temporarily increased lactate, hypoxanthine and K+ concentra-
tions (33, 38) • The long-standing reduct on in perfusion pres-
sure distal to the stenotic lesion may induce alterations in 
the complex mechanism of coronary blood flow autoregulation 
(39), and a prolonged period of time might be needed before 
these abnormalities subside (40). Finally, the impaired 
coronary flow reserve could be directly related to the resi-
dual stenosis. The cross-sectional obstruction area measured 
immediately after PTCA, generally is about threefold increased 
as result of the procedure but remains grossly abnormal 
(18,19,41). 
Although changes in cross-sectional area due to the PTCA 
procedure do not particularly correlate absolutely with 
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changes in coronary flow reserve. there is nevertheless a 
tendency towards changes in the same direction despite the 
marked scatter of the data, see figure 7. In the 6 months 
after PTCA important morphological changes may take place. 
Johnson et al (41) reported a late increase in obstruction 
area in about 1/3 of their patients. Nine of our 25 patients 
had a late increase in obstruction area. The relation we found 
between the change in obstruction area and the change in flow 
reserve occuring between immediately after PTCA and 3 to 5 
months later, suggests that these morphological alterations 
,play an important role in the restoration of coronary flow 
reserve (see figure 9). 
There are two important limitations of coronary angio-
graphy in the setting of PTCA. Firstly, the mechanical disrup-
tion of its internal wall may be difficult to assess by 
angiographic means (19,42). The irregular shape with intimal 
tears that fill with contrast medium to a variable extent will 
result in some overestimation of the true functional luminal 
size immediately following PTCA. Secondly, the extent of 
coronary atherosclerosis may be difficult to delineate angie-
graphically. McPherson et al (43) documented that substantial 
intimal atherosclerosis resulting in diffuse obstructive 
disease that involves the entire length of an epicardial arte-
ry is often present, even when angiograms reveal only discrete 
lesions. This may explain why despite only minimal residual 
stenosis, our patients that had no restenosis, had a coronary 
flow reserve of the dilated as well as the non-dilated coro-
nary arteries still somewhat lower than the normal values for 
coronary flow reserve as previously reported (9,13,18). 
Conclusion 
Coronary flow reserve measurement from digitized coronary 
cineangiograms is a reproducible means to assess the functio-
nal capacity of coronary arteries. Short-, medium-, and long-
term investigations of the functional results of interventions 
such as PTCA can be performed reliably with this technique. 
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Samenvatting 
In 1959 ontwikkelde Sones de selectieve coronaire angio-
grafie. Tot nu toe is deze techniek de enige marlier gebleven 
die ons in staat stelt de aanwezigheid en de ernst van ver-
nauwingen in de kransslagaderen met een adequate resolutie af 
te beelden. Daardoor is coronaire angiografie het belangrijk-
ste hulpmiddel geworden dat de cardioloog ter beschikking 
staat bij het nemen van beslissingen. omtrent het te voeren 
beleid bij patienten met aandoeningen van de kransslagaderen. 
De relatie tussen de angiografische ernst van een vernauwing 
en de daaruit voortkomende vermindering of beperking van de 
doorbloeding van de kransslagader is echter nog steeds een 
onzekere faktor. 
In hoofdstuk 1 worden de vorm en de functie van de 
coronaire circulatie in het kort beschreven. Het concept van 
de coronaire doorstromingsreserve wordt geschetst. De vele 
methoden die parameters van de coronaire doorstroming meten, 
worden beschreven met nadruk op radiologische technieken. Een 
essentieel onderdeel van alle methoden om de coronaire 
doorstromingsreserve te meten is de pharmacologische inductie 
van een (kort-durende) maximale coronaire doorstroming. De 
waarde en de beperkingen van intracoronaire toediening van 
papaverine en adenosine voor de bepaling van de doorstromings-
reserve worden respectievelijk beschreven in hoofdstukken 2 en 
3 en hoofdstuk 4. 
In hoofdstuk 5 wordt de radiologische bepaling van de 
coronaire doorstromingsreserve in detail beschreven, en wordt 
een eerste poging ondernomen de coronaire doorstromingsreserve 
te relateren aan kwantitatief bepaalde afmetingen van de 
kransslagaderen. Afbeelding van de hartspier middels thallium-
201 tijdens en na inspanning is een belangrijke, niet-bloedige 
manier om de fysiologische betekenis van een vernauwing in een 
kransslagader te bepalen. In hoofdstuk 6 worden de resultaten 
van de toepassing van deze techniek bij 38 patienten verge-
leken met de gemeten coronaire doorstromingsreserve en kwanti-
tatief bepaalde afmetingen van de kransslagaderen. In hoofd-
stuk 7 worden de relaties tussen de kwantitatief bepaalde 
afmetingen van de kransslagaderen en de coronaire doorstro-
mingsreserve beschreven bij 81 patienten. Tevens wordt een 
poging gedaan de resultaten van deze invasieve methoden te 
relateren aan de klinische uitingen van vernauwingen van de 
kransslagaderen, namelijk angina pectoris en niet-invasief 
verkregen aanwij zingen voor het bestaan van een tekortschie-
tende doorstroming van de hartspier. 
Sinds de introductie van ballondilatatie van de kransslag-
aderen in 1977, is deze behandeling uitgegroeid tot een van de 
belangrijkste behandelingsmogelijkheden voor patienten met 
vernauwingen van de kransslagaderen. Geslaagde ballondilatatie, 
gedefinieerd als een residuele vernauwing van minder dan 50% 
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van de diameter van de kransslagader, leidt tot duidelijke 
verbetering in de klinische toestand van de patient. Of deze 
behandeling de doorbloeding van de hartspier echter geheel kan 
normaliseren werd aanvankelijk betwijfeld. Dit probleem komt 
aan de orde in de hoofdstukken 8,9 en 10. In hoofdstuk 8 wordt 
de doorstromingsreserve voor en onmiddellijk na ballondilata-
tie gemeten met 2 technieken: de radiologische techniek en 
intracoronaire stroomsnelheidsmeting middels het Doppler-
effekt. In hoofdstuk 9 wordt aangetoond dat bij geselecteerde 
patienten de coronaire doorstromingsreserve na ballondilatatie 
op langere termijn normaal kan worden. In hoofdstuk 10 worden 
de functionele resultaten van ballondilatatie op korte en 
lange termijn bij 25 patienten in detail beschreven. Tevens 
wordt de variabiliteit van de radiologische techniek om de 
coronaire doorstromingsreserve te meten, beschreven. 
Dit proefschrift beschrijft de implementatie en validatie 
van een radiologische techniek die, gebruikmakend van selec-
tieve coronairangiografie, de mE!ting van de coronaire door-
stromingsreserve mogenlijk maakt tijdens een hartcatheteri-
satie. Deze techniek is een praktische en waardevolle toevoeg-
ing aan de angiografische visualisatie van de kransslagaderen. 
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